 EXHIBIT 2.1        

 

Exhibit 2.1

  

Execution Version

  

  

AGREEMENT AND PLAN OF MERGER

  

  

AMONG 
 

  

  

BAXTER INTERNATIONAL INC., 
 

  

  

TWINS MERGER SUB, INC. 
 

  

  

AND 
 

  

  

SYNOVIS LIFE TECHNOGIES, INC. 
 

  

  

Dated as of December 12, 2011

   
 

 

 

 

  

   

  

 

 

 

  

  

AGREEMENT OF PLAN AND MERGER

  

  

TABLE OF CONTENTS

  

  

 

     |  |  |  |  

Page

   
---|---|---|---|--- 
  

ARTICLE I THE MERGER

  |  |  

1

   
   |  |  |  |   
  

Section 1.1

  |  |  

The Merger

  |  |  

1

   
  

Section 1.2

  |  |  

Effective Time

  |  |  

2

   
  

Section 1.3

  |  |  

Effects of the Merger

  |  |  

2

   
  

Section 1.4

  |  |  

Charter and Bylaws; Directors and Officers

  |  |  

2

   
  

Section 1.5

  |  |  

Conversion of Securities

  |  |  

2

   
  

Section 1.6

  |  |  

Exchange of Shares

  |  |  

3

   
  

Section 1.7

  |  |  

Withholding

  |  |  

4

   
  

Section 1.8

  |  |  

Return of Exchange Fund

  |  |  

5

   
  

Section 1.9

  |  |  

Adjustment of Per Share Merger Consideration

  |  |  

5

   
  

Section 1.10

  |  |  

No Further Ownership Rights in Company Common Stock

  |  |  

5

   
  

Section 1.11

  |  |  

Closing of Company Transfer Books

  |  |  

5

   
  

Section 1.12

  |  |  

Lost Certificates

  |  |  

5

   
  

Section 1.13

  |  |  

Further Assurances

  |  |  

6

   
  

Section 1.14

  |  |  

Closing

  |  |  

6

   
  

Section 1.15

  |  |  

Tax Treatment

  |  |  

6

   
   |  |  |  |   
  

ARTICLE II REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

  |  |  

6

   
   |  |  |  |   
  

Section 2.1

  |  |  

Organization, Standing and Power

  |  |  

6

   
  

Section 2.2

  |  |  

Authority

  |  |  

7

   
  

Section 2.3

  |  |  

Consents and Approvals; No Violation

  |  |  

7

   
  

Section 2.4

  |  |  

Information Supplied

  |  |  

8

   
  

Section 2.5

  |  |  

Financing

  |  |  

8

   
  

Section 2.6

  |  |  

Operations of Merger Sub

  |  |  

8

   
  

Section 2.7

  |  |  

No Other Representations; Non-Reliance

  |  |  

8

   
   |  |  |  |   
  

ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  |  |  

9

   
   |  |  |  |   
  

Section 3.1

  |  |  

Organization, Standing and Power

  |  |  

9

   
  

Section 3.2

  |  |  

Capital Structure

  |  |  

9

   
  

Section 3.3

  |  |  

Authority

  |  |  

11

   
  

Section 3.4

  |  |  

Consents and Approvals; No Violation

  |  |  

11

   
  

Section 3.5

  |  |  

SEC Documents and Other Reports; Internal Controls and Procedures

  |  |  

12

   
  

Section 3.6

  |  |  

Information Supplied

  |  |  

14

   
  

Section 3.7

  |  |  

No Undisclosed Liabilities

  |  |  

14

   
  

Section 3.8

  |  |  

Absence of Certain Changes or Events

  |  |  

15

   
 

  

  

 

 

 

  

   

  

 

 

 

  

     

Section 3.9

  |  |  

Litigation

  |  |  

15

   
---|---|---|---|--- 
  

Section 3.10

  |  |  

Permits and Compliance

  |  |  

15

   
  

Section 3.11

  |  |  

Properties

  |  |  

16

   
  

Section 3.12

  |  |  

Tax Matters

  |  |  

16

   
  

Section 3.13

  |  |  

Certain Agreements

  |  |  

18

   
  

Section 3.14

  |  |  

ERISA

  |  |  

22

   
  

Section 3.15

  |  |  

Compliance with Worker Safety and Environmental Laws

  |  |  

24

   
  

Section 3.16

  |  |  

Labor Matters

  |  |  

24

   
  

Section 3.17

  |  |  

Intellectual Property

  |  |  

25

   
  

Section 3.18

  |  |  

Information Technology; Security and Privacy

  |  |  

26

   
  

Section 3.19

  |  |  

Insurance

  |  |  

26

   
  

Section 3.20

  |  |  

Opinion of Financial Advisor

  |  |  

27

   
  

Section 3.21

  |  |  

State Takeover Statutes

  |  |  

27

   
  

Section 3.22

  |  |  

Required Vote of Company Shareholders

  |  |  

27

   
  

Section 3.23

  |  |  

Brokers

  |  |  

27

   
  

Section 3.24

  |  |  

Regulatory Compliance

  |  |  

27

   
  

Section 3.25

  |  |  

Relationships with Customers and Suppliers

  |  |  

30

   
  

Section 3.26

  |  |  

Rights Agreement

  |  |  

30

   
   |  |  |  |   
  

ARTICLE IV COVENANTS RELATING TO CONDUCT OF BUSINESS

  |  |  

30

   
   |  |  |  |   
  

Section 4.1

  |  |  

Conduct of Business Pending the Merger

  |  |  

30

   
  

Section 4.2

  |  |  

No Solicitation

  |  |  

34

   
  

Section 4.3

  |  |  

Third Party Standstill Agreements

  |  |  

38

   
   |  |  |  |   
  

ARTICLE V ADDITIONAL AGREEMENTS

  |  |  

38

   
   |  |  |  |   
  

Section 5.1

  |  |  

Preparation of the Proxy Statement

  |  |  

38

   
  

Section 5.2

  |  |  

Company Shareholder Meeting

  |  |  

39

   
  

Section 5.3

  |  |  

Access to Information; Confidentiality

  |  |  

40

   
  

Section 5.4

  |  |  

Company Stock Options and ESPP

  |  |  

40

   
  

Section 5.5

  |  |  

Reasonable Best Efforts

  |  |  

42

   
  

Section 5.6

  |  |  

HSR and Competition Filings.

  |  |  

42

   
  

Section 5.7

  |  |  

Public Announcements

  |  |  

43

   
  

Section 5.8

  |  |  

State Takeover Laws

  |  |  

44

   
  

Section 5.9

  |  |  

Indemnification; Directors and Officers Insurance

  |  |  

44

   
  

Section 5.10

  |  |  

Notification of Certain Matters

  |  |  

44

   
  

Section 5.11

  |  |  

Employee Benefit Plans and Agreements

  |  |  

45

   
  

Section 5.12

  |  |  

Tax and Accounting Matters

  |  |  

46

   
  

Section 5.13

  |  |  

Certain Litigation

  |  |  

46

   
   |  |  |  |   
  

ARTICLE VI CONDITIONS PRECEDENT TO THE MERGER

  |  |  

46

   
   |  |  |  |   
  

Section 6.1

  |  |  

Conditions to Each Party's Obligation to Effect the Merger

  |  |  

46

   
  

Section 6.2

  |  |  

Conditions to Obligation of the Company to Effect the Merger

  |  |  

47

   
  

Section 6.3

  |  |  

Conditions to Obligations of Parent and Merger Sub to Effect the Merger

  |  |  

47

   
  

  

 

 

 

  

   

  

 

 

 

  

     

ARTICLE VII TERMINATION, AMENDMENT AND WAIVER

  |  |  

48

   
---|---|--- 
   |  |  |  |   
  

Section 7.1

  |  |  

Termination

  |  |  

48

   
  

Section 7.2

  |  |  

Effect of Termination

  |  |  

50

   
  

Section 7.3

  |  |  

Payments.

  |  |  

50

   
  

Section 7.4

  |  |  

Amendment

  |  |  

51

   
  

Section 7.5

  |  |  

Waiver

  |  |  

51

   
   |  |  |  |   
  

ARTICLE VIII GENERAL PROVISIONS

  |  |  

52

   
   |  |  |  |   
  

Section 8.1

  |  |  

Non-Survival of Representations and Warranties

  |  |  

52

   
  

Section 8.2

  |  |  

Notices

  |  |  

52

   
  

Section 8.3

  |  |  

Interpretation

  |  |  

53

   
  

Section 8.4

  |  |  

Counterparts

  |  |  

53

   
  

Section 8.5

  |  |  

Entire Agreement; No Third-Party Beneficiaries

  |  |  

54

   
  

Section 8.6

  |  |  

Governing Law

  |  |  

54

   
  

Section 8.7

  |  |  

Specific Performance; Submission To Jurisdiction

  |  |  

54

   
  

Section 8.8

  |  |  

Waiver of Jury Trial

  |  |  

54

   
  

Section 8.9

  |  |  

Assignment

  |  |  

55

   
  

Section 8.10

  |  |  

Expenses

  |  |  

55

   
  

Section 8.11

  |  |  

Severability

  |  |  

55

   
  

Section 8.12

  |  |  

Definitions

  |  |  

55

   
 

  


 

  


 

  

    

Exhibit A

  |  

Form of Voting Agreement

   
---|--- 
 

  

    

Exhibit B

  |  

Amended and Restated Articles of Incorporation of the Surviving Corporation

   
---|--- 
 

   
 

 

 

 

  

   

  

 

 

 

   
 

 

 

AGREEMENT AND PLAN OF MERGER

 

  


 

  

THIS AGREEMENT AND PLAN OF MERGER, dated as of December 12, 2011 (this
"Agreement"), is made by and among Baxter International Inc., a Delaware
corporation ("Parent"), Twins Merger Sub, Inc., a Minnesota corporation and a
wholly owned subsidiary of Parent ("Merger Sub"), and Synovis Life
Technologies, Inc., a Minnesota corporation (the "Company").

  

  

W I T N E S S E T H:

  

  

WHEREAS, the respective Boards of Directors of Parent, Merger Sub and the
Company have approved and declared advisable the merger of Merger Sub with and
into the Company (the "Merger"), upon the terms and subject to the conditions
set forth herein, whereby each issued and outstanding share of common stock,
$.01 par value, of the Company ("Company Common Stock") not owned directly or
indirectly by Parent or any Subsidiary of the Company, except shares of
Company Common Stock held by holders who comply with the provisions of the
Minnesota Business Corporation Act (the "MBCA") regarding the right of
shareholders to dissent from the Merger, will be converted into the right to
receive the Per Share Merger Consideration (as hereinafter defined);

  

  

WHEREAS, the Board of Directors of the Company (i) has determined that the
Merger is advisable and in the best interest of the Company and its
shareholders, (ii) has approved this Agreement, the plan of merger (as such
term is used in Section 302A.611 of the MBCA) contained in this Agreement (the
"Plan of Merger") and the Merger upon the terms and subject to the conditions
set forth in this Agreement and (iii) is recommending that the Company's
shareholders approve the Merger and adopt the Plan of Merger, as applicable;
and

  

  

WHEREAS, simultaneously with the execution and delivery of this Agreement and
as a condition and inducement to Parent's and Merger Sub's willingness to
enter into this Agreement, Parent is entering into a voting agreement with the
members of the Board of Directors of the Company and certain officers of the
Company, substantially in the form attached hereto as Exhibit A (each, a
"Voting Agreement").

  

  

NOW, THEREFORE, in consideration of the representations, warranties, covenants
and agreements herein contained, the parties agree as follows:

  

  

ARTICLE I

  

  

THE MERGER

  

  

Section 1.1 The Merger. Upon the terms and subject to the conditions set forth
in this Agreement, and in accordance with the MBCA, Merger Sub shall be merged
with and into the Company at the Effective Time (as hereinafter defined).
Following the Merger, the separate corporate existence of Merger Sub shall
cease and the Company shall continue as the surviving corporation (the
"Surviving Corporation") and shall succeed to and assume all the rights and
obligations of Merger Sub in accordance with the MBCA.

  

   
 

 

 

 

  

   

  

 

 

 

   
 

Section 1.2 Effective Time. The Merger shall become effective when the
articles of merger (the "Articles of Merger"), executed in accordance with the
relevant provisions of the MBCA, are filed with the Secretary of State of the
State of Minnesota; provided, however, that, upon the mutual consent of Merger
Sub and the Company, the Articles of Merger may provide for a later date or
time of effectiveness of the Merger. The filing of the Articles of Merger
shall be made on the date of the Closing (as hereinafter defined).

  

  

Section 1.3 Effects of the Merger. The Merger shall have the effects set forth
in this Agreement and in Section 302A.641 of the MBCA.

  

  

Section 1.4 Charter and Bylaws; Directors and Officers.

  

  

(a) At the Effective Time, the Restated Articles of Incorporation, as amended,
of the Company shall be amended as set forth in Exhibit B and, as so amended,
shall be the Amended and Restated Articles of Incorporation of the Surviving
Corporation until thereafter changed or amended as provided therein by the
MBCA or any other applicable foreign, federal, state, local or municipal laws,
statutes, ordinances, regulations and rules of any Governmental Entity,
including all Orders ("Laws"). At the Effective Time, the Bylaws of Merger
Sub, as in effect immediately prior to the Effective Time, shall become the
Amended and Restated Bylaws of the Surviving Corporation until thereafter
changed or amended as provided therein or in the Amended and Restated Articles
of Incorporation of the Surviving Corporation.

  

  

(b) The directors and officers of Merger Sub at the Effective Time shall be
the directors and officers of the Surviving Corporation, until the earlier of
their resignation or removal or until their respective successors are duly
elected and qualified, as the case may be.

  

  

Section 1.5 Conversion of Securities. At the Effective Time, by virtue of the
Merger and without any action on the part of Parent, Merger Sub, the Company
or the holders of any securities of Parent, Merger Sub or the Company:

  

  

(a) Each issued and outstanding share of common stock, $.01 par value, of
Merger Sub shall be converted into one validly issued, fully paid and
nonassessable share of common stock of the Surviving Corporation.

  

  

(b) All shares of Company Common Stock ("Company Shares") that are held by any
wholly owned Subsidiary of the Company and any Company Shares owned by Parent
or any wholly owned Subsidiary of Parent shall be canceled and shall cease to
exist and no consideration shall be delivered in exchange therefor.

  

  

(c) Subject to the provisions of Section 1.9, each Company Share issued and
outstanding immediately prior to the Effective Time, other than Dissenting
Shares (as hereinafter defined) and shares to be canceled in accordance with
Section 1.5(b), shall be converted into the right to receive $28.00 in cash
without interest (the "Per Share Merger Consideration"). At the Effective
Time, all such Company Shares shall no longer be outstanding and shall
automatically be canceled and retired, and each holder of a certificate
representing any such shares shall cease to have any rights with respect
thereto, except the right to receive any Per Share Merger Consideration upon
the surrender of such certificate in accordance with Section 1.6.

  

   
 

 

 

 

  

 

-2-  

  

 

 

 

   
 

(d) Notwithstanding anything in this Agreement to the contrary, Company Shares
issued and outstanding immediately prior to the Effective Time which are held
of record by shareholders who shall not have approved the Merger and who shall
have properly exercised dissenters' rights in accordance with Sections
302A.471 and 302A.473 of the MBCA ("Dissenting Shares") shall not be converted
into the right to receive the Per Share Merger Consideration as set forth in
Section 1.5(c), but the holders thereof instead shall be entitled to, and the
Dissenting Shares shall only represent the right to receive, payment of the
fair value (including interest determined in accordance with Section 302A.473
of the MBCA) of such Dissenting Shares in accordance with the provisions of
Sections 302A.471 and 302A.473 of the MBCA; provided, however, that (i) if
such a holder fails to properly exercise dissenters' rights with respect to
his, her or its shares in accordance with Sections 302A.471 and 302A.473 of
the MBCA or, after making a demand for dissenters' rights, subsequently
delivers an effective written withdrawal of such demand, or fails to establish
his or its entitlement to dissenters' rights as provided in Sections 302A.471
and 302A.473 of the MBCA, if so required, or (ii) if a court shall determine
that such holder is not entitled to receive payment for his, her or its
Dissenting Shares or such holder shall otherwise lose his, her or its
dissenters' rights, then, in any such case, each share of Company Common Stock
held of record by such holder or holders shall automatically be converted into
and represent only the right to receive the Per Share Merger Consideration as
set forth in Section 1.5(c), upon surrender of the certificate or certificates
representing such Dissenting Shares. The Company shall give Parent and Merger
Sub prompt notice of any demands received by the Company pursuant to Section
302A.473 of the MBCA, and Parent and Merger Sub shall have the right to
participate in all negotiations and proceedings with respect to such demands,
except as required by applicable Law. The Company shall not, except with the
prior written consent of Parent, make any payment with respect to any demands
for fair value for Dissenting Shares or offer to settle, settle or negotiate
in respect of any such demands.

  

  

(e) Each Company Stock Option that is outstanding and unexercised immediately
prior thereto shall immediately and fully vest. Subject to the terms and
conditions set forth below in this Section 1.5(e), each such Company Stock
Option shall terminate and be cancelled at the Effective Time and each holder
of a Company Stock Option will be entitled to receive from the Company, and
Parent shall cause the Company to pay as soon as practicable (and in any event
within five Business Days) following the Effective Time, in settlement of each
Option a single lump sum cash payment equal to the net amount of (i) the
product of (A) the excess, if any, of the Per Share Merger Consideration over
the exercise price per share of such Company Stock Option, multiplied by (B)
the number of shares subject to such Company Stock Option, less (ii) any
income or employment Tax required to be withheld under any applicable state,
local, or foreign Tax Laws or any other applicable Law. If the exercise price
per share of any Company Stock Option equals or exceeds the Per Share Merger
Consideration, the Cash Amount therefor shall be zero and, for the avoidance
of doubt, such Company Stock Options shall terminate and be canceled at the
Effective Time.

  

  

Section 1.6 Exchange of Shares. Parent shall authorize a reputable bank or
trust company that is reasonably satisfactory to the Company to act as
Exchange Agent hereunder (the "Exchange Agent"). Promptly following the
Effective Time, Parent shall deposit with the Exchange Agent for exchange with
outstanding Company Shares all cash payable pursuant to Section 1.5(c) (such
cash deposit being hereinafter referred to as the "Exchange Fund"). The
Exchange Agent shall cause the Exchange Fund to be (i) held for the benefit of
the holders of Company Shares and (ii) promptly applied to making the payments
provided for in the agreement with the Exchange Agent. The Exchange Agent
shall invest any cash in the Exchange Fund as directed by Parent; provided,
however, that such investments shall be in obligations of or guaranteed by the
United States of America or any agency or instrumentality thereof and backed
by the full faith and credit of the United States of America, in commercial
paper obligations rated A-1 or P-1 or better by Moody's Investors Service,
Inc. or Standard and Poor's Corporation, respectively, or in certificates of
deposit, bank repurchase agreements or banker's acceptances of commercial
banks with capital exceeding $1 billion (based on the most recent financial
statements of such bank which are then publicly available). Any interest and
other income resulting from such investments shall be paid to Parent. To the
extent that there are losses with respect to such investments, or the Exchange
Fund diminishes for other reasons below the level required to make prompt
payments of the cash payable pursuant to Section 1.5(c) as contemplated
hereby, Parent shall promptly replace or restore the portion of the Exchange
Fund lost through investments or other events so as to ensure that the
Exchange Fund is, at all times, maintained at a level sufficient to make such
payments. The Exchange Agent shall deliver the Per Share Merger Consideration
contemplated to be paid pursuant to Section 1.5(c) out of the Exchange Fund.
Parent shall instruct the Exchange Agent, as soon as reasonably practicable
after the Effective Time (but in no event later than five Business Days
following the Effective Time), to mail to each record holder of Company
Shares, which at the Effective Time were converted into the right to receive
the Per Share Merger Consideration pursuant to Section 1.5(c), a letter of
transmittal (which shall specify that delivery shall be effected, and risk of
loss and title to the Company Shares shall pass, only upon actual delivery of
the Company Shares to the Exchange Agent, and shall contain instructions for
use in effecting the surrender of such Company Shares in exchange for the Per
Share Merger Consideration (the "Transmittal Letter")). Upon surrender for
cancellation to the Exchange Agent of its, his or her Company Shares, together
with the Transmittal Letter, duly completed and validly executed, the holder
of such Company Shares shall be entitled to receive in exchange therefor the
Per Share Merger Consideration to which such holder is entitled pursuant to
Section 1.5(c), and any Company Shares so surrendered shall forthwith be
canceled. If any portion of the Per Share Merger Consideration is to be paid
to any person other than the person in whose name the applicable surrendered
Company Share is registered, it shall be a condition to the payment thereof
that the surrendered Company Share be in proper form for transfer and that the
person requesting such payment of the Per Share Merger Consideration pay any
transfer or other similar Taxes required as a result of such payment to a
person other than the registered holder of such Company Share or establish to
the satisfaction of the Exchange Agent that such Tax has been paid or is not
payable. Until surrendered as contemplated by this Section 1.6, each Company
Share shall be deemed at any time after the Effective Time to represent only
the right to receive the Per Share Merger Consideration upon such surrender.
Except for interest required to be paid in respect of Dissenting Shares
pursuant to the MBCA, no interest shall be paid or will accrue on any cash
payable to holders of Company Shares pursuant to the provisions of this
Article I.

   
 

 

 

 

  

 

-3-  

  

 

 

 

   
 

Section 1.7 Withholding. Parent, Merger Sub, the Surviving Corporation or the
Exchange Agent shall be entitled to deduct and withhold from the consideration
otherwise payable pursuant to this Agreement (including any payments made in
respect of the Dissenting Shares) to any Person such amounts as Parent, Merger
Sub, the Surviving Corporation or the Exchange Agent is required to deduct and
withhold with respect to the making of such payment under the Code or under
any provision of state, local or foreign Tax Law. To the extent that amounts
are so withheld by Parent, Merger Sub, the Surviving Corporation or the
Exchange Agent, such withheld amounts shall be treated for all purposes of
this Agreement as having been paid to the Person who otherwise would have
received the payment in respect of which such deduction and withholding was
made by Parent, Merger Sub, the Surviving Corporation or the Exchange Agent.

  

  

 

 

 

  

 

-4-  

  

 

 

 

   
 

Section 1.8 Return of Exchange Fund. Any portion of the Exchange Fund which
remains undistributed to the former shareholders of the Company for six months
after the Effective Time shall be delivered to Parent, upon demand of Parent,
and any such former shareholders who have not theretofore complied with this
Article I shall thereafter look only to Parent for payment of their claim for
Per Share Merger Consideration. None of Parent, the Surviving Corporation or
the Exchange Agent shall be liable to any former holder of Company Common
Stock for any such Per Share Merger Consideration which is delivered to a
public official pursuant to any applicable abandoned property, escheat or
similar Law.

  

  

Section 1.9 Adjustment of Per Share Merger Consideration. In the event of any
reclassification, stock split, reverse stock split, division or subdivision of
shares, combination of shares, recapitalization, stock dividend or other
similar transaction (including the declaration of any such transaction) with
respect to Company Common Stock or any change or conversion of Company Common
Stock into other securities (or if a record date with respect to any of the
foregoing should occur) prior to the Effective Time (but excluding any change
that results from any exercise of Company Stock Options (as defined in Section
3.2(b)) or from the vesting and settlement of awards under the Company Stock
Plans (as defined in Section 5.4), in each case, outstanding as of the date
hereof), appropriate and proportionate adjustments, if any, shall be made to
the Per Share Merger Consideration, and all references to the Per Share Merger
Consideration in this Agreement shall be deemed to be to the Per Share Merger
Consideration as so adjusted.

  

  

Section 1.10 No Further Ownership Rights in Company Common Stock. Subject to
Section 1.5(d) hereof with respect to any Dissenting Shares, all Per Share
Merger Consideration paid upon the surrender for exchange of Company Shares in
accordance with the terms of this Agreement shall be deemed to have been paid
in full satisfaction of all rights pertaining to the Company Shares.

  

  

Section 1.11 Closing of Company Transfer Books. At the Effective Time, the
stock transfer books of the Company shall be closed, and no transfer of
Company Shares shall thereafter be made on the records of the Company. If,
after the Effective Time, certificates representing Company Shares are
presented to the Surviving Corporation, the Exchange Agent or Parent, such
certificates shall be canceled and exchanged as provided in this Article I.

  

  

Section 1.12 Lost Certificates. If any certificate representing any Company
Share(s) shall have been lost, stolen or destroyed, upon the making of an
affidavit of that fact by the Person claiming such certificate representing
Company Share(s) to be lost, stolen or destroyed and, if required by Parent or
the Exchange Agent, the posting by such Person of a bond, in such reasonable
amount as Parent or the Exchange Agent may direct as indemnity against any
claim that may be made against Parent, the Surviving Corporation or the
Exchange Agent with respect to such certificate, the Exchange Agent or Parent
will pay or cause to be paid in exchange for such lost, stolen or destroyed
certificate representing any Company Share(s) the Per Share Merger
Consideration to which the holder thereof is entitled.

  

  

 

 

 

  

 

-5-  

  

 

 

 

   
 

Section 1.13 Further Assurances. If at any time after the Effective Time the
Surviving Corporation shall consider or be advised that any deeds, bills of
sale, assignments or assurances or any other acts or things are necessary,
desirable or proper (a) to vest, perfect or confirm, of record or otherwise,
in the Surviving Corporation its right, title or interest in, to or under any
of the rights, privileges, powers, franchises, properties or assets of either
of Merger Sub or the Company or (b) otherwise to carry out the purposes of
this Agreement, the Surviving Corporation and its proper officers and
directors or their designees shall be authorized to execute and deliver, in
the name and on behalf of either Merger Sub or the Company, all such deeds,
bills of sale, assignments and assurances and to do, in the name and on behalf
of either Merger Sub or the Company, all such other acts and things as may be
necessary, desirable or proper to vest, perfect or confirm the Surviving
Corporation's right, title or interest in, to or under any of the rights,
privileges, powers, franchises, properties or assets of Merger Sub or the
Company and otherwise to carry out the purposes of this Agreement.

  

  

Section 1.14 Closing. The closing of the transactions contemplated by this
Agreement (the "Closing") and all actions specified in this Agreement to occur
at the Closing shall take place at the offices of Kirkland and Ellis LLP, 300 N.
LaSalle St., Chicago, IL 60654, at 10:00 a.m., local time, no later than the
second Business Day following the day on which the last of the conditions set
forth in Article VI shall have been fulfilled or waived (if permissible) or at
such other time and place as Parent and the Company shall agree.

  

  

Section 1.15 Tax Treatment. The parties agree and acknowledge that the Merger
will be treated as a taxable purchase of each of the Company Shares for the
Per Share Merger Consideration (and not as a reorganization within the meaning
of Section 368(a) of the Code) for United States federal, state and local
income Tax purposes.

  

  

ARTICLE II

  

  

REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

  

  

Parent and Merger Sub represent and warrant to the Company as follows:

  

  

Section 2.1 Organization, Standing and Power. Parent is a corporation duly
organized, validly existing and in good standing under the Laws of the State
of Delaware and has the requisite corporate power and authority to carry on
its business as now being conducted. Merger Sub is a corporation duly
organized, validly existing and in good standing under the Laws of the State
of Minnesota and has the requisite corporate power and authority to carry on
its business as now being conducted. Parent and Merger Sub are duly qualified
to do business, and are in good standing, in each jurisdiction where the
character of their properties owned or held under lease or the nature of their
activities makes such qualification or good standing necessary, except where
the failure to be so qualified and in good standing would not, individually or
in the aggregate, have a Parent Material Adverse Effect.

  

  

 

 

 

  

 

-6-  

  

 

 

 

   
 

Section 2.2 Authority. On or prior to the date of this Agreement, the Boards
of Directors of each of Parent and Merger Sub have approved this Agreement,
the Plan of Merger and the transactions contemplated hereby, including the
Merger. Each of Parent and Merger Sub has all requisite corporate power and
authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement by Parent
and Merger Sub and the consummation by Parent and Merger Sub of the
transactions contemplated hereby, including the Merger, have been duly
authorized by all necessary corporate action on the part of Parent and Merger
Sub, subject to the filing of appropriate merger documents as required by the
MBCA. This Agreement, the Plan of Merger and the consummation of the
transactions contemplated hereby have been approved by the sole shareholder of
Merger Sub. This Agreement has been duly executed and delivered by Parent and
Merger Sub and (assuming the valid authorization, execution and delivery of
this Agreement by the Company and the validity and binding effect of this
Agreement on the Company) except to the extent enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or similar
Laws affecting the enforcement of creditors' rights generally and by the
effect of general principles of equity (regardless of whether enforcement is
considered in a proceeding in equity or at law), this Agreement constitutes
the valid and binding obligation of Parent and Merger Sub enforceable against
each of them in accordance with its terms. Parent has delivered or made
available to the Company complete and correct copies of the Certificate of
Incorporation and Bylaws of Parent, and the Articles of Incorporation and
Bylaws of Merger Sub.

  

  

Section 2.3 Consents and Approvals; No Violation. Assuming that all consents,
approvals, authorizations and other actions described in this Section 2.3 have
been obtained and all filings and obligations described in this Section 2.3
have been made, the execution and delivery of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance with the
provisions of this Agreement will not, conflict with, result in any violation
of, or default (with or without notice or lapse of time, or both) under, or
give to others a right of termination, cancellation or acceleration of any
obligation or the loss of a material benefit under, or result in the creation
of any Encumbrance upon any of the properties or assets of Parent or any of
its Subsidiaries under, any provision of (i) the Certificate of Incorporation
or Bylaws of Parent or the Articles of Incorporation or Bylaws of Merger Sub;
(ii) any Contract applicable to Parent or any of its Subsidiaries or any of
their respective properties or assets; or (iii) any judgment, order, decree,
injunction, statute, Law, ordinance, rule or regulation applicable to Parent
or any of its Subsidiaries or any of their respective properties or assets,
other than, in the case of clauses (ii) or (iii), any such violations,
defaults, rights or Encumbrances that would not, individually or in the
aggregate, have a Parent Material Adverse Effect or materially impair or delay
the ability of Parent or Merger Sub to perform their respective obligations
hereunder or prevent the consummation of any of the transactions contemplated
hereby by Parent or Merger Sub. No filing or registration with, or
authorization, consent or approval of, any domestic (federal and state),
foreign court, commission, governmental body, regulatory agency, authority or
tribunal (a "Governmental Entity") is required by or with respect to Parent or
any of its Subsidiaries in connection with the execution and delivery of this
Agreement by Parent or Merger Sub or is necessary for the consummation by
Parent or Merger Sub of the Merger and the other transactions contemplated by
this Agreement, except for (i) in connection, or in compliance, with the
provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (together with the rules and regulations promulgated thereunder, the
"HSR Act") and the Securities Exchange Act of 1934 (together with the rules
and regulations promulgated thereunder, the "Exchange Act"); (ii) the filing
of the Articles of Merger with the Secretary of State of the State of
Minnesota and appropriate documents with the relevant authorities of other
states in which the Company or any of its Subsidiaries is qualified to do
business; (iii) such filings, authorizations, orders and approvals as may be
required by state takeover Laws (the "State Takeover Approvals"); (iv)
applicable requirements, if any, of state securities or "blue sky" Laws ("Blue
Sky Laws") and the New York Stock Exchange; (v) applicable requirements, if
any, under foreign Laws relating to antitrust and to competition clearances;
and (vi) such other consents, orders, authorizations, registrations,
declarations and filings the failure of which to be obtained or made would
not, individually or in the aggregate, have a Parent Material Adverse Effect
or materially impair or delay the ability of Parent or Merger Sub to perform
its obligations hereunder or prevent the consummation of any of the
transactions contemplated hereby by Parent or Merger Sub.

  

  

 

 

 

  

 

-7-  

  

 

 

 

   
 

Section 2.4 Information Supplied. None of the information to be supplied by
Parent or Merger Sub for inclusion or incorporation by reference in the proxy
statement included therein relating to the Company Shareholder Meeting (as
defined in Section 5.1(a)) (together with any amendments or supplements
thereto, the "Proxy Statement") will at the time of the mailing of the Proxy
Statement and at the time of the Company Shareholder Meeting, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not
misleading.

  

  

Section 2.5 Financing. Parent and Merger Sub have, and will at the Effective
Time have, sufficient funds available to pay (i) the aggregate Per Share
Merger Consideration (the "Merger Consideration") and (ii) to the Company such
amounts as are sufficient to pay holders of Company Stock Options in
accordance with Section 1.5(e) and Section 5.4.

  

  

Section 2.6 Operations of Merger Sub. Merger Sub is a direct, wholly owned
subsidiary of Parent, was formed solely for the purpose of engaging in the
transactions contemplated hereby, has engaged in no other business activities
and has conducted its operations only as contemplated hereby.

  

  

Section 2.7 No Other Representations; Non-Reliance. Parent acknowledges that
the Company has not made and is not making any representations or warranties
whatsoever regarding the subject matter of this Agreement, express or implied,
except as provided in this Agreement, the Company Letter or any agreement
entered into or certificate delivered pursuant to this Agreement, and that is
not relying and has not relied on any representations or warranties whatsoever
regarding the subject matter of this Agreement, express or implied, except
with respect to the representations and warranties set forth in this
Agreement, the Company Letter or any agreement entered into or certificate
delivered pursuant to this Agreement.

  

   
 

 

 

 

  

 

-8-  

  

 

 

 

   
 

ARTICLE III

  

  

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  

  

Except (i) as disclosed in the disclosure letter (with specific reference to
the particular Section or subsection of this Agreement to which the
information set forth in such disclosure letter relates; provided, however,
that any information set forth in one section of such disclosure letter shall
be deemed to apply to each other Section or subsection thereof to which its
relevance is reasonably apparent on its face) delivered by the Company to
Parent immediately prior to the execution of this Agreement (the "Company
Letter"), and (ii) subject to the last sentence of Section 8.3, as disclosed
in the Company SEC Documents (excluding any exhibit or schedule thereto) filed
with, or furnished to, the SEC since October 31, 2010 and prior to the date
hereof (provided that any disclosure in the Company SEC Documents shall
qualify the representations and warranties set forth in this Article III only
to the extent to which the applicability of such disclosure is reasonably
apparent on its face and provided further that in no event shall the Company
SEC Documents qualify or serve as exceptions to any of Sections 3.1-3.4,
3.8(v), 3.20-3.23 or 3.25-3.26), the Company represents and warrants to Parent
and Merger Sub as follows:

  

  

Section 3.1 Organization, Standing and Power. The Company is a corporation
duly organized, validly existing and in good standing under the Laws of the
State of Minnesota and has the requisite corporate power and authority to
carry on its business as now being conducted. Each Subsidiary of the Company
is duly organized, validly existing and in good standing under the Laws of the
jurisdiction in which it is organized and has the requisite corporate (in the
case of a Subsidiary that is a corporation) or other power and authority to
carry on its business as now being conducted, except where the failure to be
so organized, existing or in good standing or to have such power or authority
would not, individually or in the aggregate, have a Company Material Adverse
Effect. The Company and each of its Subsidiaries are duly qualified to do
business, and are in good standing, in each jurisdiction where the character
of their properties owned or held under lease or the nature of their
activities makes such qualification or good standing necessary, except where
the failure to be so qualified and in good standing would not, individually or
in the aggregate, have a Company Material Adverse Effect.

  

  

Section 3.2 Capital Structure.

  

  

(a) The authorized capital stock of the Company consists of 20,000,000 Company
Shares and 5,000,000 shares of preferred stock, each with $.01 par value per
share ("Company Preferred Stock").

  

  

(b) At the close of business on December 9, 2011, (A) 11,167,690 Company
Shares were issued and outstanding, (B) 815,556 Company Shares were reserved
for issuance pursuant to outstanding options (the "Company Stock Options") and
(C) no shares of Company Preferred Stock were issued or outstanding.

  

  

(c) Since the close of business on December 9, 2011, (A) there have been no
issuances by the Company of shares of capital stock or other voting securities
or equity interests of the Company, other than issuances of Company Shares
pursuant to the exercise of Company Stock Options and purchase rights under
the Company's Employee Stock Purchase Plan, as amended effective December 10,
2009 (the "ESPP"), outstanding as of the close of business on December 9,
2011, and (B) there have been no issuances by the Company of securities
convertible into, or exchangeable or exercisable for, or options, warrants or
other rights to acquire, or shares of deferred stock, restricted stock units,
stock-based performance units, stock appreciation rights or "phantom" stock
awards with respect to, any such stock, interests or securities, or derivative
securities or other rights that are linked to the value of Company Shares or
the value of the Company or any part thereof, other than purchase rights under
the ESPP.

  

  

 

 

 

  

 

-9-  

  

 

 

 

   
 

(d) All outstanding shares of capital stock of the Company are, and all shares
which may be issued pursuant to the Company Stock Options or purchase rights
under the ESPP will be, when issued in accordance with the terms thereof, duly
authorized, validly issued, fully paid and nonassessable and not subject to
preemptive rights. Except as set forth above in this Section 3.2 and except
for the transactions contemplated by this Agreement and except as provided by
the Rights Agreement dated as of June 1, 2006, between the Company and
American Stock Transfer and Trust Company, as Rights Agent (the "Rights
Agreement"), as of the date hereof, (A) there are not issued, reserved for
issuance or outstanding (1) any shares of capital stock or other voting
securities or equity interests of the Company or any of its Subsidiaries, (2)
any securities of the Company or any of its Subsidiaries convertible into or
exchangeable or exercisable for shares of capital stock or other voting
securities or equity interests of the Company or any of its Subsidiaries, (3)
any warrants, calls, options or other rights to acquire from the Company or
any of its Subsidiaries, and no obligation of the Company or any of its
Subsidiaries to issue, any capital stock, voting securities, equity interests
or securities convertible into or exchangeable or exercisable for capital
stock or voting securities of the Company or any of its Subsidiaries or (4)
any shares of deferred stock, restricted stock units, stock-based performance
units, stock appreciation rights or "phantom" stock awards with respect to any
capital stock of the Company or any of its Subsidiaries, or derivative
securities or other rights that are linked to the value of the Company Shares
or the value of the Company, any of its Subsidiaries or any part thereof and
(B) there are not any outstanding obligations of the Company or any of its
Subsidiaries to repurchase, redeem or otherwise acquire any such securities or
to issue, deliver or sell, or cause to be issued, delivered or sold, any such
securities (except pursuant to the forfeiture of Company Stock Options or the
acquisition by the Company of Company Shares in settlement of the exercise
price of a Company Stock Option or the Tax withholding obligations of holders
of Company Stock Options, in each case in accordance with their terms as in
effect on the date of this Agreement).

  

  

(e) Exhibit 21.1 to the Company's Annual Report on Form 10-K for the year
ended October 31, 2010, as filed with the SEC, constituted a true, accurate
and correct statement in all material respects of all of the information
required to be set forth therein by the regulations of the SEC as of the date
thereof.

  

  

(f) Section 3.2 of the Company Letter sets forth a list of all Subsidiaries
and Joint Ventures of the Company and the jurisdiction in which such
Subsidiary or Joint Venture is organized. Section 3.2 of the Company Letter
also sets forth the nature and extent of the ownership and voting interests
held by the Company in each such Joint Venture. The Company has no obligation
to make any capital contributions, or otherwise provide assets or cash, to any
Joint Venture.

  

  

 

 

 

  

 

-10-  

  

 

 

 

   
 

Section 3.3 Authority. On or prior to the date of this Agreement, the Board of
Directors of the Company has (i) determined that this Agreement and the
transactions contemplated hereby, including the Merger, are advisable and fair
to and in the best interests of the Company and its shareholders, (ii)
approved this Agreement, the Plan of Merger and the transactions contemplated
hereby, including the Merger, (iii) resolved, subject to its right to
withdraw, qualify, modify or amend such recommendation pursuant to Section
4.2(d), to recommend the approval of the Merger and adoption of the Plan of
Merger by the Company's shareholders and (iv) directed that the Merger and the
Plan of Merger be submitted to the Company's shareholders for approval and
adoption. The Company has all requisite corporate power and authority to enter
into this Agreement and, subject to approval of the Merger and adoption of the
Plan of Merger by the shareholders of the Company, to consummate the
transactions contemplated hereby. The execution and delivery of this Agreement
by the Company and the consummation by the Company of the transactions
contemplated hereby, including the Merger, have been duly authorized by all
necessary corporate action on the part of the Company, subject to (x) approval
of the Merger and adoption of the Plan of Merger by the shareholders of the
Company and (y) the filing of appropriate Merger documents as required by the
MBCA. This Agreement has been duly executed and delivered by the Company and
(assuming the valid authorization, execution and delivery of this Agreement by
Parent and Merger Sub and the validity and binding effect of this Agreement on
Parent and Merger Sub) except to the extent enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws
affecting the enforcement of creditors' rights generally and by the effect of
general principles of equity (regardless of whether enforcement is considered
in a proceeding in equity or at law), this Agreement constitutes the valid and
binding obligation of the Company enforceable against the Company in
accordance with its terms. The filing of the Proxy Statement with the SEC and
the execution and delivery of the Rights Agreement Amendment have been duly
authorized and approved by the Company's Board of Directors. The Company has
delivered or made available to Parent complete and correct copies of the
Amended and Restated Articles of Incorporation, as amended, of the Company
(the "Company Charter") and the Amended and Restated Bylaws of the Company
(the "Company Bylaws") and the Certificate or Articles of Incorporation and
Bylaws (or comparable organizational documents) of each of its Subsidiaries.

  

  

Section 3.4 Consents and Approvals; No Violation. Assuming that all consents,
approvals, authorizations and other actions described in this Section 3.4 have
been obtained and all filings and obligations described in this Section 3.4
have been made, the execution and delivery of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance with the
provisions of this Agreement will not, conflict with, result in any violation
of, or default (with or without notice or lapse of time, or both) under, or
give to others a right of termination, cancellation or acceleration of any
obligation under, or result in the creation of any Encumbrance upon any of the
properties or assets of the Company or any of its Subsidiaries under, any
provision of (i) the Company Charter or the Company Bylaws; (ii) the
comparable charter, bylaws or organizational documents of any of the Company's
Subsidiaries; (iii) any Contract applicable to the Company or any of its
Subsidiaries or any of their respective properties or assets; or (iv) any
judgment, order, decree, injunction, statute, Law, ordinance, rule or
regulation applicable to the Company or any of its Subsidiaries or any of
their respective properties or assets, other than, in the case of clauses
(iii) and (iv), any such violations, defaults, rights or Encumbrances that
would not, individually or in the aggregate, have a Company Material Adverse
Effect or materially impair or delay the ability of the Company to perform its
obligations hereunder or prevent the consummation of any of the transactions
contemplated hereby by the Company. No filing or registration with, or
authorization, consent or approval of, any Governmental Entity is required by
or with respect to the Company or any of its Subsidiaries in connection with
the execution and delivery of this Agreement by the Company or is necessary
for the consummation by the Company of the Merger and the other transactions
contemplated by this Agreement, except for (i) in connection, or in
compliance, with the provisions of the HSR Act and the Exchange Act; (ii) the
filing of the Articles of Merger with the Secretary of State of the State of
Minnesota and appropriate documents with the relevant authorities of other
states in which the Company or any of its Subsidiaries is qualified to do
business; (iii) such filings, authorizations, orders and approvals as may be
required to obtain the State Takeover Approvals; (iv) applicable requirements,
if any, of Blue Sky Laws and the Nasdaq Global Market; (v) applicable
requirements, if any, under foreign Laws relating to antitrust and to
competition clearances; and (vi) such other consents, orders, authorizations,
registrations, declarations and filings the failure of which to be obtained or
made would not, individually or in the aggregate, have a Company Material
Adverse Effect or materially impair or delay the ability of the Company to
perform its obligations hereunder or prevent the consummation of any of the
transactions contemplated hereby by the Company.

  

  

 

 

 

  

 

-11-  

  

 

 

 

   
 

Section 3.5 SEC Documents and Other Reports; Internal Controls and Procedures.

  

  

(a) The Company has timely filed with the SEC all reports, schedules, forms,
statements and other documents required to be filed by it since October 31,
2008 under the Securities Act or the Exchange Act (such documents, together
with any documents filed during such period by the Company with the SEC on a
voluntary basis, the "Company SEC Documents"). As of their respective filing
dates, or, if amended, as of the date of the last amendment prior to the date
of this Agreement, the Company SEC Documents complied in all material respects
with the requirements of the Securities Act of 1933, as amended (including the
rules and regulations promulgated thereunder, the "Securities Act"), the
Exchange Act and the Sarbanes-Oxley Act of 2002 (including the rules and
regulations promulgated thereunder, "SOX"), and, at the respective times they
were filed, none of the Company SEC Documents contained any untrue statement
of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading. Except to the extent
that information contained in any Company SEC Document has been revised,
amended, supplemented or superseded by a later-filed Company SEC Document,
none of the Company SEC Documents contains any untrue statement of a material
fact or omits to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading, which individually
or in the aggregate would require an amendment, supplement or corrective
filing to any such Company SEC Document. The consolidated financial statements
(including, in each case, any notes thereto) of the Company included in the
Company SEC Documents complied as to form in all material respects with
applicable accounting requirements and the published rules and regulations of
the SEC with respect thereto, were prepared in accordance with generally
accepted accounting principles ("GAAP") (except, in the case of the unaudited
statements, as permitted by the rules and regulations of the SEC) applied on a
consistent basis during the periods involved (except as may be indicated
therein or in the notes thereto) and fairly presented in all material respects
the consolidated financial position of the Company and its consolidated
Subsidiaries as at the respective dates thereof and the consolidated results
of their operations and their consolidated cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal year-end audit
adjustments). Except as disclosed in the Company SEC Documents filed with the
SEC prior to the date of this Agreement, the Company has not, since October
31, 2010, made or adopted any material change in its accounting methods,
practices or policies in effect on October 31, 2010.

  

  

 

 

 

  

 

-12-  

  

 

 

 

   
 

(b) The Company is in compliance in all material respects with (i) the
applicable provisions of SOX and (ii) the applicable rules and regulations of
the Nasdaq Global Market.

  

  

(c) The Company has made available to Parent true and complete copies of all
written comment letters from the staff of the SEC received since October 31,
2010, relating to the Company SEC Documents and all written responses of the
Company thereto other than with respect to requests for confidential
treatment. There are no outstanding or unresolved comments in comment letters
received from the SEC staff with respect to any Company SEC Documents and, to
the Knowledge of the Company, none of the Company SEC Documents (other than
confidential treatment requests) is the subject of ongoing SEC review. To the
Knowledge of the Company, there are no SEC inquiries or investigations, other
governmental inquiries or investigations or internal investigations pending or
threatened, in each case regarding any accounting practices of the Company.

  

  

(d) The Company has established and maintains disclosure controls and
procedures and internal control over financial reporting (as such terms are
defined in paragraphs (e) and (f), respectively, of Rule 13a-15 and paragraph
(e) of Rule 15d-15 under the Exchange Act) as required by Rules 13a-15 and
15d-15 under the Exchange Act. The Company's disclosure controls and
procedures are designed to ensure that all information (both financial and
non-financial) required to be disclosed by the Company in the reports that it
files or furnishes under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the
SEC, and that all such information is accumulated and communicated to the
Company's management as appropriate to allow timely decisions regarding
required disclosure and to make the certifications required pursuant to
Sections 302 and 906 of SOX. The Company's management has completed an
assessment of the effectiveness of the Company's disclosure controls and
procedures and, to the extent required by applicable Law, presented in any
applicable Company SEC Document that is a report on Form 10-K or Form 10-Q, or
any amendment thereto, its conclusions about the effectiveness of the
disclosure controls and procedures as of the end of the period covered by such
report or amendment based on such evaluation. Based on the Company's
management's most recently completed evaluation of the Company's internal
control over financial reporting prior to the date of this Agreement, (i) to
the Knowledge of the Company, the Company had no significant deficiencies or
material weaknesses in the design or operation of its internal control over
financial reporting that would reasonably be expected to adversely affect the
Company's ability to record, process, summarize and report financial
information and (ii) to the Knowledge of the Company, there has been no fraud,
whether or not material, that involves management or other employees who have
a significant role in the Company's internal control over financial reporting.

  

  

 

 

 

  

 

-13-  

  

 

 

 

   
 

(e) Neither the Company nor any of its Subsidiaries is a party to, or has any
commitment to become a party to, any joint venture, off balance sheet
partnership or any similar Contract (including any Contract or arrangement
relating to any transaction or relationship between or among the Company and
any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate,
including any structured finance, special purpose or limited purpose entity or
person, on the other hand, or any "off balance sheet arrangements" (as defined
in Item 303(a) of Regulation S-K under the Exchange Act)), where the result,
purpose or intended effect of such joint venture, off balance sheet
partnership or similar Contract is to avoid disclosure of any material
transaction involving, or material liabilities of, the Company or any of its
Subsidiaries in the Company's or such Subsidiary's published financial
statements or other Company SEC Documents.

  

  

(f) Since October 31, 2008, the Company has not received any oral or written
notification of any (x) "significant deficiency" or (y) "material weakness" in
the Company's internal control over financial reporting. There is no
outstanding "significant deficiency" or "material weakness" which the
Company's independent accountants certify has not been appropriately and
adequately remedied by the Company. For purposes of this Agreement, the terms
"significant deficiency" and "material weakness" shall have the meanings
assigned to them in Release 2004-001 of the Public Company Accounting
Oversight Board, as in effect on the date hereof.

  

  

Section 3.6 Information Supplied. None of the information to be supplied by
the Company for inclusion or incorporation by reference in the Proxy Statement
will, at the time of the mailing of the Proxy Statement and at the time of the
Company Shareholder Meeting, contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under
which they are made, not misleading. The Proxy Statement will comply (with
respect to the Company) as to form in all material respects with the
provisions of the Exchange Act.

  

  

Section 3.7 No Undisclosed Liabilities. Except as reflected or reserved
against in the balance sheet of the Company dated July 31, 2011 included in
the Form 10-Q filed by the Company with the SEC on September 9, 2011 (or
described in the notes thereto), neither the Company nor any of its
Subsidiaries has any debts, liabilities, commitments or obligations, whether
accrued or fixed, absolute or contingent, matured or unmatured, determined or
determinable, known or unknown, asserted or unasserted, including those
arising under any Law, Action or any judgment, order, writ, award, preliminary
or permanent injunction or decree of any Governmental Entity (an "Order") or
those arising under any Contract ("Liabilities"), except (a) Liabilities
incurred since July 31, 2011, in the ordinary course of business consistent
with past practice which, individually or in the aggregate, would not
reasonably be expected to have a Company Material Adverse Effect and (b)
Liabilities expressly contemplated by this Agreement.

  

  

 

 

 

  

 

-14-  

  

 

 

 

   
 

Section 3.8 Absence of Certain Changes or Events. Since July 31, 2011, (i) the
Company and its Subsidiaries have conducted their businesses in the ordinary
course consistent with past practice, (ii) there has not been any action taken
or committed to be taken by the Company or any Subsidiary of the Company
which, if taken following entry by the Company into this Agreement, would have
required the consent of Parent pursuant to Section 4.1, (iii) the Company has
not filed any Tax Return inconsistent with past practice or, on any such Tax
Return, taken any position, made any election or adopted any method that is
inconsistent with positions taken, elections made or methods used in preparing
or filing similar Tax Returns in prior periods, (iv) neither the Company nor
any of its Subsidiaries has amended, terminated or granted any waiver under
the Rights Agreement (other than the amendment to the Rights Agreement
described in Section 3.26) or any "standstill" or similar agreement and (v)
there has been no event, occurrence, fact, condition, effect, change or
development which, individually or in the aggregate, has had or would
reasonably be expected to have, a Company Material Adverse Effect.

  

  

Section 3.9 Litigation. There is no material Action by or before any
Governmental Entity or other Person pending or, to the Knowledge of the
Company, threatened against the Company or any of its Subsidiaries or any of
its or their respective properties or assets. Neither the Company nor any of
its Subsidiaries is subject to any Order or, to the Knowledge of the Company,
any investigation by any Governmental Entity.

  

  

Section 3.10 Permits and Compliance. Each of the Company and its Subsidiaries
is in possession of all franchises, grants, authorizations, licenses, permits,
charters, easements, variances, exceptions, consents, certificates, approvals
and orders of any Governmental Entity necessary for the Company or any of its
Subsidiaries to own, lease and operate its properties or other assets or to
carry on its business or operations as now being conducted (the "Company
Permits"), except where the failure to have any of the Company Permits has not
had and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, and no suspension or
cancellation of any of the Company Permits is pending or, to the Knowledge of
the Company, threatened, except where the suspension or cancellation of any of
the Company Permits would not, individually or in the aggregate, have a
Company Material Adverse Effect. Neither the Company nor any of its
Subsidiaries is in violation of (i) its charter, bylaws or other
organizational documents; (ii) any applicable Law; or (iii) any Order, except,
in the case of clauses (ii) and (iii), for any violations that would not,
individually or in the aggregate, have a Company Material Adverse Effect. No
written or, to the Knowledge of the Company, other notice of any such
violation or non-compliance has been received by the Company or any of its
Subsidiaries. The consummation of the Merger, in and of itself, would not
cause the revocation or cancellation of any such Permit that individually or
in the aggregate would reasonably be expected to have a Company Material
Adverse Effect. Neither the Company nor any of its Subsidiaries has received
written or, to the Knowledge of the Company, other notice that any action,
demand or investigation by any Governmental Entity with respect to the Company
or any of its Subsidiaries or any of their respective properties or assets
under any Law is pending, and no suit (other than suits currently under seal),
action or proceeding by any other person with respect to the Company or any of
its Subsidiaries or any of their respective properties or other assets under
any Law, is pending, or to the Knowledge of the Company, is threatened or
currently under seal, except, in each case, as individually or in the
aggregate has not had and would not reasonably be expected to have a Company
Material Adverse Effect.

  

  

 

 

 

  

 

-15-  

  

 

 

 

   
 

Section 3.11 Properties.

  

  

(a) Neither the Company nor any of its Subsidiaries owns any real property.

  

  

(b) Section 3.11(b) of the Company Letter sets forth a true, correct and
complete list of all real property leases, subleases and other occupancy
arrangements to which the Company or any of its Subsidiaries is a party and
each amendment thereto (the "Real Property Leases"). Each premises subject to
a Real Property Lease is hereinafter referred to as a "Leased Property." The
Company has made available to Parent a true, correct and complete copy of each
Real Property Lease. Neither the Company nor any of its Subsidiaries has
transferred, mortgaged or assigned any interest in any such Real Property
Lease, nor has the Company nor any of its Subsidiaries subleased or otherwise
granted rights of use or occupancy of any of the premises described therein to
any other Person. With respect to each Real Property Lease: (i) such Real
Property Lease is in full force and effect and is valid and binding on the
Company and its Subsidiaries, as applicable and, to the Knowledge of the
Company, each other party thereto and enforceable in accordance with its
terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance,
reorganization, rehabilitation, liquidation, preferential transfer, moratorium
and similar Laws now or hereafter affecting creditors' rights generally and
subject, as to enforceability, to general principles of equity (regardless of
whether enforcement is sought in a proceeding at equity or law); (ii) neither
the Company nor any of its Subsidiaries nor, to the Knowledge of the Company,
any other party to such Real Property Lease, is in material breach or
violation of, or in material default under, such Real Property Lease; (iii)
the Company's and its Subsidiaries', as applicable, possession and quiet
enjoyment of the Leased Property under such Real Property Lease has not been
disturbed in any material respect and, to the Knowledge of the Company, there
are no disputes with respect to such Real Property Lease; (iv) neither the
Company nor any of its Subsidiaries owes any brokerage commissions or finder's
fees with respect to such Real Property Lease; (v) to the Knowledge of the
Company, no event has occurred or circumstance exists which, with the delivery
of notice, the passage of time or both, would result in such a material breach
or violation of, or a material default under, such Real Property Lease, or
permit the termination, modification or acceleration of rent under such Real
Property Lease and (vi) to the Knowledge of the Company, there is no pending
or threatened condemnation or similar proceeding affecting any Leased
Property.

  

  

(c) Each of the Company and its Subsidiaries, in all material respects, (i)
has good and valid title to all of its properties, assets and other rights
that would not constitute real property (other than Intellectual Property),
free and clear of all Encumbrances and (ii) owns, has valid leasehold
interests in or valid contractual rights to use, all of the assets, tangible
and intangible (other than Intellectual Property), used by its business free
and clear of all Encumbrances, in each case, except for Permitted
Encumbrances.

  

  

Section 3.12 Tax Matters.

  

  

(a) The Company, each of its Subsidiaries and the Affiliated Group has timely
filed all Tax Returns required to be filed by it, each such Tax Return has
been prepared in compliance with all applicable Laws, and all such Tax Returns
are true and accurate in all material respects. All Taxes due and payable by
the Company and its Subsidiaries have been paid, and the Company and its
Subsidiaries have withheld and paid over to the appropriate taxing authority
all Taxes which they are required to withhold from amounts paid or owing to
any employee, shareholder, creditor or other third party.

  

   
 

 

 

 

  

 

-16-  

  

 

 

 

   
 

(b) Except as set forth on Section 3.12(b) of the Company Letter:

  

  

(i) none of the Company or any of its Subsidiaries has requested or been
granted an extension of the time for filing any Tax Return which has not yet
been filed;

  

  

(ii) none of the Company or any of its Subsidiaries has consented to extend
the time in which any material Tax may be assessed or collected by any taxing
authority;

  

  

(iii) no deficiency or proposed adjustment for any amount of Tax has been
proposed, asserted or assessed by any taxing authority against the Company or
any Subsidiary, other than deficiencies or proposed adjustments which have
been settled or otherwise resolved;

  

  

(iv) there is no action, suit, proceeding by a taxing authority or audit now
in progress, or to the Company's Knowledge, pending or threatened against or
with respect to the Company or any Subsidiary;

  

  

(v) no claim has been made during the five-year period preceding the date of
the Agreement and remains pending or otherwise unresolved by a taxing
authority of a jurisdiction where the Company or any Subsidiary does not file
Tax Returns that the Company or any such Subsidiary, respectively, is or may
be subject to taxation by that jurisdiction;

  

  

(vi) none of the Company or any of its Subsidiaries will be required to
include any item of income in, or exclude any item of deduction from, taxable
income for any taxable period (or portion thereof) ending after the date of
the Closing as a result of any (A) change in method of accounting for a
taxable period ending on or prior to the date of the Closing; (B) "closing
agreement" as described in Section 7121 of the Code (or any corresponding or
similar provision of state, local or foreign income Tax Law) executed on or
prior to the date of the Closing; (C) intercompany transactions or any excess
loss account described in Treasury Regulations under Code  1502 (or any
corresponding or similar provision of state, local or foreign income Tax Law);
(D) installment sale or open transaction disposition made on or prior to the
date of the Closing; or (E) prepaid amount received on or prior to the date of
the Closing;

  

  

(vii) none of the Company or any of its Subsidiaries is a party to or bound by
any Tax allocation or Tax sharing agreement;

  

  

(viii) none of Company or any of its Subsidiaries has been a U.S. real
property holding corporation within the meaning of Section 897(c)(2) of the
Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the
Code;

  

  

 

 

 

  

 

-17-  

  

 

 

 

   
 

(ix) none of the Company or its Subsidiaries (A) has been a member of an
affiliated group filing a consolidated federal income Tax Return or a
combined, consolidated, unitary or other affiliated group Tax Return for
state, local or foreign Tax purposes (other than the Affiliated Group) or (B)
has any liability for the Taxes of any Person (other than the Company and its
Subsidiaries) under Treasury Regulation  1.1502-6 (or any similar provision
of Law), as a transferee or successor, by Contract, or otherwise;

  

  

(x) the Company and its Subsidiaries have disclosed on their federal income
Tax Returns all positions taken that could give rise to a substantial
understatement of federal income Tax within the meaning of Code Section 6662;

  

  

(xi) since October 31, 2010, neither the Company nor any of its Subsidiaries
has incurred any liability for Taxes arising from extraordinary gains or
losses, as that term is used in GAAP, outside the ordinary course of business
consistent with past custom and practice;

  

  

(xii) neither the Company nor any of its Subsidiaries has ever been either a
"controlled corporation" or a "distributing corporation" (within the meaning
of Code Section 355(a)(1)(A)) with respect to a transaction that was described
in, or intended to qualify as a tax-free transaction pursuant to, Code Section
355;

  

  

(xiii) neither the Company nor any of its Subsidiaries has ever made an
election under Code Section 1362 to be treated as an S corporation for federal
income Tax purposes, or similar election under any comparable provision of any
state, local or foreign Tax Law;

  

  

(xiv) neither the Company nor any of its Subsidiaries has been required to
file any report pursuant to Code Section 999(a)(1) or participated in an
international boycott within the meaning of Code Section 999(b); and

  

  

(xv) neither the Company nor any of its Subsidiaries has participated in any
listed transaction within the meaning of Treasury Regulation Section
1.6011-4(b)(2).

  

  

(c) Section 3.12(c) of the Company Letter lists all U.S. federal, foreign, and
material state and local income and franchise Tax Returns filed with respect
to the Company or any of its Subsidiaries for taxable periods ended on or
after October 31, 2008, indicates those Tax Returns that have been audited,
and indicates those Tax Returns that currently are the subject of an audit.
The Company has delivered or made available to Parent correct and complete
copies of all U.S. federal income Tax Returns, examination reports, and
statements of deficiencies assessed against or agreed to by the Company or any
of its Subsidiaries filed or received since October 31, 2008.

  

  

(d) The Company is not a partner or a member of any partnership, limited
liability company or joint venture, or any other entity classified as a
partnership for federal income Tax purposes.

  

  

Section 3.13 Certain Agreements.

  

  

 

 

 

  

 

-18-  

  

 

 

 

   
 

(a) Neither the Company nor any of its Subsidiaries is a party to or bound by
any:

  

  

(i) Contract which is a "material contract" (as such term is defined in Item
601(b)(10) of Regulation S-K under the Exchange Act);

  

  

(ii) Contract which purports to limit or restrict in any material respect the
manner or localities in which the Company or any of its Affiliates may conduct
business or which gives or grants to a customer or supplier of the Company or
any of its Affiliates most favored nation pricing or exclusivity or which
contains non-solicitation provisions that restrict the actions of the Company
or any of its Affiliates with respect to customers or suppliers;

  

  

(iii) Contract for the employment of any officer, employee or other Person (to
the extent the Company or any of its Subsidiaries have any obligations
thereunder that have not been fully satisfied) or relating to loans to
officers, directors or Affiliates;

  

  

(iv) Contract under which the Company or any of its Subsidiaries has advanced
or loaned any other Person amounts in the aggregate exceeding $100,000
(excluding ordinary course advances of travel and similar expenses to
employees of the Company and its Subsidiaries);

  

  

(v) Contract relating to borrowed money or other Indebtedness in excess of
$100,000, or the mortgaging, pledging or otherwise placing of any Encumbrance
(other than immaterial Permitted Encumbrances) on any asset or group of assets
of the Company or any of its Subsidiaries with a fair market value in excess
of $100,000;

  

  

(vi) any Guaranty for the Indebtedness of any Person in excess of $100,000;

  

  

(vii) Real Property Lease or any other Contract under which the Company or any
of its Subsidiaries is lessee of or holds or operates any property, real or
personal, owned by any other party, except for any lease of real or personal
property under which the aggregate annual rental payments do not exceed
$500,000;

  

  

(viii) Contract under which the Company or any of its Subsidiaries is lessor
of or permits any third party to hold or operate any property, real or
personal, owned or controlled by the Company or any of its Subsidiaries with
annual payments to the Company in excess of $100,000, other than Contracts for
lease of the Company's products made in the ordinary course of business and
Contracts that contain licenses or other use rights with respect to
Intellectual Property Rights made in the ordinary course of business;

  

  

(ix) Contract or group of related Contracts with the same party or group of
affiliated parties, including outstanding purchase orders and other
Contract(s) requiring the Company or any of its Subsidiaries to make purchases
from any other Person (including such Person's Affiliates), the performance of
which involves consideration not yet paid in the aggregate in excess of
$500,000;

  

  

 

 

 

  

 

-19-  

  

 

 

 

   
 

(x) assignment, license or Contract with respect to any intangible property
(including any Intellectual Property Rights) granted or made to the Company or
any of its Subsidiaries, or granted or made by the Company or any of its
Subsidiaries to third parties, except licenses to the Company or any of its
Subsidiaries of commercially available, "off the shelf" software used solely
for the Company's and its Subsidiaries' own internal use ("Commercial
Software") or for an aggregate fee, royalty or other consideration for any
such software or group of related software licenses of no more than $250,000
annually and licenses granted with respect to the Company's software made in
the ordinary course of business;

  

  

(xi) warranty Contract other than in the ordinary course of business with
respect to its services rendered or its products sold or leased and which
involves consideration in excess of $250,000 annually;

  

  

(xii) Contract under which it has granted any Person any registration rights;

  

  

(xiii) sales, distribution, manufacturing or franchise Contract that involves
a consideration in excess of $500,000 annually;

  

  

(xiv) Contract with a term of more than six months which is not terminable by
the Company or any of its Subsidiaries upon 30 days' (or less) notice without
penalty and involves a consideration in excess of $500,000 annually;

  

  

(xv) Contract regarding voting, transfer or other similar arrangements related
to (a) the Company's or any Subsidiary's capital stock (or any equivalents or
other securities) or (b) warrants, options or other rights to acquire any of
the Company's or any Subsidiary's capital stock (or any equivalents or other
securities);

  

  

(xvi) Contract containing a right of first refusal, right of first negotiation
or right of first offer in favor of a party other than the Company or its
Subsidiaries;

  

  

(xvii) Contract to which the Company or any of its Subsidiaries is a party and
pursuant to which amounts of more than $500,000 in the aggregate over the term
of such Contract have been paid to any party other than the Company and its
Subsidiaries, relating to research, clinical trial, development, distribution,
sale, supply, license, marketing, co-promotion or manufacturing by third
parties of (A) products (including products under development) of the Company
or any Subsidiary of the Company, (B) products (including products under
development) licensed by the Company or any Subsidiary of the Company or (C)
the Intellectual Property Rights of the Company or any Subsidiary of the
Company, other than software licenses for Commercial Software and other
generally available software and except pursuant to employee proprietary
inventions agreements (or similar employee agreements), non-disclosure
agreements, material transfer agreements and product distribution agreements
entered into by the Company or any of its Subsidiaries in the ordinary course
of business;

  

  

(xviii) Contract that (A) grants or obligates the Company or any Subsidiary of
the Company to grant an exclusive right to such third party for the research,
clinical trial, development, distribution, sale, supply, license, marketing,
co-promotion or manufacturing of any (i) product involving consideration of in
excess of $50,000 annually or (ii) Intellectual Property Right or (B) requires
or obligates the Company or any Subsidiary of the Company to purchase
specified minimum amounts in excess of $250,000 of any product or to perform
or conduct research, clinical trials or development for the benefit of any
person other than the Company or any Subsidiary of the Company;

  

   
 

 

 

 

  

 

-20-  

  

 

 

 

   
 

(xix) pension, profit sharing, stock option, employee stock purchase or other
plan, arrangement or other Contract providing for deferred or other
compensation (including any bonuses or other remuneration and whether in cash
or otherwise), to employees, former employees or consultants, or any other
employee benefit plan, arrangement or other Contract, or any collective
bargaining agreement or any other Contract with any labor union, or severance
Contracts, programs, policies or arrangements; or

  

  

(xx) other Contract which is material to its operations and business prospects
or involves a consideration in excess of $500,000 annually.

  

  

(b) The Company has previously made available to Parent complete and correct
copies of each written Contract of the type described in this Section 3.13
that is in force as of the date of this Agreement. All Contracts of the type
described in this Section 3.13 shall be referred to as "Company Contracts"
regardless of whether they were entered into before, on or after the date of
this Agreement.

  

  

(c) All of the Company Contracts are valid and in full force and effect
(except those which are cancelled, rescinded or terminated after the date of
this Agreement in the ordinary course of business in accordance with their
terms), except where the failure to be in full force and effect have not had
and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. To the Knowledge of the Company,
no Person is challenging the validity or enforceability of any Company
Contract. Neither the Company nor any of its Subsidiaries and, to the
Knowledge of the Company, none of the other parties thereto, is in breach of
any provision of, or committed or failed to perform any act which (with or
without notice or lapse of time or both) would constitute a default under the
provisions of, any Company Contract, except for those violations and defaults
which have not had and would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect. With respect to each
Contract including minimum purchase requirements by the Company or any of its
Subsidiaries, the Company and its Subsidiaries have either fully satisfied
such requirements (with respect to preceding periods) or have satisfied all
such requirements on a pro rata basis for applicable periods beginning prior
to the date on which this representation is given and ending on a date after
the date of this representation (such that, for the avoidance of doubt, the
Company and its Subsidiaries will not be disproportionately responsible for
satisfying the minimum purchase requirements in the post-Closing portion of
such period). There are no renegotiations of, attempts or requests to
renegotiate or outstanding rights to renegotiate, any terms of any of the
agreements and instruments set forth or required to be set forth on Section
3.13 of the Company Letter.

  

  

(d) Each Person who has proprietary knowledge of or information relating to
the material and confidential elements of the design, the manufacturing
processes or the formulation of the products of the Company or any of its
Subsidiaries has executed and delivered to the Company or the applicable
Subsidiary of the Company an agreement or agreements restricting such person's
right to use and disclose confidential information of the Company or any of
its Subsidiaries.

  

  

 

 

 

  

 

-21-  

  

 

 

 

   
 

Section 3.14 ERISA.

  

  

(a) Each Company Plan is listed in Section 3.14(a) of the Company Letter. With
respect to each Company Plan, to the extent applicable, the Company has
delivered to Parent a true and correct copy of (i) the three (3) most recent
annual reports (Forms 5500) filed with the IRS; (ii) each such Company Plan
that has been reduced to writing and all amendments thereto; (iii) each trust,
insurance and administrative Contract relating to each such Company Plan; (iv)
a written summary of each unwritten Company Plan; (v) the most recent summary
plan description or other written explanation of each Company Plan provided to
participants; (vi) the most recent determination or opinion letter issued by
the IRS with respect to any Company Plan intended to be qualified under
Section 401(a) of the Code; (vii) any request for a determination currently
pending before the IRS; and (viii) all correspondence with the IRS, the
Department of Labor, the SEC or Pension Benefit Guaranty Corporation relating
to any outstanding inquiry, controversy or audit. Each Company Plan has been
funded, administered and maintained, in form and operation, in all material
respects with its terms, the Employee Retirement Income Security Act of 1974
("ERISA"), the Code and all other applicable statutes and governmental rules
and regulations, and the plan sponsor of each Company Plan is in compliance
with all filing and disclosure requirements imposed on it with respect to such
Company Plans. Neither the Company nor any current or former ERISA Affiliate
has sponsored, has contributed to, has or had an obligation to contribute to,
or has any liability with respect to (x) a plan subject to Title IV of ERISA,
including any defined benefit plan (as defined in Section 3(35) of ERISA), a
multiemployer plan (as defined in Section 3(37) of ERISA), or a multiple
employer plan subject to Section 4063 or 4064 of ERISA, (y) a multiple
employer welfare benefit arrangement (as defined in Section 3(40)(A) of ERISA)
or (z) a plan subject to Section 302 of ERISA or Section 412 of the Code.

  

  

(b) Neither the Company nor any ERISA Affiliate has any liability of any kind
whatsoever, whether direct, indirect, contingent or otherwise, (i) on account
of any violation of the health care requirements of Part 6 or 7 of Subtitle B
of Title I of ERISA or Section 4980B or 4980D of the Code, (ii) under Section
502(i) or 502(l) of ERISA or Section 4975 of the Code, (iii) under Section 302
of ERISA or Section 412 of the Code or (iv) under Title IV of ERISA. No
fiduciary (within the meaning of Section 3(21) of ERISA) of any Company Plan
subject to Part 4 of Subtitle B of Title I of ERISA has committed a breach of
fiduciary duty with respect to that Company Plan that could subject such
fiduciary, the Company or any of the Subsidiaries of the Company to any
material liability. There is no pending or, to the Knowledge of the Company,
threatened action, claim or lawsuit relating to any Company Plan (other than
routine claims for benefits) that could result in a material liability. There
is no audit, inquiry or examination pending or, to the Knowledge of the
Company, threatened by the IRS, the Department of Labor, the Pension Benefit
Guaranty Corporation or any other governmental body with respect to any
Company Plan. All Company Plans that are intended by their terms to be, or are
otherwise treated by the Company as, qualified under Section 401(a) of the
Code have been determined by the IRS to be so qualified, are entitled to rely
on a prototype opinion letter issued by the IRS, or a timely application for
such determination is now pending and no circumstances exist (x) which could
result in loss of such qualification under Section 401(a) of the Code or (ii)
which could result in a material penalty under the IRS Closing Agreement
Program if discovered during an IRS audit or investigation. Neither the
Company nor any of its Subsidiaries has any liability or obligation under any
Company Plan or otherwise to provide benefits after termination of employment
to any person other than as required by Section 4980B of the Code or
applicable state Law. All contributions, premiums or other payments that are
due have been paid on a timely basis with respect to each Company Plan

   
 

 

 

 

  

 

-22-  

  

 

 

 

   
 

(c) Except to the extent set forth in Sections 5.4 and any required
distribution from the Company's 401(k) Plan as a result of the termination of
the Company's 401(k) Plan in accordance with Section 5.11, neither the
execution of this Agreement nor the consummation of the transactions
contemplated by this Agreement (either alone or in combination with another
event) will or is reasonably expected to (i) entitle any current or former
director, officer, employee or consultant of the Company to any payment
(including severance pay or similar compensation), any cancellation of
indebtedness, or any increase in compensation, (ii) result in the acceleration
of payment, funding or vesting under any Company Plan or (iii) result in any
forfeiture of or increase in benefits payable under any Company Plan.

  

  

(d) Each Company Plan which is a nonqualified deferred compensation plan
within the meaning of, and subject to, Section 409A of the Code has been at
all times administered, operated and maintained in all respects in accordance
with its terms and according to the requirements of Section 409A of the Code,
except for any failure that would not result in a material liability to the
Company. No person is entitled to receive any additional payment from the
Company or any of its Subsidiaries as a result of the imposition of a Tax
under Section 409A of the Code and no person is entitled to receive any
additional payment as a result of the imposition of a Tax under Section 409A
of the Code.

  

  

(e) With respect to each Company Plan not subject to United States Law (a
"Company Foreign Benefit Plan"), (i) the fair market value of the assets of
each funded Company Foreign Benefit Plan, the liability of each insurer for
any Company Foreign Benefit Plan funded through insurance or the reserve shown
on the consolidated financial statements of the Company included in the
Company SEC Documents for any unfunded Company Foreign Benefit Plan, together
with any accrued contributions, is sufficient to procure or provide for the
projected benefit obligations, as of the Effective Time, with respect to all
current and former participants in such plan based on reasonable, country
specific actuarial assumptions and valuations and no transaction contemplated
by this Agreement shall cause such assets or insurance obligations or book
reserve to be less than such projected benefit obligations and (ii) each
Company Foreign Benefit Plan required to be registered has been registered and
has been maintained in good standing with the appropriate regulatory
authorities.

  

  

(f) The Company, with respect to employees outside of the United States, (i)
is not under any legal liability to pay pensions, gratuities, superannuation
allowances or the like to any past or present directors, officers, employees
or dependents of employees; (ii) has not made ex-gratia or voluntary payments
by way of superannuation allowance or pension; and/or (iii) does not maintain
and has not contemplated any pension schemes or arrangements for payment of
the pensions or death benefits or similar arrangements.

  

  

 

 

 

  

 

-23-  

  

 

 

 

   
 

Section 3.15 Compliance with Worker Safety and Environmental Laws. Since
January 1, 2009, the properties, assets and operations of the Company and its
Subsidiaries are and have at all times been in compliance in all material
respects with all applicable federal, state, local and foreign Laws, rules and
regulations, orders, decrees, judgments, permits and licenses relating to
public and worker health and safety (collectively, "Worker Safety Laws") and
the protection and clean-up of the environment and activities or conditions
related thereto, including those relating to the generation, handling,
disposal, transportation or release of hazardous materials (collectively,
"Environmental Laws"). There have been no Releases of Hazardous Materials in,
on, under or affecting any properties currently or formerly owned, leased or
operated by the Company or any of its Subsidiaries that would require any
material investigation or clean-up under Environmental Laws. There is no
material investigation, suit, claim, action or proceeding pending, or, to the
Knowledge of the Company, threatened against the Company or any of its
Subsidiaries relating to or arising under Environmental Laws, and neither the
Company nor any of its Subsidiaries has received any notice of any such
investigation, suit, claim, action or proceeding. Neither the Company nor any
of its Subsidiaries is subject to any material restriction on the sale or
distribution of its products as a result of any existing or pending (but not
yet final) requirement of Environmental Law, and such products are not subject
to any material restriction regarding post-consumer use, handling or
recycling. Neither the Company nor any of its Subsidiaries has entered into or
assumed, by Contract or operation of Law or otherwise, any material
obligation, liability, order, settlement, judgment, injunction or decree
relating to or arising under Environmental Laws that imposes ongoing
obligations on the Company or any of its Subsidiaries. To the Knowledge of the
Company there are no facts, circumstances or conditions, and there has been no
exposure to Hazardous Materials, that would reasonably be expected to form the
basis for any material investigation, suit, claim, action, proceeding or
liability against or affecting the Company or any of its Subsidiaries relating
to or arising under Environmental Laws. The term "Hazardous Materials" means
any chemical, material, substance, waste, pollutant or contaminant that is
prohibited, limited or regulated by or pursuant to any Environmental Law,
including certain metals (e.g., lead, mercury or cadmium), petroleum products
and by-products, asbestos and asbestos-containing materials, urea formaldehyde
foam insulation, medical or infectious wastes, polychlorinated biphenyls,
radon gas, radioactive substances, chlorofluorocarbons and all other ozone-
depleting substances. The term "Release" means any spilling, leaking, pumping,
pouring, emitting, emptying, discharging, injecting, escaping, leaching,
dumping, disposing or migrating into or through to the environment.

  

  

Section 3.16 Labor Matters. Neither the Company nor any of its Subsidiaries is
a party to any collective bargaining Contract or any labor Contract. Neither
the Company nor any of its Subsidiaries has engaged in any unfair labor
practice or violation of state or local labor, wage and hour, or employment
Laws with respect to any Persons employed by or otherwise performing services
for the Company or any of its Subsidiaries (the "Company Business Personnel"),
and there is no unfair labor practice complaint or grievance or other
administrative or judicial complaint, action or investigation pending or
threatened in writing against the Company or any of its Subsidiaries by the
National Labor Relations Board, any state or federal agency, or any other
third party with respect to the Company Business Personnel, except where such
unfair labor practice, complaint, grievance or other administrative or
judicial complaint, action or investigation would not, individually or in the
aggregate, have a Company Material Adverse Effect. There is no labor strike,
dispute, slowdown or stoppage pending or, to the Knowledge of the Company,
threatened against or affecting the Company or any of its Subsidiaries which
may interfere with the respective business activities of the Company or any of
its Subsidiaries, except where such dispute, strike or work stoppage would
not, individually or in the aggregate, have a Company Material Adverse Effect.

  

   
 

 

 

 

  

 

-24-  

  

 

 

 

   
 

Section 3.17 Intellectual Property.

  

  

(a) Except for computer software licensed pursuant to a "shrink-wrap" or
"click-wrap" agreement or pursuant to a commercially available license
agreement with annual license fees less than $50,000, the Company and its
Subsidiaries either own, free and clear of all Encumbrances except Permitted
Encumbrances, or have a perpetual royalty-free right to use under a valid and
enforceable license or other agreement, all patents, trademarks, trade names,
service marks, domain names, copyrights and any applications and registrations
for any of the foregoing, trade secrets, know-how, technology, computer
software and other tangible and intangible proprietary information and
intellectual property rights (collectively, "Intellectual Property Rights"),
that, to the Knowledge of the Company and its Subsidiaries, are necessary to
conduct the business of the Company and its Subsidiaries as currently
conducted by the Company and its Subsidiaries. Immediately following the
Closing, the Company and its Subsidiaries will continue to have all such
Intellectual Property Rights. Neither the Company nor any of its Subsidiaries
is infringing, misappropriating or violating or has infringed, misappropriated
or violated in any material respect any Intellectual Property Rights of any
third party. To the Knowledge of the Company, no third party infringes,
misappropriates or violates, or since January 1, 2006 has infringed,
misappropriated or violated, in any material respect any Intellectual Property
Rights owned by or exclusively licensed by or to the Company or any of its
Subsidiaries.

  

  

(b) Section 3.17(b) of the Company Letter contains a list of (i) all
registered United States, state and foreign trademarks, service marks, logos,
trade dress and trade names and pending applications to register the
foregoing; (ii) all United States and foreign patents and pending patent
applications, (iii) all material registered United States and foreign
copyrights and pending applications to register the same and (iv) all domain
names, in each case owned by the Company and its Subsidiaries.

  

  

(c) Except for objections or rejections in the normal course of patent and
trademark application proceedings, (i) there are no actions, suits or claims
or administrative proceedings or investigations pending or to the Knowledge of
the Company threatened that challenge or question the Intellectual Property
Rights of the Company or any of its Subsidiaries and (ii) the Company has not
within the past three years received any written correspondence from any third
party demanding that the Company, inviting the Company to, or suggesting that
the Company is required to, license any Intellectual Property Rights from such
third party.

  

  

(d) Since January 1, 2009, the Company and its Subsidiaries have taken
reasonable steps to maintain the confidentiality of or otherwise protect and
enforce their rights in the Intellectual Property Rights owned by them ("Owned
Intellectual Property Rights"), and to protect and preserve through the use of
customary non-disclosure agreements the confidentiality of material
confidential information that is owned, used or held by the Company and its
Subsidiaries in the conduct of the business. To the Knowledge of the Company,
such material confidential information has not been used, disclosed to or
discovered by any Person except pursuant to valid and appropriate non-
disclosure agreements which have not been breached.

  

  

 

 

 

  

 

-25-  

  

 

 

 

   
 

(e) All employees, agents, consultants and contractors, who have contributed
to or participated in the conception or development, or both, of the Owned
Intellectual Property Rights (i) have at all times since their engagement or
hire been and are a party to "work-for-hire" arrangements with Company or one
of its Subsidiaries or (ii) have assigned to Company or one of its
Subsidiaries all ownership of all tangible and intangible property arising in
connection with the conception or development of such Owned Intellectual
Property Rights.

  

  

Section 3.18 Information Technology; Security and Privacy.

  

  

(a) All information technology and computer systems owned or leased by the
Company or any of its Subsidiaries that are used in the transmission, storage,
maintenance, organization, presentation, generation, processing or analysis of
data and information, whether or not in electronic format, that is used in or
necessary for the conduct of the business of the Company and its Subsidiaries
(collectively, "Company IT Systems") have been maintained, in all material
respects, in a commercially reasonably manner, and are in good working
condition. The Company and its Subsidiaries have in place a commercially
reasonable disaster recovery program which provides for the regular back-up
and recovery of the data and information necessary to the conduct of the
business of the Company and its Subsidiaries (including such data and
information that is stored on magnetic or optical media in the ordinary
course).

  

  

(b) The use by the Company and its Subsidiaries of the data included in the
Intellectual Property Rights that is material to the business of the Company
and its Subsidiaries and contained in any database used or maintained by the
Company or its Subsidiaries (collectively, the "Company Data") does not
violate the rights of any third party. To the Knowledge of the Company, all
computer programs included within the Owned Intellectual Property Rights are
not licensed pursuant to a so-called "open source" license and do not
incorporate any computer programs that are licensed pursuant to a so-called
"open source" license.

  

  

(c) The Company has established and is in material compliance with a written
information security program or programs covering the Company and its
Subsidiaries that the Company believes in good faith is reasonable and
sufficient to protect Company Data and provide reasonable assurance that
adequate internal controls can be maintained over Company IT Systems, and (i)
includes adequate safeguards for the security, confidentiality, and integrity
of transactions and confidential or proprietary Company Data and (ii) are
designed to protect against unauthorized access to the Company IT Systems and
Company Data.

  

  

Section 3.19 Insurance. Section 3.19 of the Company Letter sets forth a
complete and accurate list of all insurance policies which are maintained by
the Company or its Subsidiaries or which names the Company or any of its
Subsidiaries as an insured (or loss payee), including those which pertain to
the Company's or its Subsidiaries' assets, employees or operations. All such
insurance policies are in full force and effect and all premiums due
thereunder have been paid. Neither the Company nor any of its Subsidiaries
have received notice of cancellation of any such insurance policy or is in
breach of, or default under, any such insurance policy. There is no material
claim by the Company or any of its Subsidiaries pending under any such
insurance policy covering the assets, business, equipment, properties,
operations, employees, officers and directors of the Company and its
Subsidiaries. Neither the Company nor any of its Subsidiaries has been refused
any insurance with respect to its assets or operations by any insurance
carrier to which it has applied for any such insurance or with which it has
carried insurance, during the last five years prior.

  

  

 

 

 

  

 

-26-  

  

 

 

 

   
 

Section 3.20 Opinion of Financial Advisor. The Company has received the
written opinion of Piper Jaffray and Co., dated as of the date of this
Agreement, to the effect that, as of the date of this Agreement, the Per Share
Merger Consideration is fair to the Company's shareholders from a financial
point of view, a copy of which opinion has been delivered to Parent.

  

  

Section 3.21 State Takeover Statutes. No further action is required by the
Board of Directors of the Company (or any committee thereof) or the
shareholders of the Company to render inapplicable to this Agreement, the
Merger, the Amended Company Rights Agreement and the other transactions
contemplated by this Agreement the restrictions on (i) a "control share
acquisition" (as defined in Section 302A.011 of the MBCA) set forth in Section
302A.671 of the MBCA and (ii) "business combinations" with an "interested
shareholder" (each as defined in Section 302A.011 of the MBCA) set forth in
Section 302A.673 of the MBCA to the extent such restrictions would otherwise
be applicable to this Agreement, the Merger, the Amended Company Rights
Agreement and the other transactions contemplated by this Agreement, and
accordingly, none of the foregoing sections or any other Minnesota
antitakeover or similar statute applies to any such transactions. To the
Knowledge of the Company, no other state takeover statutes or charter or bylaw
provisions are applicable to the Merger, the Amended Company Rights Agreement,
this Agreement or the transactions contemplated hereby.

  

  

Section 3.22 Required Vote of Company Shareholders. The affirmative vote of
the holders of a majority of the outstanding Company Shares is required to
approve and adopt this Agreement. No other vote of the securityholders of the
Company is required by Law, the Company Charter, the Company Bylaws or
otherwise in order for the Company to consummate the Merger and the
transactions contemplated hereby.

  

  

Section 3.23 Brokers. No broker, investment banker or other Person, other than
Piper Jaffray and Co., the fees and expenses of which (in an amount that has
been separately provided to Parent) will be paid by the Company (as reflected
in an agreement between Piper Jaffray and Co. and the Company, dated August 2,
2011, a redacted copy of which has been furnished to Parent), is entitled to
any broker's, finder's or other similar fee or commission in connection with
the transactions contemplated by this Agreement based upon arrangements made
by or on behalf of the Company or any of its Subsidiaries.

  

  

Section 3.24 Regulatory Compliance.

  

  

(a) As to each product or product candidate subject to the FDCA and the
regulations of the FDA promulgated thereunder or similar Laws in any foreign
jurisdiction that is or has been developed, manufactured, tested, distributed
and/or marketed by or on behalf of the Company or any of its Subsidiaries
(each such product or product candidate, a "Medical Device", a "Biologic", a
"Drug", a Human Cell, Tissues, and Cellular and Tissue-Based Product (a
"HCT/P")), each such Medical Device, Biologic, Drug or HCT/P is being or has
been developed, manufactured, tested, distributed and/or marketed in
compliance with all applicable requirements under the FDCA and the regulations
of the FDA promulgated thereunder and similar Laws, including those relating
to investigational use, premarket clearance, listing, approval to market a
Medical Device, and applications or abbreviated applications to market a new
Biologic, a new Drug or a new HCT/P, good manufacturing practices, quality
systems regulations, ISO requirements, good clinical practices, good
laboratory practices, labeling, advertising, record keeping and filing of
required reports and security, except for failures in compliance that
individually or in the aggregate have not had and would not reasonably be
expected to have a Company Material Adverse Effect. Neither the Company nor
any of its Subsidiaries has received any notice or other communication from
the FDA or any other Governmental Entity (A) contesting the investigational
device exemption, premarket clearance or premarket approval of, the uses of or
the labeling and promotion of any products of the Company or any of its
Subsidiaries or (B) otherwise alleging any material violation applicable to
any Medical Device, Biologic, Drug or HCT/P by the Company or any of its
Subsidiaries of any Law.

  

  

 

 

 

  

 

-27-  

  

 

 

 

   
 

(b) No Medical Device, Biologic, Drug or HCT/P is under consideration by the
Company or, to the Company's Knowledge, by any Governmental Entity for or has
been recalled, withdrawn, suspended or discontinued (other than for commercial
or other business reasons that are not in any way related to safety,
regulatory requirements, noncompliance with any Law or any other similar
reason) by the Company or any of its Subsidiaries in the United States or
outside the United States (whether voluntarily or otherwise). No proceedings
in the United States or outside of the United States of which the Company has
Knowledge (whether completed or pending) seeking the recall, withdrawal,
suspension, seizure or discontinuance of any Medical Device, Biologic, Drug or
HCT/P are pending against the Company or any of its Subsidiaries or, to the
Knowledge of the Company, any licensee or distributor of any Medical Device,
nor have any such proceedings been pending at any prior time.

  

  

(c) As to each Medical Device, Biologic, HCT/P or Drug of the Company or any
of its Subsidiaries for which a premarket notification submission under
Section 510(k) of the FDCA, premarket approval application, premarket
notification, biological license application, new drug application,
investigational device exemption or similar state or foreign regulatory
application has been granted, cleared or approved, the Company and its
Subsidiaries are in compliance with 21 U.S.C.  355, 360 and 360e, 42 U.S.C.
262 and 21 C.F.R. Parts 312, 314, 600 and 601, 807, 812 or 814, respectively,
as applicable, and similar Laws and all terms and conditions of such
applications, except for any such failure or failures to be in compliance
which individually or in the aggregate has not had and would not reasonably be
expected to have a Company Material Adverse Effect. As to each such Medical
Device, Biologic, HCT/P or Drug of the Company, the Company and any relevant
Subsidiary of the Company, and the officers, employees or agents of the
Company or such Subsidiary, have included in the application for such Medical
Device, Biologic, HCT/P or Drug of the Company, where required, the
certification described in 21 U.S.C.  335a(k)(1) or any similar Law and the
list described in 21 U.S.C.  335a(k)(2) or any similar Law, and each such
certification and list was true, complete and correct in all material respects
when made. In addition, the Company and its Subsidiaries are in compliance in
all material respects with all applicable registration requirements set forth
in 21 U.S.C.  360, 42 U.S.C.  262 and 21 C.F.R. Part 207, 601 and 807 and
all similar Laws.

  

  

 

 

 

  

 

-28-  

  

 

 

 

   
 

(d) No article of any Medical Device, Biologic, Drug or HCT/P manufactured
and/or distributed by the Company or any of its Subsidiaries is (i)
adulterated within the meaning of 21 U.S.C.  351 (or similar Legal
Provisions), (ii) misbranded within the meaning of 21 U.S.C.  352 (or similar
Legal Provisions) or (iii) a product that is in violation of 21 U.S.C.  355,
360, 350e, 42 U.S.C.  262 and 21 C.F.R 1271 (or similar Laws), in any manner
which individually or in the aggregate has had or would reasonably be expected
to have a Company Material Adverse Effect.

  

  

(e) Neither the Company nor any of its Subsidiaries, nor, to the Knowledge of
the Company, any officer, employee, agent or distributor of the Company or any
of its Subsidiaries, has made an untrue statement of a material fact or
fraudulent statement to the FDA or any other Governmental Entity, failed to
disclose a material fact required to be disclosed to the FDA or any other
Governmental Entity, or committed an act, made a statement, or failed to make
a statement that, at the time such disclosure was made, would reasonably be
expected to provide a basis for the FDA or any other Governmental Entity to
invoke its policy respecting "Fraud, Untrue Statements of Material Facts,
Bribery, and Illegal Gratuities", set forth in 56 Fed. Reg. 46191 (September
10, 1991) or any similar policy. Neither the Company nor any of its
Subsidiaries, nor, to the Knowledge of the Company, any officer, employee or
agent of the Company or any of its Subsidiaries, has been convicted of any
crime or engaged in any conduct for which debarment is mandated by 21 U.S.C. 
335a(a) or any similar Law or authorized by 21 U.S.C.  335a(b) or any similar
Law. Neither the Company nor any of its Subsidiaries, nor, to the Knowledge of
the Company, any officer, employee or agent of the Company or any of its
Subsidiaries, has been convicted of any crime or engaged in any conduct for
which such person or entity could be excluded from participating in the
Federal health care programs under Section 1128 of the Social Security Act of
1935, as amended (the "Social Security Act") or any similar Law.

  

  

(f) Neither the Company nor any of its Subsidiaries has received any written
notice that the FDA or any other Governmental Entity has (i) commenced, or
threatened to initiate, any action to enjoin the distribution of any Medical
Device, Biologic, Drug or HCT/P or (ii) commenced, or threatened to initiate,
any action to enjoin the manufacture of any Medical Device, Biologic, Drug or
HCT/P produced at any facility where any Medical Device, Biologic, Drug or
HCT/P is manufactured, tested, processed, packaged or held for sale.

  

  

(g) To the Knowledge of the Company, there are no material investigations,
suits, claims, actions or proceedings against or affecting the Company or any
of its Subsidiaries relating to or arising under (i) the FDCA and the
regulations of the FDA promulgated thereunder or similar Laws, (ii) the Public
Health Service Act of 1944, (iii) the Social Security Act or regulations of
the Office of the Inspector General of the Department of Health and Human
Services or similar Laws, (iv) applicable Laws relating to government health
care programs, private health care plans, or the privacy and confidentiality
of patient health information, including United States federal and state Laws
pertaining to the Medicare and Medicaid programs, United States federal and
state Laws applicable to health care fraud and abuse, kickbacks, physician
self-referral, false claims made to a government or private health care
program, and United States federal or state Laws pertaining to contracting
with the government and similar Laws or (v) the Foreign Corrupt Practices Act.

  

  

 

 

 

  

 

-29-  

  

 

 

 

   
 

(h) Each of the Company and its Subsidiaries has in effect all material
Company Permits under the FDCA and the regulations of the FDA promulgated
thereunder (such Company Permits, the "Regulatory Permits"), necessary for it
to own, lease and operate its properties and other assets and to carry on its
business and operations as presently conducted. There has occurred no material
default under, or material violation of, any such Regulatory Permit. The
consummation of the Merger, in and of itself, would not cause the revocation
or cancellation of any such Regulatory Permit.

  

  

Section 3.25 Relationships with Customers and Suppliers. Since October 31,
2010, no customer or supplier of the Company or any of its Subsidiaries that
is material to the Company and its Subsidiaries, taken as a whole, has
canceled or otherwise terminated, or provided written notice to the Company or
any of its Subsidiaries of its intent, or, to the Knowledge of the Company,
threatened, to terminate its relationship with the Company or the applicable
Subsidiary, or, since October 31, 2010, decreased or limited in any material
respect, or provided notice to the Company or any of its Subsidiaries of its
intent, or, to the Knowledge of the Company, threatened, to decrease or limit
in any material respect, its purchases from or sales to the Company or any of
its Subsidiaries.

  

  

Section 3.26 Rights Agreement. The Company has amended the Rights Agreement to
provide that: (a) none of the Parent, any of its stockholders nor any of their
respective Affiliates or Associates (as such terms are defined in the Rights
Agreement), shall be deemed to be an Acquiring Person (as defined in the
Rights Agreement) as a result of the execution, delivery or performance of
this Agreement, the Voting Agreements or the consummation of the Merger or any
of the other transactions contemplated by this Agreement; (b) neither a Stock
Acquisition Date (as defined in the Rights Agreement) nor a Distribution Date
(as defined in the Rights Agreement) shall be deemed to occur as a result of
the execution, delivery or performance of this Agreement, the Voting
Agreements or the consummation of the Merger or any of the other transactions
contemplated by this Agreement; (c) the Rights (as defined in the Rights
Agreement) will not separate from the Company Shares as a result of the
execution, delivery or performance of this Agreement, the Voting Agreements or
the consummation of the Merger or any of the other transactions contemplated
by this Agreement; (d) the Rights Agreement is inapplicable to this Agreement,
the Merger and the other transactions contemplated by this Agreement; and (e)
the Expiration Date (as defined in the Rights Agreement) shall occur
immediately prior to the Effective Time (the Rights Agreement, as so amended,
being referred to as the "Amended Company Rights Agreement").

  

  

ARTICLE IV

  

  

COVENANTS RELATING TO CONDUCT OF BUSINESS

  

  

Section 4.1 Conduct of Business Pending the Merger. Except as expressly
permitted by clauses (a) through (v) of this Section 4.1, during the period
from the date of this Agreement until the Effective Time, the Company shall,
and shall cause each of its Subsidiaries to, conduct its business in the
ordinary course consistent with past practice (including with respect to
research, development and clinical trial activities and programs) and, to the
extent consistent therewith, use commercially reasonable efforts to preserve
intact its current business organization, keep available the services of its
current officers and employees and preserve its relationships with customers,
suppliers and others having business dealings with the intention that its
goodwill and ongoing business shall be unimpaired at the Effective Time.
Without limiting the generality of the foregoing, and except as otherwise
expressly contemplated by this Agreement or as set forth in Section 4.1 of the
Company Letter (with specific reference to the applicable subsection below),
the Company shall not, and shall not permit any of its Subsidiaries to,
without the prior written consent of Parent (which consent shall not be
unreasonably withheld, conditioned or delayed):

  

  

 

 

 

  

 

-30-  

  

 

 

 

   
 

(a) (i) declare, set aside or pay any dividends on, or make any other actual,
constructive or deemed distributions in respect of, any of its capital stock,
or otherwise make any payments to its shareholders in their capacity as such
other than dividends or distributions from wholly owned Subsidiaries of the
Company to the Company or other wholly owned Subsidiary of the Company, (ii)
split, combine or reclassify any of its capital stock or issue or authorize
the issuance of any other securities in respect of, in lieu of or in
substitution for shares of its capital stock or (iii) purchase, redeem or
otherwise acquire, or modify or amend, any shares of capital stock of the
Company or any Subsidiary or any other securities thereof or any rights,
warrants or options to acquire, any such shares or other securities;

  

  

(b) (i) authorize for issuance, issue, deliver, sell, pledge, dispose of,
grant, transfer or otherwise encumber or subject to any Encumbrance or agree
or commit to issue, deliver, sell, pledge, dispose of, grant, transfer or
encumber or subject to any Encumbrance any shares of its capital stock, any
other voting securities or equity equivalent, or any "phantom" stock,
"phantom" stock rights, stock appreciation rights or stock based performance
units, or any securities convertible into or exchangeable for, or any rights,
warrants or options of any kind to acquire, any such shares, voting
securities, equity equivalent, or any "phantom" stock, "phantom" stock rights,
stock appreciation rights or stock based performance units, or convertible or
exchangeable securities (other than the issuance of Company Shares (A) upon
the exercise of Company Stock Options outstanding on the date of this
Agreement in accordance with their current terms or (B) pursuant to the rights
outstanding under the ESPP on the date hereof, in accordance with their terms
as of the date hereof, subject to Section 5.4), (ii) enter into any amendment
of any term of any of its outstanding securities or (iii) accelerate the
vesting of any options, warrants or other rights of any kind to acquire any
shares of capital stock to the extent that such acceleration of vesting does
not occur automatically under the terms of any such interests or plans
governing such interests;

  

  

(c) amend or propose to amend its certificate of incorporation or bylaws or
other comparable organizational documents;

  

  

(d) acquire or agree to acquire by merging or consolidating with, by
purchasing a substantial portion of the assets of or equity in or by any other
manner, any business or any corporation, limited liability company,
partnership, joint venture, association or other business organization or
division thereof or otherwise acquire or agree to acquire any assets, other
than assets acquired in the ordinary course of business consistent with past
practice and not material to the Company and its Subsidiaries, taken as a
whole;

  

  

 

 

 

  

 

-31-  

  

 

 

 

   
 

(e) sell, transfer, lease, license (as licensor of Intellectual Property
Rights of the Company), mortgage, pledge, encumber or subject to any
Encumbrance, or otherwise dispose of any of its properties or assets, other
than sales, leases or licenses of products or services in the ordinary course
of business consistent with past practice and not material to the Company and
its Subsidiaries, taken as a whole;

  

  

(f) (i) incur, assume or modify any indebtedness for borrowed money,
guarantee, endorse or otherwise become liable or responsible for (whether
directly, contingently or otherwise), any such indebtedness or other
obligations of another Person or make any loans, advances or capital
contributions to, or other investments in, any other Person, other than
indebtedness, obligations, loans, advances, capital contributions and
investments between the Company and any of its wholly owned Subsidiaries or
between any of such wholly owned Subsidiaries, (ii) issue or sell any debt
securities or warrants or other rights to acquire any debt securities of the
Company or any of its Subsidiaries, (iii) enter into any "keep well" or other
agreement to maintain any financial statement condition of another Person
other than any of the wholly owned Subsidiaries of the Company or (iv) enter
into any arrangement having the economic effect of any of the foregoing, in
each case, other than in the ordinary course of business, and in amounts and
on terms consistent with past practice, in an aggregate amount up to $100,000;

  

  

(g) alter (through merger, liquidation, dissolution, reorganization,
restructuring, recapitalization or in any other fashion) the corporate
structure or ownership of the Company or any Subsidiary;

  

  

(h) enter into, adopt or amend any Company Plan, collective bargaining
agreement or employment or consulting Contract, except as required by
applicable Law;

  

  

(i) increase the compensation or benefits payable or to become payable to its
directors, officers or employees (except, in the case of employees below the
level of Vice President, for increases in the ordinary course of business
consistent with past practice in salaries or wages of employees of the Company
or any of its Subsidiaries) or grant any severance, change of control,
retention or termination pay to, or enter into or amend any employment, change
of control, retention or severance Contract with, any current or former
director, officer or employee of the Company or any of its Subsidiaries, or
establish, adopt, enter into or, except as may be required to comply with
applicable Law, amend or take action to enhance or accelerate any rights or
benefits under, any labor, bonus, profit sharing, thrift, compensation, stock
option, restricted stock, pension, retirement, deferred compensation,
employment, termination, severance or other plan, Contract, trust, fund,
policy or arrangement for the benefit of any current or former director,
officer or employee;

  

  

(j) knowingly violate or knowingly fail to perform any obligation or duty
imposed upon it or any Subsidiary by any applicable material federal, state or
local Law;

  

  

(k) make or adopt any change to its accounting methods, practices or policies
(other than actions required to be taken by GAAP or Regulation S-X of the
Exchange Act);

  

  

 

 

 

  

 

-32-  

  

 

 

 

   
 

(l) (i) enter into, amend, cancel, terminate, extend or request any material
change in, or agree to any material change in, any Company Contract (or any
other Contract to the extent such action would cause such Contract to be a
Company Contract), other than in the ordinary course of business consistent
with past practice or (ii) waive, release or assign, in any respect, any
material rights under any Company Contract (or any other Contract to the
extent such action would cause such Contract to be a Company Contract);

  

  

(m) enter into any Contract, or amend or extend any existing Contract, (i)
that would, after the Effective Time, restrict the Company or any of its
Affiliates with respect to engaging in any line of business or in any
geographical area, (ii) that contains exclusivity, most favored nation pricing
or non-solicitation provisions with respect to any customer or supplier that
would, after the Effective Time, apply to Parent or any of its Affiliates or
(iii) that would reasonably be expected to impair in any material respect the
ability of the Company to perform its obligations under this Agreement;

  

  

(n) authorize, or enter into any commitment for, any capital expenditures not
contemplated by capital expenditure budgets made available to Parent and
exceeding $500,000 for any one project or series of related projects;

  

  

(o) waive or release any material right or claim or pay, discharge or satisfy
any material claims, liabilities or obligations (absolute, accrued, asserted
or unasserted, contingent or otherwise), other than the payment, discharge or
satisfaction, in the ordinary course of business consistent with past practice
or in accordance with their terms, of liabilities reflected or reserved
against in the most recent Company SEC Documents filed prior to the date of
this Agreement, or incurred in the ordinary course of business consistent with
past practice;

  

  

(p) initiate any material litigation or arbitration proceeding or settle or
compromise any material litigation or arbitration proceeding or any claim
involving intellectual property;

  

  

(q) enter into any agreement or arrangement that would be required to be
reported by the Company pursuant to Item 404 of Regulation S-K promulgated by
the SEC;

  

  

(r) (i) enter into (A) any material line of business in the United States
other than the line of business in the United States in which the Company and
its Subsidiaries is currently engaged or (B) any line of business outside of
the United States other than the line of business outside of the United States
in which the Company and its Subsidiaries is currently engaged, in each case
as of the date of this Agreement or (ii) distribute products or services (A)
in the United States other than the products and services that the Company and
its Subsidiaries are currently distributing in the United States or (B) to any
country outside the United States other than the products and services that
the Company and its Subsidiaries are currently distributing outside the United
States, in each case as of the date of this Agreement;

  

  

(s) (i) other than in the ordinary course of business consistent with past
practice and for an amount which is less than $250,000 in the aggregate, enter
into any Contracts relating to research, development, sale, supply, marketing
or manufacturing by third parties of products (including products under
development) of the Company or any Subsidiary of the Company or products
(including products under development) licensed by the Company or any
Subsidiary of the Company, (ii) other than in the ordinary course of business
consistent with past practice and for an amount which is less than $250,000 in
the aggregate, enter into any Contracts relating to clinical trials or (iii)
initiate, launch or commence any sale, marketing, distribution, co-promotion
or any similar activity with respect to any new product (including products
under development) in or outside the United States;

  

  

 

 

 

  

 

-33-  

  

 

 

 

   
 

(t) convene any annual or special meeting (or any adjournment thereof) of the
shareholders of the Company other than the Company Shareholder Meeting;

  

  

(u) authorize, recommend, propose or announce an intention to do any of the
foregoing or enter into any Contract to do any of the foregoing; or

  

  

(v) take any action, or omit to take any action, where such action or omission
would reasonably be expected to prevent, materially delay or impede the
consummation of the Merger or the other transactions contemplated by this
Agreement except as otherwise expressly permitted under Section 4.2.

  

  

None of the covenants contained in this Section 4.1 is intended to give Parent
or Merger Sub the right to control or direct the Company's or any of its
Subsidiary's operations prior to the Effective Time. Prior to the Effective
Time, the Company and its Subsidiaries shall exercise, in accordance with the
terms and conditions of this Agreement, operational control over their
respective businesses, assets and properties.

  

  

Section 4.2 No Solicitation.

  

  

(a) From the date of this Agreement until the earlier of the Effective Time or
the date on which this Agreement is terminated in accordance with the terms of
this Agreement, the Company shall not, nor shall it permit any of its
Subsidiaries to, nor shall it authorize or permit any officer, director,
employee, agent, financial advisor, attorney, accountant, investment banker or
other advisor or representative ("Representatives") of the Company or any of
its Subsidiaries to, directly or indirectly, (i) solicit, initiate or
knowingly facilitate, induce or encourage the making, announcement or
submission of, any Alternative Proposal (as hereinafter defined) or any
proposal that could reasonably be expected to lead to an Alternative Proposal;
(ii) enter into any letter of intent or agreement in principle or any Contract
contemplating, providing for, relating to or in connection with, any
Alternative Proposal or any proposal that could reasonably be expected to lead
to an Alternative Proposal; (iii) knowingly furnish any information regarding
the Company or any of its Subsidiaries to any Person in connection with or in
response to an Alternative Proposal; (iv) approve, endorse or recommend any
Alternative Proposal or any proposal that could reasonably be expected to lead
to an Alternative Proposal or (v) enter into, continue or otherwise
participate in any discussions or negotiations (including furnishing any
information) regarding any Alternative Proposal or any proposal that could
reasonably be expected to lead to an Alternative Proposal. Without limiting
the foregoing, it is agreed that (x) any violation of the restrictions set
forth in this Section 4.2(a) by any of the Company or its Subsidiaries or
their respective directors, officers, employees or Representatives and (y) any
violation of the restrictions set forth in Section 4.3 of the Voting Agreement
shall be deemed to be a breach of this Section 4.2(a) by the Company. The
Company will, and will cause each of its Subsidiaries and each of the
directors, officers, employees and Representatives of the Company and its
Subsidiaries to, immediately cease and cause to be terminated any and all
existing activities, discussions or negotiations with any Person conducted
heretofore with respect to any Alternative Proposal. The Company will promptly
request each Person that has heretofore executed a confidentiality agreement
in connection with its consideration of any Alternative Proposal to return or
destroy all confidential information furnished prior to the execution of this
Agreement to or for the benefit of such Person by or on behalf of the Company
or any of its Subsidiaries. The Company agrees that it will take the necessary
steps to promptly inform its directors, officers, employees and
Representatives of the obligations undertaken in this Section 4.2.

  

  

 

 

 

  

 

-34-  

  

 

 

 

   
 

(b) Notwithstanding anything to the contrary contained in Section 4.2(a) or
elsewhere in this Agreement, in the event that the Company receives after the
date of this Agreement and prior to obtaining the Company Shareholder
Approval, an unsolicited, bona fide written Alternative Proposal that did not
result from any breach of any of the provisions in this Section 4.2 and that
the Board of Directors of the Company determines in good faith (after
consultation with its outside legal counsel and a financial advisor of
nationally recognized reputation) to be a Superior Proposal or to be
reasonably likely to result in a Superior Proposal, the Company may, in
response to such Alternative Proposal, subject to compliance with this Section
4.2 and receiving from such Person an executed confidentiality agreement
containing terms no less favorable to the Company than the terms of the
Confidentiality Agreement (provided that such confidentiality agreement may
contain a less restrictive or no standstill restriction for any Person or any
of such Person's Affiliates not already subject to a confidentiality agreement
with the Company, in which case the Confidentiality Agreement shall be deemed
to be amended to contain only such less restrictive provision, or to omit such
provision, as applicable), then (i) furnish non-public information with
respect to the Company and its Subsidiaries to the Person making such
Alternative Proposal; provided that, contemporaneously with furnishing any
such information to such Person, it furnishes such information to Parent and
(ii) engage in discussions or negotiations with such Person with respect to
such Alternative Proposal; provided that, at least one Business Day prior to
furnishing any such information to, or entering into discussions or
negotiations with, such Person, the Company gives Parent written notice of the
identity of such Person and of the Company's intention to furnish information
to, or enter into discussions or negotiations with, such Person. It is
understood that the Company may enter into negotiations solely with respect to
entering into a confidentiality agreement with a Person who has made an
unsolicited, bona fide written Alternative Proposal that is or is reasonably
likely to result in a Superior Proposal without breaching, or being deemed to
breach, this Section 4.2.

  

  

The Company agrees that it and its Subsidiaries shall not enter into any
confidentiality agreement with any Person subsequent to the date of this
Agreement that prohibits the Company from providing information to Parent that
is required to be provided under this Section 4.2.

  

  

(c) In addition to the obligations of the Company set forth in Sections
4.2(a), 4.2(b) and 4.2(d), as promptly as practicable (and in any event within
one Business Day) after receipt of any Alternative Proposal or any request for
nonpublic information or any inquiry that, in any such case, relates in any
way to, or would reasonably be expected to lead to, any Alternative Proposal,
the Company shall provide Parent with written notice of the material terms and
conditions of such Alternative Proposal, request or inquiry, and the identity
of the Person or group making any such Alternative Proposal, request or
inquiry and a copy of all written materials provided to it in connection with
such Alternative Proposal, request or inquiry. In addition, the Company shall
provide Parent as promptly as practicable (and in any event within one
Business Day) with such information as is reasonably necessary to keep Parent
fully informed of all material written communications regarding, and the
status and changes to the economic or other material terms of, any such
Alternative Proposal, request or inquiry, and shall provide, as promptly as
reasonably practicable, to Parent a copy of all material written
communications (including material written communications provided by email or
otherwise in electronic format) provided by or to the Company, any of its
Subsidiaries or any of their Representatives in connection with such
Alternative Proposal, request or inquiry. The Company shall provide Parent
with forty eight (48) hours prior written notice, or if such meeting is
scheduled on less than 48 hours notice then as promptly as practicable prior
to such meeting, of any meeting of its Board of Directors at which its Board
of Directors is reasonably expected to consider any Alternative Proposal.

  

  

 

 

 

  

 

-35-  

  

 

 

 

   
 

(d) Neither the Board of Directors of the Company nor any committee thereof
shall, directly or indirectly, (i) (A) withhold, withdraw or qualify (or amend
or modify in a manner adverse to Parent) or publicly propose to withhold,
withdraw or qualify (or amend or modify in a manner adverse to Parent), the
approval, recommendation or declaration of advisability by such Board of
Directors or any committee thereof of this Agreement, the Plan of Merger, the
Merger or the other transactions contemplated by this Agreement or make any
public statement in connection with such recommendations by the Company's
Board of Directors or Company Shareholder Meeting or in reference to an
Alternative Proposal, that is inconsistent with the recommendation of the
Company's Board of Directors to the Company's shareholders to approve the
Merger and adopt the Plan of Merger, (B) recommend, adopt or approve, or
publicly propose to recommend, adopt or approve, any Alternative Proposal or
(C) (1) fail to publicly reaffirm the recommendation of the Company's Board of
Directors to the Company's shareholders to approve the Merger and adopt the
Plan of Merger, or fail to publicly state that the Merger and this Agreement
are in the best interest of the Company's shareholders, within five Business
Days after Parent requests in writing that such action be taken; (2) fail to
publicly announce, within five Business Days after a tender offer or exchange
offer relating to the securities of the Company and, in each case, which is an
Alternative Proposal, shall have been commenced, a statement disclosing that
the Company's Board of Directors recommends rejection of such tender or
exchange offer; or (3) fail to issue publicly, within five Business Days after
an Alternative Proposal is publicly announced, a press release announcing its
opposition to such Alternative Proposal (any action described in this clause
(i) being referred to as a "Company Adverse Recommendation Change") or (ii)
approve, adopt or recommend, or publicly propose to approve, adopt or
recommend, or allow the Company or any of its Affiliates to execute or enter
into, any letter of intent, memorandum of understanding, agreement in
principle, merger agreement, acquisition agreement, option agreement, joint
venture agreement, partnership agreement or other similar agreement,
arrangement or understanding or any tender offer (A) constituting, or relating
to, any Alternative Proposal or (B) requiring it (or that would require it) to
abandon, terminate or fail to consummate the Merger or any other transaction
contemplated by this Agreement. Notwithstanding anything to the contrary set
forth in this Section 4.2(d) or in any other provision of this Agreement, the
Board of Directors of the Company may make a Company Adverse Recommendation
Change or terminate this Agreement pursuant to Section 7.1(f) and (solely with
respect to clause (x) of this sentence) concurrently enter into a definitive
agreement with respect to such Superior Proposal, if and only if either (x)
such action is taken in response to a Superior Proposal that was made after
the date of this Agreement and that did not otherwise result from a breach of
this Section 4.2 or (y) in the absence of a Superior Proposal, there are
material events or changes in circumstances after the date hereof that were
neither known to nor reasonably foreseeable by the Company as of or prior to
the date hereof, that materially improve the financial condition, results of
operations or prospects of the Company and its Subsidiaries and that do not
relate to (1) an Alternative Proposal, (2) any events or changes in
circumstances relating to Parent or Merger Sub (or any of their respective
Affiliates), (3) clearance of the Merger under the HSR Act or any other
Antitrust Laws or (4) the fact, in each case in and of itself, that the
Company meets or exceeds any internal or published projections, forecasts or
estimates of its revenue, earnings or other financial performance or results
of operations for any period ending on or after the date hereof, or changes
after the date of this Agreement in the market price or trading volume of the
Company Common Stock or any credit rating of the Company (provided that the
events or changes giving rise to or contributing to such material improvement
or improvements may be taken into account in making the determination under
this clause (y)) (an "Intervening Event"); provided that all of the following
conditions in clauses (i) through (vi) are met, as applicable:

  

  

 

 

 

  

 

-36-  

  

 

 

 

   
 

(i) in the case of a Company Adverse Change Recommendation or termination in
response to a Superior Proposal, such Superior Proposal has been made and has
not been withdrawn and continues to be a Superior Proposal;

  

  

(ii) the Company Shareholder Approval has not been obtained;

  

  

(iii) the Company has (A) provided to Parent four (4) Business Days' prior
written notice which shall state expressly (1) that it has received a Superior
Proposal or that there has been an Intervening Event, (2) the material terms
and conditions of any Superior Proposal (including the per share value of the
consideration offered therein and the identity of the Person or group of
Persons making the Superior Proposal), and shall have contemporaneously
provided a copy of the relevant proposed transaction agreements with the
Person or group of Persons making such Superior Proposal and other material
documents, including the definitive agreement with respect to such Superior
Proposal (the "Alternative Transaction Agreement") (it being understood and
agreed that any amendment to the financial terms or any other material term of
such Superior Proposal shall require a new notice and a new four (4) Business
Day period), (3) the material details of any Intervening Event (including
specifying the estimated dollar value or range of estimated dollar values
attributed to such Intervening Event) and (4) that it intends to terminate
this Agreement, and the manner in which it intends to do so, and (B) prior to
terminating this Agreement, to the extent requested by Parent, engaged in good
faith negotiations with Parent to amend this Agreement in such a manner that,
in the case of a Superior Proposal, the transaction contemplated by the
Alternative Transaction Agreement ceases to constitute a Superior Proposal or,
in the case of an Intervening Event, that causes the Company's Board of
Directors not to adopt a Company Adverse Recommendation Change;

  

  

 

 

 

  

 

-37-  

  

 

 

 

   
 

(iv) the Company shall have complied with this Section 4.2;

  

  

(v) the Company pays all fees and expenses as required pursuant to Section
7.3; and

  

  

(vi) the Company's Board of Directors determines in good faith, after having
consulted with its outside legal counsel, that, in light of the Superior
Proposal or Intervening Event, a failure to make a Company Adverse
Recommendation Change would reasonably constitute a breach of the fiduciary
duties of the Company's Board of Directors to the Company's shareholders under
applicable Law.

  

  

(e) Notwithstanding anything to the contrary in Section 4.2(a) or 4.2(d),
prior to the Company Shareholder Meeting, nothing contained in this Agreement
shall prevent the Company or its Board of Directors from complying with Rules
14d-9 and 14e-2 under the Exchange Act or publicly disclosing the existence of
an Alternative Proposal to the extent the Board of Directors of the Company
determines in good faith (after consultation with its outside counsel) that
the failure to make such disclosure is reasonably likely to result in a breach
of its fiduciary duties to the Company's shareholders under applicable Law;
provided, however, that in no event shall the Company or its Board of
Directors or any committee thereof take, or agree or resolve to take, any
action prohibited by Section 4.2(d) (it being understood that any accurate
disclosure of factual information required to be made under applicable Law
shall not be considered a modification prohibited by Section 4.2(d) and that
the issuance of any "stop, look and listen" communication under Rule 14d-9(f)
of the Exchange Act would not violate Section 4.2(d)).

  

  

Section 4.3 Third Party Standstill Agreements. During the period from the date
of this Agreement through the Effective Time, the Company shall not terminate,
amend, modify or waive, or permit the release of any Person from, any
provision of any confidentiality, non-solicitation, no hire, "standstill" or
similar Contract to which the Company or any of its Subsidiaries is a party or
under which the Company or any of its Subsidiaries has any rights, and will
use commercially reasonable efforts to cause each such agreement to be
enforced at the request of Parent, including obtaining injunctions to prevent
any breaches of, and to enforce specifically, such agreements.

  

  

ARTICLE V

  

  

ADDITIONAL AGREEMENTS

  

  

Section 5.1 Preparation of the Proxy Statement. Parent and the Company will as
promptly as practicable after the date of this Agreement jointly prepare the
Proxy Statement, and the Company shall file the Proxy Statement with the SEC,
and shall use all commercially reasonable efforts to respond to the comments
of the SEC and to cause the Proxy Statement to be mailed to the Company
Shareholders at the earliest practical time. The Company shall furnish all
information concerning it and the holders of its capital stock as Parent may
reasonably request in connection with such actions, and Parent shall furnish
all information concerning it and Merger Sub as the Company may reasonably
request in connection with such actions. Each party to this Agreement will
notify the other parties promptly of the receipt of the comments of the SEC,
if any, and of any request by the SEC for amendments or supplements to the
Proxy Statement or for additional information with respect thereto, and will
supply the other parties with copies of all correspondence between such party
or its Representatives, on the one hand, and the SEC or members of its staff,
on the other hand, with respect to the Proxy Statement or the Merger.
Notwithstanding the foregoing, prior to filing or mailing the Proxy Statement
(or any amendment or supplement thereto) or responding to any comments of the
SEC or the staff of the SEC with respect thereto, the Company (a) shall
provide Parent an opportunity to review and comment on such document or
response and (b) shall include in such document or response all comments
reasonably proposed by Parent; provided that Parent shall use commercially
reasonable efforts to provide or cause to be provided its comments to the
Company as promptly as reasonably practicable after such document or response
is transmitted to Parent for its review. If at any time prior to the Effective
Time, any information relating to the Company or Parent, or any of their
respective Affiliates, directors or officers, should be discovered by the
Company or Parent that should be set forth in an amendment or supplement to
the Proxy Statement, so that such document would not include any misstatement
of a material fact or omit to state any material fact necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading, the party that discovers such information shall promptly
notify the other parties hereto and an appropriate amendment or supplement
describing such information shall be promptly filed with the SEC and, to the
extent required by Law, disseminated to the shareholders of the Company.

  

  

 

 

 

  

 

-38-  

  

 

 

 

   
 

Section 5.2 Company Shareholder Meeting.

  

  

(a) The Company will, as soon as practicable following the date on which the
SEC's comments to the Proxy Statement, if any, are resolved, establish a
record date for, duly call, give notice of, convene and hold a meeting of
shareholders (the "Company Shareholder Meeting") for the purpose of the
Company's shareholders duly approving the Merger and adopting the Plan of
Merger (the "Company Shareholder Approval") and to vote, on an advisory basis,
on a proposal to approve the compensation that may be payable to the Company's
named executive officers in connection with the Merger (a "say-on-golden
parachute compensation" vote) as required by Section 14A of the Exchange Act
and the applicable SEC rules issued thereunder, and shall not submit any other
proposals to such holders without the prior written consent of Parent. The
Company shall take all action necessary in accordance with applicable Law and
the Company Charter and Company Bylaws to duly call, give notice of, and
convene the Company Shareholder Meeting. Subject to Section 4.2(d), the
Company shall (i) solicit from the Company's shareholders entitled to vote at
the Company Shareholder Meeting proxies in favor of such approval and (ii)
take all other action reasonably necessary to secure the vote or consent of
such holders required by the MBCA or this Agreement to effect the Merger. The
Company shall ensure that all proxies solicited by the Company and its
Subsidiaries and their Representatives in connection with the Company
Shareholder Meeting are solicited in compliance with all applicable Laws.

  

  

(b) The Company shall, through its Board of Directors, recommend to its
shareholders approval of the Merger and adoption of the Plan of Merger, shall
use commercially reasonable efforts to solicit such approvals and adoption by
its shareholders and such Board of Directors or committee thereof shall not,
directly or indirectly, withhold, withdraw, qualify, amend or modify in a
manner adverse to Parent such recommendation or its declaration that this
Agreement and the Merger are advisable and fair to and in the best interest of
the Company and its shareholders or resolve or propose to do any of the
foregoing, except to the extent expressly permitted by Section 4.2(d). The
Proxy Statement shall include the recommendation of the Board of Directors of
the Company, subject to any modification, amendment or withdrawal thereof, and
the Company represents that Piper Jaffray and Co. has, subject to the terms of
its engagement letter with the Company and the Board of Directors of the
Company, consented to the inclusion of references to its opinion in the Proxy
Statement.

  

   
 

 

 

 

  

 

-39-  

  

 

 

 

   
 

Section 5.3 Access to Information; Confidentiality. The Company shall afford
to Parent, and to Parent's officers, employees, accountants, counsel,
financial advisors and other Representatives, reasonable access during normal
business hours and upon reasonable prior notice to the Company during the
period prior to the Effective Time or the termination of this Agreement to all
its and its Subsidiaries' properties, books, Contracts and records but only to
the extent that such access is not prohibited by applicable Law and does not
unreasonably interfere with the business or operations of the Company and its
Subsidiaries, and, during such period, the Company shall furnish promptly to
Parent (a) a copy of each report, schedule, registration statement and other
document filed by it after the date of this Agreement pursuant to the
requirements of Federal or state securities Laws, other than any such report,
schedule, registration statement or other document that is available in
unredacted form on EDGAR, (b) a copy of each correspondence or written
communication, other than immaterial correspondence and written communication,
with any United States Federal or state Governmental Entity and (c) all other
information concerning its and its Subsidiaries' business, properties and
personnel as Parent may reasonably request; provided, however, that the
Company shall not be required to (or to cause any of its Subsidiaries to)
afford such access or furnish such copies or other information to the extent
that doing so would result in a violation of applicable Law or the loss of
attorney-client privilege (provided that the Company shall use its reasonable
efforts to allow for such access or disclosure in a manner that does not
result in a violation of applicable Law or loss of attorney-client privilege).
Except for disclosures expressly permitted by the terms of the Confidentiality
Agreement, Parent shall hold, and shall cause its officers, employees,
accountants, counsel, financial advisors and other Representatives to hold,
all information received from the Company, directly or indirectly, in
confidence in accordance with the Confidentiality Agreement and shall
otherwise comply with the Confidentiality Agreement with respect to such
information; provided that the Confidentiality Agreement shall terminate at
the Effective Time. No investigation pursuant to this Section 5.3 or
information provided or received by any party hereto pursuant to this
Agreement will affect any of the representations or warranties of the parties
hereto contained in this Agreement or the conditions hereunder to the
obligations of the parties hereto.

  

  

Section 5.4 Company Stock Options and ESPP.

  

  

(a) As soon as practicable following the date of this Agreement, the Board of
Directors of the Company (or, if appropriate, any committee thereof
administering the Company's 2006 Stock Incentive Plan, the ESPP and any other
plan pursuant to which stock options or employee stock purchase rights are
outstanding (collectively, the "Company Stock Plans") shall adopt such
resolutions or take such other actions as may be required to effect the
following:

  

  

 

 

 

  

 

-40-  

  

 

 

 

   
 

(i) adjust the terms of all outstanding Company Stock Options, whether vested
or unvested, as necessary to provide that, at the Effective Time, each Company
Stock Option outstanding immediately prior to the Effective Time shall be
canceled and the holder thereof shall then become entitled to receive the cash
payment described in Section 1.5(e); and

  

  

(ii) make such other changes to the Company Stock Plans as the Company and
Parent may agree are appropriate to give effect to the Merger.

  

  

(b) As soon as practicable following the date of this Agreement, the Board of
Directors of the Company (or, if appropriate, any committee of the Board of
Directors of the Company administering the ESPP), shall adopt such resolutions
or take such other actions as may be required to provide that with respect to
the ESPP (i) participation following the date of this Agreement shall be
limited to those employees who participate on the date of this Agreement, (ii)
except to the extent necessary to maintain the status of the ESPP as an
"employee stock purchase plan" within the meaning of Section 423 of the Code
and the Treasury Regulations thereunder, participants may not increase their
payroll deductions or purchase elections from those in effect on the date of
this Agreement, (iii) no offering period shall be commenced after the date of
this Agreement, (iv) each participant's outstanding right to purchase Company
Shares under the ESPP shall terminate on the day immediately prior to the day
on which the Effective Time occurs (if not earlier terminated pursuant to the
terms of the ESPP); provided that all amounts allocated to each participant's
account under the ESPP as of such date shall thereupon be used to purchase
from the Company whole shares of Company Common Stock at the applicable price
determined under the terms of the ESPP for the then outstanding offering
periods using such date as the final purchase date for each such offering
period, and (v) assuming the occurrence of the Effective Time, the ESPP shall
terminate immediately following such purchases of Company Shares.

  

  

(c) All amounts payable pursuant to Sections 5.4(a) and 5.4(b) shall be
subject to any required withholding of Taxes and shall be paid without
interest as soon as practicable following the Effective Time.

  

  

(d) The Company shall ensure that following the Effective Time, no holder of a
Company Stock Option or other stock-based award (or former holder of a Company
Stock Option or other stock-based award) or any current or former participant
in any Company Stock Plan or Company Plan shall have any right thereunder to
acquire any capital stock of the Company, the Surviving Corporation or their
Subsidiaries or any other equity interest therein (including "phantom" stock,
"phantom" stock rights, stock appreciation rights or stock based performance
units).

  

  

(e) Prior to the Effective Time, the Company shall take all steps reasonably
required to cause the transactions contemplated by this Section 5.4 and any
other dispositions of Company equity securities (including derivative
securities) in connection with this Agreement by each individual who is a
director or officer of the Company subject to Section 16 of the Exchange Act
to be exempt under Rule 16b-3 under the Exchange Act.

  

  

 

 

 

  

 

-41-  

  

 

 

 

   
 

Section 5.5 Reasonable Best Efforts. Subject to the terms and conditions of
this Agreement, except with respect to filings under the HSR Act and matters
involving Antitrust Laws (which shall be governed by Section 5.6), each party
will use its reasonable best efforts to take, or cause to be taken, all
actions and to do, or cause to be done, all things necessary, proper or
advisable under applicable Law to consummate the transactions contemplated by
this Agreement, including preparing and filing as promptly as practicable all
documentation to effect all necessary filings, notices, petitions, statements,
submissions of information, applications and other documents, and to obtain
all Company Permits which are material to the Company and its Subsidiaries,
taken as a whole, with respect to the transactions contemplated by this
Agreement.

  

  

Section 5.6 HSR and Competition Filings.

  

  

(a) As promptly as reasonably practicable (but in no event later than ten (10)
Business Days after the date of this Agreement), each of Parent and the
Company shall file any Notification and Report Forms and related material
required to be filed by it with the Federal Trade Commission and the Antitrust
Division of the United States Department of Justice under the HSR Act with
respect to the transactions contemplated by this Agreement and shall promptly
make any further filings pursuant thereto that may be necessary, proper or
advisable (the "HSR Filings") and in any other jurisdictions in which a
competition filing may be required.

  

  

(b) Upon and subject to the terms of this Section 5.6, Parent and the Company
shall, and shall cause their respective Subsidiaries to (i) use their
commercially reasonable efforts to obtain prompt termination of any waiting
period under the HSR Act or other Antitrust Laws; (ii) cooperate and consult
with each other in connection with the making of all HSR Filings and any other
material actions pursuant to this Section 5.6, including subject to applicable
Law, by permitting counsel for the other party to review in advance, and
consider in good faith the views of the other party in connection with, any
proposed written communication to any Antitrust Authority and by providing
counsel for the other party with copies of all filings and submissions made by
such party and all correspondence between such party (and its advisors) with
any Antitrust Authority and any other information supplied by such party and
such party's Subsidiaries to an Antitrust Authority or received from an
Antitrust Authority in connection with such HSR Filings or any applicable
Antitrust Laws in connection with the transactions contemplated by this
Agreement; provided, however, that materials may be redacted before being
provided to the other party (A) to remove references concerning the valuation
of Parent, the Company, or any of their Subsidiaries, (B) as necessary to
comply with contractual arrangements and (C) as necessary to address
reasonable privilege concerns or reasonable confidentiality concerns that
cannot be addressed by limiting the distribution of the document to outside
counsel; (iii) furnish to the other parties such information and assistance as
such parties reasonably may request in connection with the preparation of any
submissions to, or agency proceedings by, any Antitrust Authority; and (iv)
promptly inform the other party of any communications with, and inquiries or
requests for information from, such Antitrust Authority in connection with the
transactions contemplated by the Agreement and permit the other party to
participate in such communications to the extent permitted by the Antitrust
Authority (with the same provisos as in clauses (ii)(A)-(C) of this Section
5.6(b)). In furtherance and not in limitation of the covenants of the parties
contained in Section 5.6(a) and this Section 5.6(b), each party agrees to
cooperate and use its commercially reasonable efforts to assist in any defense
by any other party hereto of the transactions contemplated by this Agreement
before any Antitrust Authority reviewing the transactions contemplated by this
Agreement, including by providing (as promptly as practicable) such
information as may be requested by such Antitrust Authority or such assistance
as may be reasonably requested by the other party hereto in such defense.

  

  

 

 

 

  

 

-42-  

  

 

 

 

   
 

(c) If any objections are asserted by any Antitrust Authority with respect to
the transactions contemplated hereby, or if any Action is instituted by any
Governmental Entity challenging any of the transactions contemplated hereby as
violative of any applicable Antitrust Law or an Order is issued enjoining the
transactions contemplated by this Agreement, in each case under any applicable
Antitrust Law, Parent shall, subject to the provisions of this Section 5.6,
use its commercially reasonable efforts to resolve any such objections or
challenge as such Antitrust Authority may have to such transactions under such
Law or to have such Order vacated, reversed or otherwise removed in accordance
with applicable legal procedures with the goal of enabling the transactions
contemplated by this Agreement to be consummated by the Outside Date (as
hereinafter defined), and the Company shall use its commercially reasonable
efforts to assist Parent in effectuating the foregoing; provided, however,
that (i) the Company shall not take any of the foregoing actions without the
prior written consent of Parent, (ii) Parent shall not take any of the
foregoing actions without the prior written consent of the Company if such
actions would bind the Company to take any action (including paying money or
entering into any other obligation) and (iii) that such action shall be
conditioned on the consummation of the Merger.

  

  

(d) Notwithstanding anything to the contrary contained in this Agreement,
Parent shall not be obligated to agree (and failure to so agree shall not
constitute a failure by Parent to satisfy its "commercially reasonable
efforts" obligations as provided in this Section 5.6), and neither the Company
nor any Subsidiary shall agree without Parent's prior written consent, to take
any action or accept any condition, restriction, obligation or requirement
with respect to Parent, the Company, their respective Subsidiaries or their
and their respective Subsidiaries' assets if such action, condition,
restriction, obligation or requirement (i) would reasonably be expected to
require Parent, the Company or their respective Subsidiaries to sell, license,
transfer, assign, lease, dispose of or hold separate any business or assets,
(ii) would reasonably be expected to result in any limitations on Parent, the
Company or their respective Subsidiaries to own, retain, conduct or operate
all or a material portion of their respective businesses or assets or (iii)
would reasonably be expected to require Parent, the Company or their
respective Subsidiaries to grant any material right or commercial or other
accommodation to, or enter into any commercial contractual or other commercial
relationship with, any third party, if the actions referred to in the
foregoing (i) - (iii), individually or in the aggregate, would be material to
the business or financial condition of Parent and its Subsidiaries, taken as a
whole, or the Company and its Subsidiaries, taken as a whole.

  

  

Section 5.7 Public Announcements. The parties agree that the initial press
release(s) to be issued with respect to the transactions contemplated by this
Agreement shall be in the form(s) heretofore agreed to by the parties. Except
with respect to any Company Adverse Recommendation Change made in accordance
with the terms of this Agreement, Parent and Merger Sub, on the one hand, and
the Company, on the other hand, shall, to the extent at all reasonably
practicable, consult with each other before making, and give each other a
reasonable opportunity to review and comment upon, any press release or other
public statements with respect to this Agreement, the Merger and the other
transactions contemplated by this Agreement, and shall not issue any such
press release or make any such public statement prior to such reasonably
practicable consultation, except as may be required by applicable Law, court
process or by obligations pursuant to any listing agreement with any national
securities exchange or national securities quotation system.

  

  

 

 

 

  

 

-43-  

  

 

 

 

   
 

Section 5.8 State Takeover Laws. If any "fair price," "business combination"
or "control share acquisition" statute or other similar statute or regulation
shall become, or purport to become, applicable to the transactions
contemplated hereby, Parent and the Company and their respective Boards of
Directors shall use their reasonable best efforts to grant such approvals and
take such actions as are necessary so that the transactions contemplated
hereby may be consummated as promptly as practicable on the terms contemplated
hereby and otherwise act to eliminate the effects of any such statute or
regulation on the transactions contemplated hereby.

  

  

Section 5.9 Indemnification; Directors and Officers Insurance.

  

  

(a) For a period of six (6) years after the Effective Time (and until such
later date as of which any Action commenced during such six (6) year period
shall have been finally disposed of), Parent shall, and shall cause the
Surviving Corporation and its Subsidiaries to honor and fulfill in all
respects the obligations (including both indemnification and advancement of
expenses) of the Company and its Subsidiaries under the articles of
incorporation or any bylaws of the Company or its Subsidiaries or
indemnification agreements, in each case, in effect immediately prior to the
date of this Agreement and disclosed to Parent for the benefit of any of its
current or former directors and officers and any person who becomes a director
or officer of the Company or any of its Subsidiaries prior to the Effective
Time (the "Indemnified Parties").

  

  

(b) Parent shall provide, or shall cause the Surviving Corporation to provide,
for an aggregate period of not less than six (6) years from the Effective
Time, the Company's current directors and officers an insurance and
indemnification policy that provides coverage for events occurring prior to
the Effective Time (the "DandO Insurance") that is substantially similar (with
respect to limits and deductibles) to the Company's existing policy or, if
substantially similar insurance coverage is unavailable, the best available
coverage; provided, however, that Parent and the Surviving Corporation shall
not be required to pay an annual premium for the DandO Insurance in excess of
250% of the last annual premium paid prior to the date of this Agreement (the
"Company's Current Premium"). If such premiums for such insurance would at any
time exceed 250% of the Company's Current Premium, then Parent shall use its
reasonable efforts to cause to be maintained policies of insurance which, in
Parent's good faith determination, provide the maximum coverage available at
an annual premium equal to 250% of the Company's Current Premium. The Company
represents to Parent that the Company's Current Premium is $115,000.

  

  

Section 5.10 Notification of Certain Matters. Parent shall give prompt notice
to the Company, and the Company shall give prompt notice to Parent, of (i) the
occurrence, or non-occurrence, of any event the occurrence, or non-occurrence,
of which it is aware and which would be reasonably likely to cause (x) any
representation or warranty of the notifying party contained in this Agreement
to be untrue or inaccurate in any material respect or (y) any covenant,
condition or agreement of the notifying party contained in this Agreement not
to be complied with or satisfied in all material respects, (ii) any failure of
the notifying party to comply in a timely manner with or satisfy any covenant,
condition or agreement to be complied with or satisfied by it hereunder or
(iii) any change, event or effect which would be reasonably likely to,
individually or in the aggregate, have a Company Material Adverse Effect or,
unless the impairment or delay constituting such Parent Material Adverse
Effect results from any failure of the conditions set forth in Article VI to
be satisfied, a Parent Material Adverse Effect, as the case may be, on the
notifying party; provided, however, that the delivery of any notice pursuant
to this Section 5.10 shall not limit or otherwise affect the remedies
available hereunder to the party receiving such notice.

  

  

 

 

 

  

 

-44-  

  

 

 

 

   
 

Section 5.11 Employee Benefit Plans and Agreements. Parent shall use
commercially reasonable efforts to cause each Parent Plan covering employees
of the Company or its Subsidiaries to recognize prior, continuous service of
such employees with the Company and its Subsidiaries as service with Parent
and its Subsidiaries (i) for purposes of any waiting period and eligibility
requirements (and for purposes of determining the amount of severance payable
under any severance plan or arrangement maintained by Parent or its
Subsidiaries) under any Parent Plan that is a "welfare plan" (as defined in
Section 3(1) of ERISA) (to the extent permitted under the terms of the
insurance policy of any insured benefit plans) and (ii) for purposes of
eligibility (including eligibility for early retirement benefits) and vesting
(but not benefit accrual) under any Parent Plan that is a "pension plan" (as
defined in Section 3(2) of ERISA), to the extent such service was recognized
for such purposes under the applicable Company Plan. In addition, subject to
approval by Parent's benefit plan administrative committee, for each Parent
Plan that is a "welfare plan" (as defined in Section 3(1) of ERISA that Parent
makes available to such employees in lieu of a similar Company Plan), Parent
shall use commercially reasonable efforts to cause any eligible expenses
incurred by employees of the Company or its Subsidiaries and covered
dependents of such employees during the portion of the plan year of the
applicable Company Plan in which such employees participated immediately
before the Effective time, ending on the date such employees' participation in
the corresponding Parent Plan begins, to be taken into account under such
Parent Plan for purposes of satisfying all deductible, coinsurance and maximum
out-of-pocket requirements applicable to such employees and their covered
dependents for the applicable plan year as if such amounts had been paid in
accordance with such Parent Plan (to the extent permitted under the terms of
the insurance policy of any insured benefit plans). Prior to the Effective
Time (but not earlier than five (5) Business Days prior to the Effective
Time), the Company shall (unless otherwise instructed by the Buyer prior to
the taking of such actions) take all such actions as are necessary, including
without limitation, adoption of board resolutions or consents dated no later
than the day immediately prior to the Effective Time, to terminate the
Company's 401(k) Plan, effective no later than the day immediately prior to
the Effective Time. Nothing contained herein, express or implied: (i) shall be
construed to establish, amend, or modify any benefit plan, program, agreement
or arrangement, (ii) shall alter or limit Parent's, the Company's or any of
their Subsidiaries' ability to amend, modify or terminate any benefit plan,
program, agreement or arrangement, (iii) is intended to confer upon any
current or former employee any right to employment or continued employment for
any period of time by reason of this Agreement, or any right to a particular
term or condition of employment or (iv) is intended to confer upon any
individual (including employees, retirees, or dependents or beneficiaries of
employees or retirees) any right as a third-party beneficiary of this
Agreement.

  

  

 

 

 

  

 

-45-  

  

 

 

 

   
 

Section 5.12 Tax and Accounting Matters. During the period from the date of
this Agreement to the Effective Time:

  

  

(a) Except as required by applicable Tax Law or with Parent's prior written
consent, neither the Company nor any of its Subsidiaries will (i) make or
change any material Tax election, (ii) file any material amended Tax Return,
(iii) agree to any material adjustment of any Tax attribute, (iv) change (or
make a request to any Governmental Entity to change) any of its methods of
reporting income or deductions for Federal income Tax purposes, (v) file any
claim for a material refund of Taxes, (vi) consent to any extension or waiver
of the limitation period applicable to any material Tax claim or assessment
that could adversely affect Parent's Tax liability, (vii) make any change in
any financial or Tax accounting principle, method or practice, other than as
required by GAAP, the SEC, the Public Company Accounting Oversight Board,
applicable Law or as recommended by the Company's independent auditor or
(viii) settle or compromise any suit, claim, action, investigation, proceeding
or audit pending against or with respect to the Company or any of its
Subsidiaries in respect of any material amount of Tax or enter into any
material closing agreement that could adversely affect Parent's Tax liability
for any taxable period beginning on or after the Effective Time.

  

  

(b) The Company and each of its Subsidiaries will retain all books, documents
and records reasonably necessary for the preparation of Tax Returns.

  

  

Section 5.13 Certain Litigation. The Company shall promptly advise Parent
orally and in writing of any Action commenced after the date of this Agreement
against the Company or any of its directors by any shareholder of the Company
relating to this Agreement, the Merger and the transactions contemplated
hereby and shall keep Parent reasonably informed regarding any such
litigation. The Company shall give Parent the opportunity to consult with the
Company regarding the defense or settlement of any such Action and shall
consider Parent's views with respect to such Action and shall not settle any
such Action without the prior written consent of Parent.

  

  

ARTICLE VI

  

  

CONDITIONS PRECEDENT TO THE MERGER

  

  

Section 6.1 Conditions to Each Party's Obligation to Effect the Merger. The
respective obligations of each party to effect the Merger shall be subject to
the fulfillment or waiver by Parent and the Company at or prior to the
Effective Time of the following conditions:

  

  

(a) Shareholder Approval. The Company Shareholder Approval shall have been
obtained in accordance with applicable Law and the Company Charter and the
Company Bylaws.

  

  

(b) No Injunctions or Restraints. No temporary restraining order, preliminary
or permanent injunction or other judgment, order or decree issued by a court
or agency of competent jurisdiction located in the United States or in another
jurisdiction outside of the United States in which the Company or any of its
Subsidiaries, or Parent or any of its Subsidiaries, engage in business
activities that prohibits the consummation of the Merger or any of the other
material transactions contemplated by this Agreement shall have been issued
and remain in effect, and no Law shall have been enacted, issued, enforced,
entered, or promulgated that prohibits or makes illegal the consummation of
the Merger or any of the other material transactions contemplated by this
Agreement.

  

  

 

 

 

  

 

-46-  

  

 

 

 

   
 

(c) Antitrust Laws. The waiting period applicable to the consummation of the
transactions contemplated by this Agreement under the HSR Act shall have
expired or been terminated. All filings with or permits, authorizations,
consents and approvals of or expirations of waiting periods imposed by any
Antitrust Authority (other than pursuant to the HSR Act) required to
consummate the Merger shall have been obtained or filed or shall have
occurred.

  

  

Section 6.2 Conditions to Obligation of the Company to Effect the Merger. The
obligation of the Company to effect the Merger shall be subject to the
fulfillment or waiver by the Company at or prior to the Effective Time of the
following additional conditions:

  

  

(a) Performance of Obligations. Each of Parent and Merger Sub shall have
performed in all material respects each of its agreements contained in this
Agreement required to be performed on or prior to the Effective Time.

  

  

(b) Representations and Warranties. (i) The representations and warranties of
Parent and Merger Sub contained in Sections 2.2 and 2.5 shall be true and
correct in all material respects as of the date of this Agreement and as of
the Effective Time as though made on and as of such date (except to the extent
that any such representation or warranty speaks as of an earlier date, in
which case, such representation or warranty shall be true and correct in all
material respects as of such earlier date) and (ii) the other representations
and warranties of Parent and Merger Sub shall be true and correct in all
respects as of the date of this Agreement and as of the Effective Time as
though made on and as of such date (except to the extent that any such
representation or warranty speaks as of an earlier date, in which case, such
representation or warranty shall be true and correct in all respects as of
such earlier date), except where all failures of such representations and
warranties to be so true and correct (without giving effect to any Parent
Material Adverse Effect or materiality qualifications), has not had, or would
not be reasonably expected, individually or in the aggregate, to have a Parent
Material Adverse Effect.

  

  

(c) Officer's Certificate. The Company shall have received a certificate of an
executive officer of Parent, dated as of the date of Closing, as to the
satisfaction of the conditions set forth in Sections 6.2(a) and 6.2(b).

  

  

Section 6.3 Conditions to Obligations of Parent and Merger Sub to Effect the
Merger. The obligations of Parent and Merger Sub to effect the Merger shall be
subject to the fulfillment or waiver by Parent at or prior to the Effective
Time of the following additional conditions:

  

  

(a) Performance of Obligations. The Company shall have performed in all
material respects each of its agreements contained in this Agreement required
to be performed on or prior to the Effective Time.

  

  

(b) Representations and Warranties. (i) The representations and warranties of
the Company contained in Section 3.2 shall be true and correct in all respects
(except for any de minimis inaccuracy) as of the date of this Agreement and as
of the Effective Time as though made on and as of such date (except to the
extent that any such representation or warranty speaks as of an earlier date,
in which case, such representation and warranty shall be true and correct in
all respects as of such earlier date), (ii) the representations and warranties
of the Company contained in Sections 3.3, 3.21, 3.22, 3.23 and 3.26 shall be
true and correct in all material respects as of the date of this Agreement and
as of the Effective Time as though made on and as of such date (except to the
extent that any such representation or warranty speaks as of an earlier date,
in which case, such representation or warranty shall be true and correct in
all material respects as of such earlier date) and (iii) the other
representations and warranties of the Company shall be true and correct in all
respects as of the date of this Agreement and as of the Effective Time as
though made on and as of such date (except to the extent that any such
representation or warranty speaks as of an earlier date, in which case, such
representation or warranty shall be true and correct in all respects as of
such earlier date), except in the case of this clause (iii) where all failures
of such representations and warranties to be so true and correct (without
giving effect to any Company Material Adverse Effect or materiality
qualifications), has not had, or would not be reasonably expected to have,
individually or in the aggregate, a Company Material Adverse Effect.

  

  

 

 

 

  

 

-47-  

  

 

 

 

   
 

(c) Company Material Adverse Effect. Since the date of this Agreement, there
shall not have been any event, occurrence, fact, condition, effect, change or
development that, individually or in the aggregate, has had or would be
reasonably expected to have a Company Material Adverse Effect.

  

  

(d) Officer's Certificate. Parent shall have received a certificate of an
executive officer of the Company, dated as of the date of Closing, as to the
satisfaction of the conditions set forth in Sections 6.3(a), 6.3(b) and
6.3(c).

  

  

ARTICLE VII

  

  

TERMINATION, AMENDMENT AND WAIVER

  

  

Section 7.1 Termination. This Agreement may be terminated at any time prior to
the Effective Time, whether before or after the Company Shareholder Approval:

  

  

(a) by mutual written consent of Parent and the Company;

  

  

(b) by either Parent or the Company:

  

  

(i) if the Merger shall not have been consummated on or before June 12, 2012
(as extended as set forth below, the "Outside Date"); provided, however, that
the right to terminate this Agreement under this Section 7.1(b)(i) shall not
be available to any party whose breach of a representation, warranty or
covenant in this Agreement has been a principal cause of the failure of the
Merger to be consummated on or before the Outside Date; provided, further,
that if any condition set forth in Section 6.1(c) shall not have been
satisfied on June 12, 2012, then provided that the other conditions to Closing
(other than conditions that by their nature are to be satisfied on the date of
the Closing) shall have been satisfied, at the election of either Parent or
the Company by written notice to the other party, the Outside Date may be
extended until December 12, 2012; or

  

  

 

 

 

  

 

-48-  

  

 

 

 

   
 

(ii) if any Governmental Entity of competent jurisdiction shall have issued an
order, decree or ruling or taken any other action permanently restraining,
enjoining or otherwise prohibiting the Merger, in either case, (A) on the
basis that the Merger and the transactions contemplated thereby are violative
of any Antitrust Law or (B) for any reason other than as contemplated by
Section 7.1(b)(ii)(A), and, in each case, such order decree, ruling or action
shall have become final and nonappealable; provided, however, that the right
to terminate under this Section 7.1(b)(ii) shall not be available to any party
whose breach of this Agreement has been the principal cause of such action; or

  

  

(c) by Parent (provided it is not then in material breach of any of its
obligations under this Agreement) if (i) there is any continuing inaccuracy in
the representations and warranties of the Company set forth in this Agreement
or (ii) the Company is then failing to perform any of its covenants or other
agreements set forth in this Agreement such that, in the case of either clause
(i) or (ii), the conditions to closing set forth in Section 6.3(a) or 6.3(b),
as applicable, would not be satisfied as of the time of such termination and
such breach or condition is not curable or, if curable, is not cured within
thirty (30) days after written notice thereof is given by Parent to the
Company;

  

  

(d) by the Company (provided it is not then in material breach of any of its
obligations under this Agreement) if (i) there is any continuing inaccuracy in
the representations and warranties of Parent and Merger Sub set forth in this
Agreement or (ii) Parent or Merger Sub are then failing to perform any of
their covenants or other agreements set forth in this Agreement such that, in
the case of either clause (i) or (ii), the conditions to closing set forth in
Section 6.2(a) or 6.2(b), as applicable, would not be satisfied as of the time
of such termination and such breach or condition is not curable or, if
curable, is not cured within thirty (30) days after written notice thereof is
given by the Company to Parent;

  

  

(e) by Parent or the Company, if the Company Shareholder Approval shall not
have been obtained at the Company Shareholder Meeting, or at any adjournment
or postponement thereof, at which the final vote thereon was taken;

  

  

(f) by the Company, at any time prior to obtaining the Company Shareholder
Approval, if (in each case subject to the Company's compliance with this
Agreement, including Section 4.2) (i) the Board of Directors of the Company
(or any committee thereof) authorizes the Company to enter into a definitive
agreement concerning a transaction that constitutes a Superior Proposal and
the Company enters into such definitive agreement concurrently with such
termination or (ii) the Board of Directors of the Company (or any committee
thereof) effects a Company Adverse Recommendation Change as a result of an
Intervening Event, and, in either case, as a condition to the effectiveness of
such termination, the Company pays the Termination Fee (and any other expenses
payable) in accordance with the procedures and within the time periods set
forth in Section 7.3; provided, however, that such proposal continues to
constitute a Superior Proposal or, in the case of an Intervening Event,
continues to result in the Company's Board of Directors determining that a
failure to effect a Company Adverse Recommendation Change as a result of the
Intervening Event would constitute a violation of its fiduciary duties to the
Company's shareholders;

  

  

 

 

 

  

 

-49-  

  

 

 

 

   
 

(g) by Parent if (i) the Board of Directors of the Company or any committee
thereof (A) shall not have recommended or shall have effected a Company
Adverse Recommendation Change or shall have failed to include its
recommendation of the approval and adoption of this Agreement by the Company's
shareholders in the Proxy Statement, (B) shall have taken any other action or
made any other statement in connection with the Company Shareholder Meeting
inconsistent with such recommendation that the shareholders of the Company
approve and adopt this Agreement and approval or (C) shall have publicly
announced its intention to do any of the foregoing; or (ii) the Company has
breached its obligations under Section 4.2; or

  

  

(h) by Parent if there shall have been a Company Material Adverse Effect and
such Company Material Adverse Effect is not curable or, if curable, is not
cured within thirty (30) days after written notice thereof is given by Parent
to the Company.

  

  

The right of any party hereto to terminate this Agreement pursuant to this
Section 7.1 shall remain operative and in full force and effect regardless of
any investigation made by or on behalf of any party hereto, any Person
controlling any such party or any of their respective officers or directors,
whether prior to or after the execution of this Agreement.

  

  

Section 7.2 Effect of Termination. In the event of termination of this
Agreement by either Parent or the Company, as provided in Section 7.1, this
Agreement shall forthwith become void, and there shall be no liability
hereunder on the part of the Company, Parent, Merger Sub or their respective
officers or directors (except for the penultimate sentence of Section 5.3, the
entirety of Sections 7.2 and 7.3 and the entirety of Article VIII, all of
which shall survive the termination); provided, however, that nothing
contained in this Section 7.2 shall relieve any party hereto from any
liability for any willful breach of a representation or warranty contained in
this Agreement or the willful breach of any covenant contained in this
Agreement. No termination of this Agreement shall affect the obligations of
the parties contained in the Confidentiality Agreement, all of which
obligations shall survive termination of this Agreement in accordance with
their terms.

  

  

Section 7.3 Payments.

  

  

(a) Company Termination Fee.

  

  

(i) In the event that Parent terminates this Agreement pursuant to Section
7.1(g), then the Company shall pay to Parent $9,750,000 (the "Termination
Fee") as promptly as possible (but in any event within one (1) Business Day)
following such termination.

  

  

(ii) In the event that the Company terminates this Agreement pursuant to
Section 7.1(f), then the Company shall pay to Parent the Termination Fee
concurrently with any such termination.

  

  

 

 

 

  

 

-50-  

  

 

 

 

   
 

(iii) In the event that (A) prior to the termination of this Agreement, any
Alternative Proposal is proposed or disclosed prior to the Termination Date,
and this Agreement is terminated by Parent or the Company pursuant to Section
7.1(b)(i) or this Agreement is terminated by Parent pursuant to Section 7.1(c)
or (B) prior to the Company Shareholders Meeting, an Alternative Proposal is
proposed or disclosed and this Agreement is terminated by Parent or the
Company pursuant to Section 7.1(e), then the Company shall pay to Parent the
Expenses no later than three (3) Business Days after receipt following
termination of documentation supporting such Expenses. If, concurrently with
or within twelve (12) months after any such termination described in the
immediately preceding sentence, the Company enters into a definitive agreement
with respect to, or consummates, any Alternative Proposal, then the Company
shall pay to Parent the Termination Fee as promptly as possible (but in any
event within one (1) Business Day) following the earlier of the entry into
such definitive agreement or consummation of such Alternative Proposal;
provided that, the amount of any Expenses previously paid to Parent pursuant
to this Section 7.3(a)(iii) shall be credited against the payment of such
Termination Fee.

  

  

Any fee due and Expenses to be reimbursed under this Section 7.3(a) shall be
paid by wire transfer of same-day funds to an account provided in writing by
Parent to the Company

  


 

  

(b) Each of the Company and Parent acknowledges that the agreements contained
in Section 7.3 are an integral part of the transactions contemplated by this
Agreement, and that, without these agreements neither Parent nor the Company
would have entered into this Agreement; accordingly, if the Company fails to
promptly pay the amounts due pursuant to Section 7.3(a), and, in order to
obtain such payment Parent commences a suit which results in a judgment
against the Company for any of the amounts set forth in Section 7.3(a), then
the Company shall pay to Parent its costs and expenses (including attorneys'
fees) in connection with such suit, together with interest on the amounts due
pursuant to Section 7.3(a) at the prime rate of Citibank, NA in effect on the
date plus 2% per annum from the date such amounts were required to be paid
until the date actually received by such party.

  

  

(c) Upon payment of the Termination Fee and the Expenses, as applicable, to
Parent, the Company shall have no further liability with respect to this
Agreement or the transactions contemplated hereby to Parent; provided that
nothing herein shall release any party from liability for willful or
intentional breach or fraud.

  

  

Section 7.4 Amendment. This Agreement may be amended by the parties hereto at
any time before or after approval of the matters presented in connection with
the Merger by the shareholders of the Company, but, after any such approval,
no amendment shall be made which by Law requires further approval by such
shareholders without such further approval. This Agreement may not be amended
except by an instrument in writing signed on behalf of each of the parties
hereto.

  

  

Section 7.5 Waiver. At any time prior to the Effective Time, the parties
hereto may (i) extend the time for the performance of any of the obligations
or other acts of the other parties hereto, (ii) waive any inaccuracies in the
representations and warranties contained herein or in any document delivered
pursuant hereto and/or (iii) waive compliance with any of the covenants,
agreements or conditions contained herein which may legally be waived;
provided that no such retention or waiver that by Law requires further
approval of the Company's shareholders shall be made without such further
approval. Any agreement on the part of a party hereto to any such extension or
waiver shall be valid only if set forth in an instrument in writing signed on
behalf of such party.

  

  

 

 

 

  

 

-51-  

  

 

 

 

   
 

ARTICLE VIII

  

  

GENERAL PROVISIONS

  

  

Section 8.1 Non-Survival of Representations and Warranties. The
representations and warranties in this Agreement or in any instrument
delivered pursuant to this Agreement shall terminate at the Effective Time.

  

  

Section 8.2 Notices. All notices, demands and other communications to be given
or delivered under or by reason of the provisions of this Agreement shall be
in writing and shall be deemed to have been given (i) when personally
delivered or sent by telecopy (with hard copy to follow), (ii) one business
day following the day when deposited with a reputable and established
overnight express courier (charges prepaid) or (iii) five days following
mailing by certified or registered mail, postage prepaid and return receipt
requested. Unless another address is specified in writing, notices, demands
and communications to Parent, Merger Sub and the Company shall be sent to the
addresses indicated below:

  

  

(a) if to Parent or Merger Sub, to

  

  

Baxter International Inc.

  

One Baxter Parkway

  

Deerfield, Illinois 60015

  

Attention: General Counsel

  

Facsimile No.: (847) 948-2450

  

  

with a copy (which shall not constitute notice to Parent or Merger Sub) to:

  

  

Kirkland and Ellis LLP

  

300 N. LaSalle St.

  

Chicago, Illinois 60654

  

Attention: R. Scott Falk, P.C.

  

Roger D. Rhoten

  

Facsimile No.: (312) 862-2200

   
 

 

 

 

  

 

-52-  

  

 

 

 

   
 

(b) if to the Company, to

  

  

Synovis Life Technologies, Inc.

  

2575 University Ave. W.

  

St. Paul, Minnesota 55114

  

Attention: Chief Executive Officer

  

Facsimile No.: (651) 642-9018

  

  

with a copy (which shall not constitute notice to the Company) to:

  

  

Dorsey and Whitney LLP

  

Suite 1500

  

50 South Sixth Street

  

Minneapolis, Minnesota 55402-1498

  

Attention:

  

Timothy S. Hearn

  

Jonathan Van Horn

  

Facsimile No.: (612) 340-2868

  


 

  

Section 8.3 Interpretation. When a reference is made in this Agreement to a
Section, Article, Exhibit or Schedule, such reference shall be to a Section,
Article, Exhibit or Schedule of this Agreement unless otherwise indicated. The
table of contents, table of defined terms and headings contained in this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement. Whenever the words "include,"
"includes" or "including" are used in this Agreement, they shall be deemed to
be followed by the words "without limitation." The words "hereof," "herein"
and "hereunder" and words of similar import when used in this Agreement shall
refer to this Agreement as a whole and not to any particular provision of this
Agreement. All terms defined in this Agreement shall have the defined meanings
when used in any certificate or other document made or delivered pursuant
thereto unless otherwise defined therein. The definitions contained in this
Agreement are applicable to the singular as well as the plural forms of such
terms and to the masculine as well as to the feminine and neuter genders of
such term. Any agreement, instrument or statute defined or referred to herein
or in any agreement or instrument that is referred to herein means such
agreement, instrument or statute as from time to time amended, modified or
supplemented, including (in the case of agreements or instruments) by waiver
or consent and (in the case of statutes) by succession of comparable successor
statutes and references to all attachments thereto and instruments
incorporated therein. Each of the parties has participated in the drafting and
negotiation of this Agreement. If an ambiguity or question of intent or
interpretation arises, this Agreement must be construed as if it is drafted by
all the parties, and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of authorship of any of the provisions of this
Agreement. References to matters disclosed in the Company SEC Documents
exclude any disclosures under the heading "Risk Factors" or similar headings
and any other disclosures of risks that are predictive or forward-looking in
nature.

  

  

Section 8.4 Counterparts. This Agreement may be executed in counterparts, all
of which shall be considered one and the same agreement, and shall become
effective when one or more counterparts have been signed by each of the
parties and delivered to the other parties.

  

  

 

 

 

  

 

-53-  

  

 

 

 

   
 

Section 8.5 Entire Agreement; No Third-Party Beneficiaries. This Agreement,
except as provided in the penultimate sentence of Section 5.3, constitutes the
entire agreement and supersedes all prior agreements and understandings, both
written and oral, among the parties with respect to the subject matter of this
Agreement. This Agreement, except for the provisions of Section 5.9 (which
upon the Effective Time are intended to benefit the Indemnified Parties), is
not intended to and does not confer upon any Person other than the parties
hereto any rights or remedies hereunder.

  

  

Section 8.6 Governing Law. This Agreement shall be governed by and construed
in accordance with the Laws of the State of Minnesota, without giving effect
to any choice or conflict of law provision or rule (whether of the State of
Minnesota or any other jurisdiction) that would cause the application of the
Laws of any jurisdiction other than the State of Minnesota.

  

  

Section 8.7 Specific Performance; Submission To Jurisdiction. Each of the
parties hereto acknowledges and agrees that the other parties would be damaged
irreparably in the event any of the provisions of this Agreement is not
performed in accordance with its specific terms or is otherwise breached.
Accordingly, the parties hereto agree that the other parties shall be entitled
to an injunction or injunctions to prevent breaches of the provisions of this
Agreement and to enforce specifically this Agreement and the terms and
provisions hereof in addition to any other remedy to which they may be
entitled pursuant hereto. Each of the parties hereto irrevocably submits to
the exclusive jurisdiction of the state or federal courts located in Delaware,
in any action or proceeding arising out of, or relating to, this Agreement,
irrevocably consents to the service of process by registered mail or personal
service and agrees that all claims in respect of the action or proceeding may
be heard and determined in any such court, and agrees not to bring any action
or proceeding arising out of, or relating to, this Agreement in any other
court unless and until the foregoing court renders a final order that it
lacks, and cannot acquire, the necessary jurisdiction, and either all appeals
have been exhausted or the order is no longer appealable. Each of the parties
hereto irrevocably waives, to the fullest extent permitted by Law, any defense
of inconvenient forum to the maintenance of any action or proceeding so
brought, any objection which it may have or hereafter have as to personal
jurisdiction, the laying of the venue of any such action or proceeding brought
in any such court and waives any bond, surety or other security that might be
required of any other party with respect thereto. Each party hereto agrees
that a final judgment in any action or proceeding so brought shall be
conclusive and may be enforced by suit on the judgment or in any other manner
provided by law or at equity.

  

  

Section 8.8 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT
OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS
AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY,
AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8.8.

  

  

 

 

 

  

 

-54-  

  

 

 

 

   
 

Section 8.9 Assignment. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned, in whole or in part, by
operation of law or otherwise by any of the parties without the prior written
consent of the other parties, and any assignment without such consent shall be
null and void, except that Parent or Merger Sub, upon prior written notice to
the Company, may assign, in its sole discretion, any of or all its rights,
interests and obligations under this Agreement (a) in the case of Parent, to
any direct or indirect wholly owned Subsidiary of Parent and (b) in the case
of Merger Sub, to Parent or to any direct or indirect wholly owned Subsidiary
of Parent, but no such assignment shall relieve Parent or Merger Sub, as
applicable, of any of its obligations hereunder. Subject to the preceding
sentence, this Agreement will be binding upon, inure to the benefit of, and be
enforceable by, the parties and their respective successors and assigns.

  

  

Section 8.10 Expenses. Except as provided in Section 7.3, whether or not the
Merger is consummated, all costs and expenses incurred in connection with this
Agreement and the transactions contemplated hereby, including the fees and
disbursements of counsel, financial advisors and accountants, shall be paid by
the party incurring such costs and expenses.

  

  

Section 8.11 Severability. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any rule of Law or public
policy, all other terms, conditions and provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic and legal
substance of the transactions contemplated hereby are not affected in any
manner materially adverse to any party. Upon such determination that any term
or other provision is invalid, illegal or incapable of being enforced, the
parties shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible in a mutually
acceptable manner in order that the transactions contemplated by this
Agreement may be consummated as originally contemplated to the fullest extent
possible.

  

  

Section 8.12 Definitions.

  

  

(a) In this Agreement, the following terms have the meanings specified or
referred to in this Section 8.12(b) and shall be equally applicable to both
the singular and plural forms.

  

  

(i) "Action" means any claim, action, suit, proceeding, arbitration, mediation
or investigation.

  

  

 

 

 

  

 

-55-  

  

 

 

 

   
 

(ii) "Affiliate" means, with respect to any Person, any other Person which
directly or indirectly controls, is controlled by or is under common control
with such Person.

  

  

(iii) "Affiliated Group" means the affiliated group as defined in Section 1504
of the Code (or any analogous combined, consolidated or unitary group defined
under state, local or foreign income Tax Law) of which the Company is the
common parent.

  

  

(iv) "Alternative Proposal" means any inquiry, indication of interest, request
for information, offer or proposal relating to any Alternative Transaction.

  

  

(v) "Alternative Transaction" means, with respect to any Person, any
transaction or series of related transactions other than the Merger involving,
directly or indirectly, (a) any merger, exchange, consolidation, business
combination, issuance of securities, acquisition of securities,
reorganization, recapitalization, takeover offer, tender offer, exchange offer
or other similar transaction: (i) in which such Person or any of its
Subsidiaries is a constituent corporation and which would result in a third
party, or the shareholders of that third party, beneficially owning 15% or
more of any class of equity or voting securities of such Person or any of its
Subsidiaries, or the Person resulting from such transaction or the parent of
such Person; (ii) in which a Person or "group" (as defined in the Exchange Act
and the rules promulgated thereunder) of Persons directly or indirectly
acquires beneficial or record ownership of securities representing more than
15% of the outstanding securities of any class of voting securities of such
Person or any of its Subsidiaries; or (iii) in which such Person or any of its
Subsidiaries issues securities representing more than 15% of the outstanding
securities of any class of voting securities of such Person or any of its
Subsidiaries, (b) any sale, lease, exchange, transfer, license, acquisition or
disposition of any business or businesses or assets of such Person or its
Subsidiaries that constitute or account for 15% or more of the consolidated
net revenues, or consolidated net income for the 12 full months immediately
prior to the receipt of the related Alternative Proposal or 15% or more of the
fair market value of the consolidated assets of such Person or any of its
Subsidiaries or (c) any liquidation, dissolution, recapitalization or other
significant corporate reorganization of the Company or any of its
Subsidiaries.

  

  

(vi) "Antitrust Authority" means, in their capacity as an enforcement agency
with respect to Antitrust Laws, the Federal Trade Commission, the Antitrust
Division of the United States Department of Justice, any attorney general of
any state of the United States or any Governmental Entity having competition
Law authority in any other applicable jurisdiction.

  

  

(vii) "Antitrust Laws" means the Sherman Act, the Clayton Act, the HSR Act,
the Federal Trade Commission Act and all other federal, state and foreign Laws
that are designed or intended to prohibit, restrict or regulate actions having
the purpose or effect of monopolization or restriction of trade or business or
competition through merger or acquisition.

  

  

 

 

 

  

 

-56-  

  

 

 

 

   
 

(viii) "Business Day" means any day other than a Saturday, Sunday or a day on
which the banks in New York are authorized by Law or executive order to be
closed.

  

  

(ix) "Code" means the Internal Revenue Code of 1986, as amended, and any
reference to any particular Code section shall be interpreted to include any
revision of or successor to that section regardless of how numbered or
classified.

  

  

(x) "Company Material Adverse Effect" means any event, occurrence, fact,
condition, effect, change or development that is materially adverse to the
business, assets, liabilities (contingent or otherwise), condition (financial
or otherwise) or results of operations of the Company and its Subsidiaries,
taken as a whole, other than any event, occurrence, fact, condition, effect,
change or development arising out of or resulting from: (i) general economic
conditions in the United States or conditions in the financial or commodities
markets in general, (ii) conditions generally affecting the industries in
which the Company or its Subsidiaries operate, (iii) the announcement of this
Agreement or the transactions contemplated hereby or the performance of this
Agreement, (iv) changes, after the date hereof, in Law or GAAP, (v) any
outbreak or escalation of hostilities or war (whether declared or not
declared) or act of terrorism, (vi) any change in the Company's stock price or
trading volume, (vii) the failure of the Company to meet projections of
earnings, revenues or other financial measures (it being understood that, in
the case of clauses (vi) and (vii), the events, occurrences, facts,
conditions, effects, changes or developments giving rise to any such change or
failure may be taken into account in determining whether there has been a
Company Material Adverse Effect), or (viii) any action taken by the Company
after the date of this Agreement with the written consent of Parent; except in
the case of each of clauses (i), (ii), (iv) and (v) to the extent that the
Company and its Subsidiaries are adversely affected in a disproportionate
manner relative to other participants in the industries in which the Company
and its Subsidiaries operate.

  

  

(xi) "Company Multiemployer Plan" means a "multiemployer plan" (as defined in
Section 4001(a)(3) of ERISA) to which the Company or any of its ERISA
Affiliates is or has been obligated to contribute or otherwise may have any
liability.

  

  

(xii) "Company Plan" means any "employee benefit plan" (as defined in Section
3(3) of ERISA), whether or not subject to ERISA, any other employee benefit
plan, program, policy, arrangement or agreement, including any pension,
retirement, profit-sharing, thrift, savings, bonus plan, incentive, stock
option or other equity or equity-based compensation, or deferred compensation
arrangement, stock purchase, severance pay, retention, change of control,
unemployment benefits, sick leave, vacation pay, salary continuation for
disability, hospitalization, health or medical insurance, life insurance,
fringe benefit, compensation, flexible spending account or scholarship
program, and any employment, severance or change in control agreement or
similar practice, policy or arrangement maintained by the Company or any ERISA
Affiliate, or to which the Company or any ERISA Affiliate is obligated to
contribute, on behalf of any current or former officer, director, employee or
consultant of the Company or any Subsidiary.

  

  

 

 

 

  

 

-57-  

  

 

 

 

   
 

(xiii) "Confidentiality Agreement" means that certain letter agreement, dated
as of September 19, 2011, between Baxter Healthcare Corporation and the
Company.

  

  

(xiv) "Contract" means any contract, agreement, instrument, guarantee,
indenture, note, bond, debenture, loan or credit agreement, mortgage, permit,
franchise, concession, commitment, lease, license, arrangement, obligation or
understanding, whether written or oral.

  

  

(xv) "Effective Time" means the date and time at which the Articles of Merger
are accepted for recording or such later time established by the Articles of
Merger.

  

  

(xvi) "Encumbrance" means, with respect to any asset, any mortgage, deed of
trust, lien, pledge, charge, security interest, title retention device,
collateral assignment, adverse claim, restriction or other encumbrance of any
kind in respect of such asset (including any restriction on the voting of any
security, any restriction on the transfer of any security or other asset, any
restriction on the receipt of any income derived from any asset, any
restriction on the use of any asset and any restriction on the possession,
exercise or transfer of any other attribute of ownership of any asset).

  

  

(xvii) "ERISA Affiliate" means, with respect to any Person, any trade or
business (whether or not incorporated) which is under common control or would
be considered a single employer with such Person pursuant to Section 414(b),
(c), (m) or (o) of the Code and the rules and regulations promulgated under
those sections or pursuant to Section 4001(b) of ERISA and the rules and
regulations promulgated thereunder.

  

  

(xviii) "Expenses" means documented fees and expenses incurred or paid to
Third Parties by or on behalf of Parent and its Affiliates in connection with
the Merger or the other transactions contemplated by this Agreement, or
related to the authorization, preparation, negotiation, execution and
performance of this Agreement, in each case including all documented fees and
expenses of law firms, commercial banks, investment banking firms, financing
sources, accountants, experts and consultants to Parent and its Affiliates,
but in no event more than $2,000,000.

  

  

(xix) "FDA" means the U.S. Food and Drug Administration.

  

  

(xx) "FDCA" means the Federal Food, Drug and Cosmetic Act of 1938, as amended
(including the rules and regulations promulgated thereunder).

  

  

(xxi) "Guaranty" means any agreement, undertaking or arrangement by which any
Person guarantees, endorses or otherwise becomes or is contingently liable for
the debt, obligation or other liability of any other Person, or guaranties of
the payment of dividends or other distributions upon the shares of any other
Person.

  

  

(xxii) "Indebtedness" means, with respect to any Person at any date, without
duplication: (i) all obligations of such Person for borrowed money or in
respect of loans or advances, including, (ii) all obligations of such Person
evidenced by bonds, debentures, notes or other similar instruments or debt
securities, (iii) all obligations in respect of letters of credit and bankers'
acceptances issued for the account of such Person, (iv) all obligations
arising from deferred compensation arrangements and all obligations under
severance plans or arrangements, bonus plans or similar arrangements that are
or may become payable as a result of the consummation of the transactions
contemplated hereby; (v) all obligations of such Person secured by an
Encumbrance (other than a Permitted Encumbrance); and (vi) all capital lease
obligations.

  

  

 

 

 

  

 

-58-  

  

 

 

 

   
 

(xxiii) "IRS" means the U.S. Internal Revenue Service.

  

  

(xxiv) "Joint Venture" means, with respect to a party, any corporation,
limited liability company, partnership, joint venture, trust or other entity
which is not a Subsidiary of such party and in which (i) such party, directly
or indirectly, owns or controls any shares of any class of the outstanding
voting securities or other equity interests (other than the ownership of
securities primarily for investment purposes as part of routine cash
management or investments of 1% or less in publicly traded companies) or (ii)
such party or a Subsidiary of such party is a general partner.

  

  

(xxv) "Knowledge of the Company" means the actual knowledge, after reasonable
investigation, of the individuals identified in Section 8.12(xxv) of the
Company Letter.

  

  

(xxvi) "Parent Material Adverse Effect" means any event, occurrence, fact,
condition, effect, change or development would reasonably be expected to
materially impair or delay the ability of Parent or Merger Sub to consummate
the transactions contemplated by this Agreement.

  

  

(xxvii) "Parent Plan" means any "employee benefit plan" (as defined in Section
3(3) of ERISA), whether or not subject to ERISA, any other employee benefit
plan, program, policy, arrangement or agreement, including any pension,
retirement, profit-sharing, thrift, savings, bonus plan, incentive, stock
option or other equity or equity-based compensation, or deferred compensation
arrangement, stock purchase, severance pay, retention, change of control,
unemployment benefits, sick leave, vacation pay, salary continuation for
disability, hospitalization, health or medical insurance, life insurance,
fringe benefit, compensation, flexible spending account or scholarship
program, and any employment, severance or change in control agreement or
similar practice, policy or arrangement maintained by Parent, or to which
Parent or any ERISA Affiliate is obligated to contribute, on behalf of any
current or former officer, director, employee or consultant of Parent or any
Subsidiary.

  

  

(xxviii) "Permitted Encumbrances" means (a) statutory Encumbrances for current
Taxes or other payments that are not yet due and payable, (b) deposits or
pledges made in connection with, or to secure payment of, workers'
compensation, unemployment insurance or similar programs mandated by
applicable Laws, and (c) statutory Encumbrances in favor of carriers,
warehousemen, mechanics and materialmen, to secure claims for labor, materials
or supplies and other like Encumbrances.

  

   
 

 

 

 

  

 

-59-  

  

 

 

 

   
 

(xxix) "Person" means any individual, corporation, partnership, limited
liability company, joint venture, association, joint-stock company, estate,
Governmental Entity, trust or unincorporated organization.

  

  

(xxx) "SEC" means the U.S. Securities and Exchange Commission.

  

  

(xxxi) "Subsidiary" means any corporation, partnership, limited liability
company, joint venture, trust, association or other entity of which Parent or
the Company, as the case may be (either alone or through or together with any
other Subsidiary), owns, directly or indirectly, (i) 50% or more of the stock
or other equity interests the holders of which are generally entitled to elect
at least a majority of the Board of Directors or other governing body of such
corporation, partnership, limited liability company, joint venture, trust,
association or other entity or (ii) if there are no such voting interests, 50%
or more of the equity interests in such corporation, partnership, limited
liability company, joint venture, trust, association or other entity.

  

  

(xxxii) "Superior Proposal" means a bona fide written Alternative Proposal
(provided that, for the purposes of this definition references to "15%" in the
definition of Alternative Transaction shall be deemed replaced with reference
to "50%") on terms that, in the reasonable good faith judgment of the Board of
Directors of Company, after consultation with its outside financial advisors,
are more favorable to Company's shareholders from a financial point of view
than the terms of the Merger, and is reasonably likely to be completed on a
timely basis after taking into account all the terms and conditions of such
proposal and this Agreement (including any proposal by either party to amend
the terms of this Agreement).

  

  

(xxxiii) "Tax Return" means any return, report or similar statement (including
the attached schedules) required to be filed with respect to any Tax,
including any information return, claim for refund, amended return or
declaration of estimated Tax.

  

  

(xxxiv) "Taxes" means any federal, state, local or foreign income, gross
receipts, property, sales, use, license, excise, franchise, employment,
payroll, withholding, alternative or added minimum, ad valorem, value-added,
transfer or excise tax, or other tax, custom, duty, governmental fee or other
like assessment or charge of any kind whatsoever, together with any interest
or penalty imposed by any Governmental Entity.

  

  

(xxxv) "Third Party" means any Person or group (as defined under Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder)
other than Parent and its Affiliates.

  

  

(b) Each of the following terms is defined on the pages set forth opposite
such term:

  

  

    

Defined Term

  |  |  

Section

   
---|---|--- 
   |  |   
  

Agreement

  |  |  

Introduction

   
  

Alternative Transaction Agreement

  |  |  

4.2(d)(iii)

   
  

Amended Company Rights Agreement

  |  |  

3.26

   
  

  

 

 

 

  

 

-60-  

  

 

 

 

  

     

Articles of Merger

  |  |  

1.2

   
---|---|--- 
  

Blue Sky Laws

  |  |  

2.3

   
  

Closing

  |  |  

1.14

   
  

Commercial Software

  |  |  

3.13(a)

   
  

Company

  |  |  

Introduction

   
  

Company Adverse Recommendation Change

  |  |  

4.2(d)

   
  

Company Business Personnel

  |  |  

3.16

   
  

Company Bylaws

  |  |  

3.3

   
  

Company Charter

  |  |  

3.3

   
  

Company Common Stock

  |  |  

Recitals

   
  

Company Contract

  |  |  

3.13(b)

   
  

Company Data

  |  |  

3.18(b)

   
  

Company Foreign Benefit Plan

  |  |  

3.14(e)

   
  

Company IT Systems

  |  |  

3.18(a)

   
  

Company Letter

  |  |  

Article II

   
  

Company Permits

  |  |  

3.10

   
  

Company Preferred Stock

  |  |  

3.2(a)

   
  

Company SEC Documents

  |  |  

3.5(a)

   
  

Company Shareholder Approval

  |  |  

5.2(a)

   
  

Company Shareholder Meeting

  |  |  

5.2(a)

   
  

Company Shares

  |  |  

1.5(b)

   
  

Company Stock Options

  |  |  

3.2(b)

   
  

Company Stock Plans

  |  |  

5.4(a)

   
  

Company's Current Premium

  |  |  

5.9(b)

   
  

DandO Insurance

  |  |  

5.9(b)

   
  

Dissenting Shares

  |  |  

1.5(d)

   
  

Environmental Laws

  |  |  

3.15

   
  

ERISA

  |  |  

3.14(a)

   
  

ESPP

  |  |  

3.2(c)

   
  

Exchange Act

  |  |  

2.3

   
  

Exchange Agent

  |  |  

1.6

   
  

Exchange Fund

  |  |  

1.6

   
  

GAAP

  |  |  

3.5(a)

   
  

Governmental Entity

  |  |  

2.3

   
  

Hazardous Materials

  |  |  

3.15

   
  

HCT/P

  |  |  

3.24(a)

   
  

HSR Act

  |  |  

2.3

   
  

HSR Filings

  |  |  

5.6(a)

   
  

Indemnified Parties

  |  |  

5.9(a)

   
  

Intellectual Property Rights

  |  |  

3.17(a)

   
  

Intervening Event

  |  |  

4.2(d)

   
  

Laws

  |  |  

1.5(d)

   
  

Leased Property

  |  |  

3.11(b)

   
  

Liabilities

  |  |  

3.7

   
  

MBCA

  |  |  

Recitals

   
  

Merger

  |  |  

Recitals

   
  

  

 

 

 

  

 

-61-  

  

 

 

 

  

     

Merger Consideration

  |  |  

2.5

   
---|---|--- 
  

Merger Sub

  |  |  

Introduction

   
  

Notice Period

  |  |  

4.2(d)(iii)

   
  

Order

  |  |  

3.7

   
  

Owned Intellectual Property Rights

  |  |  

3.17(d)

   
  

Parent

  |  |  

Introduction

   
  

Per Share Merger Consideration

  |  |  

1.5(c)

   
  

Plan of Merger

  |  |  

Recitals

   
  

Proxy Statement

  |  |  

2.4

   
  

Real Property Leases

  |  |  

3.11(b)

   
  

Regulatory Permits

  |  |  

3.24(h)

   
  

Release

  |  |  

3.15

   
  

Representatives

  |  |  

4.2(a)

   
  

Rights Agreement

  |  |  

3.2(d)

   
  

Securities Act

  |  |  

3.5(a)

   
  

Social Security Act

  |  |  

3.25(e)

   
  

SOX

  |  |  

3.5(a)

   
  

State Takeover Approvals

  |  |  

2.3

   
  

Surviving Corporation

  |  |  

1.1

   
  

Termination Fee

  |  |  

7.3(a)(i)

   
  

Transmittal Letter

  |  |  

1.6

   
  

Voting Agreement

  |  |  

Recitals

   
  

Worker Safety Laws

  |  |  

3.15

   
 

  


 

    

 

 

 

  

 

-62-  

  

 

 

 

   
 

IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this
Agreement to be signed by their respective officers thereunto duly authorized
all as of the date first written above.

  

  

     |  |  

BAXTER INTERNATIONAL INC.

   
---|---|--- 
   |  |   
   |  |   
   |  

By:

  |  

/s/ Ludwig N. Hantson

   
   |  |  

Name: Ludwig N. Hantson

   
   |  |  

Its: CVP / President Bioscience

   
   |  |   
   |  |   
   |  |  

TWINS MERGER SUB, INC.

   
   |  |   
   |  |   
   |  

By:

  |  

/s/ Ludwig N. Hantson

   
   |  |  

Name: Ludwig N. Hantson

   
   |  |  

Its: President

   
   |  |   
   |  |   
   |  |  

SYNOVIS LIFE TECHNOLOGIES, INC.

   
   |  |   
   |  |   
   |  

By:

  |  

/s/ Richard W. Kramp

   
   |  |  

Name: Richard W. Kramp

   
   |  |  

Its: Chief Executive Officer

   
 

  

  

 

 

 

  

   

  

 

 

 

  

  

 

EXHIBIT A

  

  

VOTING AGREEMENT

  

  

VOTING AGREEMENT, dated as of December 12, 2011 (this "Agreement"), by and
among Baxter International Inc., a Delaware corporation ("Parent"), and
_______ (the "Shareholder") in his/her capacity as a shareholder of Synovis
Life Technologies, Inc., a Minnesota corporation (the "Company").

  

  

W I T N E S S E T H:

  

  

WHEREAS, concurrently with the execution of this Agreement, Parent, the
Company and Twins Merger Sub, Inc., a Minnesota corporation and a wholly owned
subsidiary of Parent ("Merger Sub"), are entering into an Agreement and Plan
of Merger, dated as of the date hereof (as amended, supplemented, restated or
otherwise modified from time to time, the "Merger Agreement"), pursuant to
which, among other things, each outstanding share of the common stock, par
value $0.01 per share, of the Company (the "Company Common Stock") will be
converted into the right to receive the Per Share Merger Consideration
specified therein;

  

  

WHEREAS, as of the date hereof, the Shareholder is the beneficial owner of the
Existing Shares (as defined herein);

  

  

WHEREAS, as a condition and inducement to Parent entering into the Merger
Agreement, Parent has required that the Shareholder agree, and the Shareholder
has agreed, to enter into this Agreement and abide by the covenants and
obligations with respect to the Shareholder's Covered Shares (as defined
herein); and

  

  

WHEREAS, the Board of Directors of the Company has approved the Merger
Agreement and the transactions contemplated thereby and has approved the
execution and delivery of this Agreement in connection therewith,
understanding that the execution and delivery of this Agreement by the
Shareholder is a material inducement and condition to Parent's willingness to
enter into the Merger Agreement.

  

  

NOW, THEREFORE, in consideration of the foregoing and the mutual
representations, warranties, covenants and agreements herein contained, and
intending to be legally bound hereby, the parties hereto agree as follows:

  

  

ARTICLE I

  

  

GENERAL

  

  

1.1 Defined Terms. The following capitalized terms, as used in this Agreement,
shall have the meanings set forth below. Capitalized and other defined terms
used but not otherwise defined herein shall have the meanings ascribed to such
terms in the Merger Agreement.

  

  

 

 

 

  

   

  

 

 

 

  

  

"Beneficial Ownership" has the meaning ascribed to such term in Rule 13d-3
under the Securities Exchange Act of 1934, as amended. The terms "Beneficially
Own," "Beneficially Owned" and "Beneficial Owner" shall each have a
correlative meaning.

  

  

"Control" (including with its correlative meaning, "Controlled By" and "Under
Common Control With") means the possession, directly or indirectly, of the
power to direct or cause the direction of the affairs or management and
policies of a Person, whether through the ownership of voting securities, as
trustee or executor, by contract or otherwise.

  

  

"Covered Shares" means the Shareholder's Existing Shares, together with any
shares of Company Common Stock or other voting capital stock of the Company
and any shares of the Company Common Stock or other stock of the Company
issuable upon the conversion, exercise or exchange of securities that are as
of the relevant date securities convertible into or exercisable or
exchangeable for shares of Company Common Stock or other voting capital stock
of the Company, in each case that the Shareholder has or acquires Beneficial
Ownership of on or after the date hereof.

  

  

"Encumber" shall have a correlative meaning to the term Encumbrance.

  

  

"Existing Shares" means the shares of Company Common Stock that are
Beneficially Owned by the Shareholder as of the date hereof, as set forth on
Schedule 1 hereto.

  

  

"Expiration Date" shall mean the date on which this Agreement shall terminate
in accordance with its terms.

  

  

"Transfer" means, directly or indirectly, to sell, transfer, assign, pledge,
Encumber, hypothecate or similarly dispose of (by merger (including by
conversion into securities or other consideration), by tendering into any
tender or exchange offer, by testamentary disposition, by operation of law or
otherwise), either voluntarily or involuntarily, or to enter into any
contract, option or other arrangement or understanding with respect to the
voting of or sale, transfer, assignment, pledge, Encumbrance, hypothecation or
similar disposition of (by merger, by tendering into any tender or exchange
offer, by testamentary disposition, by operation of law or otherwise).

  

  

ARTICLE II

  

  

VOTING

  

  

2.1 Agreement to Vote.

  

  

(a) The Shareholder hereby irrevocably and unconditionally agrees that during
the term of this Agreement, at the Company Shareholder Meeting and at any
other meeting of the shareholders of the Company, however called, including
any adjournment or postponement thereof, and in connection with any action
proposed to be taken by written consent of the shareholders of the Company,
the Shareholder shall, in each case to the fullest extent that the Covered
Shares are entitled to vote thereon or consent thereto:

  

  

 

 

 

  

 

2  

  

 

 

 

  

  

(i) appear at each such meeting or otherwise cause the Covered Shares to be
counted as present thereat for purposes of calculating a quorum; and

  

  

(ii) vote (or cause to be voted), in person or by proxy, or deliver (or cause
to be delivered) a written consent (if then permitted under the Company
Certificate) covering, all of the Covered Shares (a) in favor of the adoption
and approval of the Merger Agreement and approve the Merger and other
transactions contemplated by the Merger Agreement and any action reasonably
requested by the Parent in furtherance of the foregoing, including, without
limiting any of the foregoing obligations, in favor of any proposal to adjourn
or postpone any meeting of the Company shareholders at which any of the
foregoing matters are submitted for consideration and vote of the Company
shareholders to a later date if there are not sufficient votes for approval of
such matters on the date on which the meeting is held to vote upon any of the
foregoing matters; (b) against any action or agreement that would result in a
breach of any covenant, representation or warranty or any other obligation or
agreement of the Company contained in the Merger Agreement, or of the
Shareholder contained in this Agreement; and (c) against any Alternative
Proposal or Alternative Transaction and against any other action, agreement or
transaction involving the Company or any of its Subsidiaries that is intended,
or would reasonably be expected to, materially impede, interfere with, delay,
postpone, adversely affect or prevent the consummation of the Merger or the
other transactions contemplated by the Merger Agreement or this Agreement or
the performance by the Company of its obligations under the Merger Agreement
or by the Shareholder of its obligations under this Agreement, including (x)
any extraordinary corporate transaction, such as a merger, consolidation or
other business combination involving the Company or its Subsidiaries (other
than the Merger); (y) a sale, lease or transfer of a material amount of assets
of the Company or any of its Subsidiaries or any reorganization,
recapitalization or liquidation of the Company or any of its Subsidiaries or
(z) any change in the present capitalization of the Company or any amendment
or other change to the Company Charter or Company Bylaws.

  

  

(b) The Shareholder hereby waives, and agrees not to exercise or assert, any
rights of dissent or similar rights (including under Sections 302A.471 and
302A.473 of the MBCA) in connection with the Merger.

  

  

(c) The Shareholder hereby agrees not to commence or join in, and agrees to
take all actions necessary to opt out of any class in any class action with
respect to, any claim, derivate or otherwise, against Parent, Merger Sub, the
Company or any of their respective successors (i) challenging the validity of,
or seeking to enjoin the operation of, any provision of this Agreement or (ii)
alleging a breach of any fiduciary duty of any person in connection with the
negotiation and entry into the Merger Agreement.

  

  

 

 

 

  

 

3  

  

 

 

 

  

  

(d) The obligations of the Shareholder specified herein (including this
Section 2.1) shall apply whether or not the Merger or any action described
above is recommended by the Board of Directors of the Company (or any
committee thereof).

  

  

2.2 No Inconsistent Agreements. The Shareholder hereby covenants and agrees
that, except for this Agreement, the Shareholder (a) has not entered into, and
shall not enter into at any time while the Merger Agreement remains in effect,
any voting agreement or voting trust with respect to the Covered Shares, (b)
has not granted, and shall not grant at any time while the Merger Agreement
remains in effect, a proxy (except pursuant to Section 2.3), consent or power
of attorney with respect to the Covered Shares and (c) has not taken and shall
not knowingly take any action that would make any representation or warranty
of the Shareholder contained herein untrue or incorrect or have the effect of
preventing or disabling the Shareholder from performing any of its obligations
under this Agreement. The Shareholder hereby represents that all proxies,
powers of attorney, instructions or other requests given by the Shareholder
prior to the execution of this Agreement in respect of the voting of the
Covered Shares, if any, are not irrevocable and the Shareholder hereby revokes
(and shall cause to be revoked) any and all previous proxies, powers of
attorney, instructions or other requests with respect to the Covered Shares.

  

  

2.3 Proxy. The Shareholder hereby irrevocably appoints as its proxy and
attorney-in-fact, David P. Scharf, the general counsel of Parent, and Ludwig
N. Hantson, Corporate Vice President of Parent, and any individual who shall
hereafter succeed any such persons, and any other Person designated in writing
by Parent, each of them individually, with full power of substitution and
resubstitution, to vote or execute written consents with respect to the
Covered Shares in accordance with Section 2.1 prior to the Expiration Date at
any annual or special meetings of shareholders of the Company (or adjournments
thereof) at which any of the matters described in Section 2.1 is to be
considered; provided however, that the Shareholder's grant of the proxy
contemplated by this Section 2.3 shall be effective if, and only if, the
Shareholder has not delivered to the Secretary of the Company at least ten
Business Days prior to the meeting at which any of the matters described in
Section 2.1 is to be considered a duly executed irrevocable proxy card
previously approved by Parent directing that the Covered Shares be voted in
accordance with Section 2.1. This proxy, if it becomes effective, is coupled
with an interest, is given as an additional inducement of Parent to enter into
the Merger Agreement and shall be irrevocable prior to the Expiration Date, at
which time any such proxy shall terminate. The Shareholder (solely in its
capacity as such) shall take such further action or execute such other
instruments as may be necessary to effectuate the intent of this proxy. Parent
may terminate this proxy at any time at its sole election by written notice
provided to the Shareholder.

  

  

ARTICLE III

  

  

REPRESENTATIONS AND WARRANTIES

  

  

3.1 Representations and Warranties of the Shareholder. The Shareholder hereby
represents and warrants to Parent as follows:

  

  

 

 

 

  

 

4  

  

 

 

 

  

  

(a) Authorization; Validity of Agreement; Necessary Action. The Shareholder
has the requisite capacity and authority to execute and deliver this
Agreement, to perform the Shareholder's obligations hereunder and to
consummate the transactions contemplated hereby. This Agreement has been duly
executed and delivered by the Shareholder and, assuming this Agreement
constitutes a valid and binding obligation of Parent, constitutes a legal,
valid and binding obligation of the Shareholder, enforceable against the
Shareholder in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, moratorium, reorganization or similar laws affecting the
rights of creditors generally and the availability of equitable remedies
(regardless of whether such enforceability is considered in a proceeding in
equity or at law).

  

  

(b) Ownership. The Existing Shares are, and all of the Covered Shares owned by
the Shareholder from the date hereof through and on the Expiration Date will
be, Beneficially Owned by the Shareholder. The Shareholder has good and valid
title to the Existing Shares, free and clear of any Encumbrances other than
pursuant to this Agreement, the Merger Agreement, under applicable federal or
state securities laws or pursuant to any written policies of the Company only
with respect to restrictions upon the trading of securities under applicable
securities laws. As of the date hereof, the Existing Shares constitute all of
the shares of Company Common Stock Beneficially Owned or owned of record by
the Shareholder. The Shareholder has and will have at all times through the
Expiration Date sole voting power (including the right to Control such vote as
contemplated herein), sole power of disposition, sole power to issue
instructions with respect to the matters set forth in Article II, and sole
power to agree to all of the matters set forth in this Agreement, in each case
with respect to all of the Existing Shares and with respect to all of the
Covered Shares owned by the Shareholder at all times through the Expiration
Date.

  

  

(c) No Violation. The execution and delivery of this Agreement by the
Shareholder do not, and the performance by the Shareholder of its obligations
under this Agreement will not, (i) conflict with or violate any Law applicable
to the Shareholder or by which any of its assets or properties is bound, or
(ii) conflict with, result in any breach of or constitute a default (or an
event that with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of any Encumbrance on the
properties or assets of the Shareholder pursuant to, any Contract or other
instrument or obligation to which the Shareholder is a party or by which the
Shareholder and/or any of its assets or properties is bound, except for any of
the foregoing as would not impair the ability of the Shareholder to perform
its obligations hereunder or to consummate the transactions contemplated
hereby on a timely basis.

  

  

(d) Consents and Approvals. The execution and delivery of this Agreement by
the Shareholder do not, and the performance by the Shareholder of its
obligations under this Agreement and the consummation by it of the
transactions contemplated hereby will not, require the Shareholder to obtain
any consent, approval, authorization or permit of, or to make any filing with
or notification to, any Governmental Entity, other than the filings of any
reports with the SEC.

  

  

 

 

 

  

 

5  

  

 

 

 

  

  

(e) Absence of Litigation. As of the date hereof, there is no Action pending
or, to the knowledge of the Shareholder, threatened against or affecting the
Shareholder and/or any of its Affiliates before or by any Governmental Entity
that would reasonably be expected to impair the ability of the Shareholder to
perform its obligations hereunder or to consummate the transactions
contemplated hereby on a timely basis.

  

  

(f) Finder's Fees. Except as described in Section 3.23 of the Merger
Agreement, no broker, investment banker or other Person is entitled to any
broker's, finder's or other similar fee or commission in connection with the
transactions contemplated by this Agreement or the Merger Agreement based upon
any arrangement or agreement made by or on behalf of such Shareholder.

  

  

(g) Reliance by Parent. The Shareholder has received and reviewed a copy of
the Merger Agreement. The Shareholder understands and acknowledges that Parent
is entering into the Merger Agreement in reliance upon the execution and
delivery of this Agreement by the Shareholder and the representations and
warranties of the Shareholder contained herein. The Shareholder understands
and acknowledges that the Merger Agreement governs the terms of the Merger and
the other transactions contemplated thereby.

  

  

3.2 Representations and Warranties of Parent. Parent hereby represents and
warrants to the Shareholder that it has the requisite capacity and authority
to execute and deliver this Agreement, to perform its obligations hereunder
and to consummate the transactions contemplated hereby. This Agreement has
been duly executed and delivered by Parent, constitutes a legal, valid and
binding obligation of Parent, enforceable against it in accordance with its
terms, subject to bankruptcy, insolvency, fraudulent conveyance, moratorium,
reorganization or similar laws affecting the rights of creditors generally and
the availability of equitable remedies (regardless of whether such
enforceability is considered in a proceeding in equity or at law).

  

  

ARTICLE IV

  

  

OTHER COVENANTS

  

  

4.1 Prohibition on Transfers; Other Actions. Until the Expiration Date, the
Shareholder agrees that it shall not (a) Transfer any Covered Shares,
Beneficial Ownership thereof or any other interest therein; (b) enter into any
agreement, arrangement or understanding with any Person, or take any other
action, that violates or conflicts with or would reasonably be expected to
violate or conflict with, or result in or give rise to a violation of or
conflict with, the Shareholder's representations, warranties, covenants and
obligations under this Agreement; or (c) take any action that could restrict
or otherwise affect the Shareholder's legal power, authority and right to
comply with and perform its covenants and obligations under this Agreement.
Any Transfer in violation of this provision shall be void ab initio. The
Shareholder shall not request that the Company or its transfer agent register
the transfer (book-entry or otherwise) of any certificate or uncertificated
interest representing any Covered Shares and hereby consents to the entry of
stop transfer instructions by the Company of any transfer of the Covered
Shares.

  

  

 

 

 

  

 

6  

  

 

 

 

  

  

4.2 Stock Dividends, etc. In the event of a stock split, stock dividend or
distribution, or any change in the Company Common Stock by reason of any
split-up, reverse stock split, recapitalization, combination,
reclassification, reincorporation, exchange of shares or the like, the terms
"Existing Shares" and "Covered Shares" shall be deemed to refer to and include
such shares as well as all such stock dividends and distributions and any
securities into which or for which any or all of such shares may be changed or
exchanged or which are received in such transaction.

  

  

4.3 No Solicitation; Support of Acquisition Proposals. From the date of this
Agreement until the earlier of the Effective Time or the date on which this
Agreement is terminated in accordance with the terms of this Agreement, the
Shareholder shall not, and shall cause each of its Representatives not to,
directly or indirectly, (i) solicit, initiate or knowingly facilitate, induce
or encourage the making, announcement or submission of, any Alternative
Proposal or any proposal that could reasonably be expected to lead to an
Alternative Proposal; (ii) enter into any letter of intent or agreement in
principle or any Contract contemplating, providing for, relating to or in
connection with, any Alternative Proposal or any proposal that could
reasonably be expected to lead to an Alternative Proposal; (iii) knowingly
furnish any information regarding the Company or any of its Subsidiaries to
any Person in connection with or in response to an Alternative Proposal; (iv)
approve, endorse or recommend any Alternative Proposal or any proposal that
could reasonably be expected to lead to an Alternative Proposal or (v) enter
into, continue or otherwise participate in any discussions or negotiations
(including furnishing any information) regarding any Alternative Proposal or
any proposal that could reasonably be expected to lead to an Alternative
Proposal. The Shareholder will, and will cause each of its Representatives to,
immediately cease and cause to be terminated any and all existing activities,
discussions or negotiations with any Person conducted heretofore with respect
to any Alternative Proposal.

  

  

4.4 Notice of Acquisitions. The Shareholder agrees to notify Parent as
promptly as practicable orally or in writing of the number of any additional
shares of Company Common Stock or other securities of the Company of which the
Shareholder acquires Beneficial Ownership on or after the date hereof.

  

  

4.5 Further Assurances. From time to time, at Parent's reasonable request and
without further consideration, the Shareholder agrees to cooperate with Parent
in making all filings and obtaining all consents of Governmental Entities and
third parties and to execute and deliver such additional documents and take
all such further actions as may be necessary or desirable to effect the
actions contemplated by this Agreement. Without limiting the foregoing, the
Shareholder hereby authorizes Parent and the Company to publish and disclose
in any announcement or disclosure required by the SEC and in the Proxy
Statement the Shareholder's identity and ownership of Covered Shares and the
nature of the Shareholder's obligations under this Agreement.

  

  

 

 

 

  

 

7  

  

 

 

 

  

  

ARTICLE V

  

  

MISCELLANEOUS

  

  

5.1 Termination. This Agreement shall terminate and be of no further force or
effect upon the earlier to occur of (a) the Effective Time; and (b) the
termination of the Merger Agreement in accordance with its terms.
Notwithstanding the foregoing, the provisions of this ARTICLE V shall survive
any termination of this Agreement without regard to any temporal limitation.
Neither the provisions of this Section 5.1 nor the termination of this
Agreement shall relieve any party hereto from any liability of such party to
any other party for any breach of this Agreement occurring prior to such
termination or expiration; provided that upon payment by the Company of the
Termination Fee and the Expenses, as applicable, to Parent pursuant to the
terms of the Merger Agreement, the Shareholder shall have no further liability
with respect to this Agreement or the transactions contemplated hereby or by
the Merger Agreement to Parent; provided further that nothing herein shall
release any party from liability for willful or intentional breach or fraud.

  

  

5.2 No Ownership Interest. The Shareholder has agreed to enter into this
Agreement and act in the manner specified in this Agreement for consideration.
The Shareholder shall be entitled to receive any cash dividend paid by the
Company with respect to the Covered Shares during the term of this Agreement.
Nothing in this Agreement shall be interpreted as (i) obligating any
Shareholder to exercise or convert any warrants, options or convertible
securities or otherwise to acquire Company Common Stock or (ii) creating or
forming a "group" with any other Person, including Parent, for purposes of
Rule 13d-5(b)(1) of the Exchange Act or any other similar provision of
applicable law.

  

  

5.3 Notices. All notices and other communications hereunder shall be in
writing and shall be deemed given if delivered personally, telecopied (upon
telephonic confirmation of receipt), on the first Business Day following the
date of dispatch if delivered by a recognized next day courier service or on
the third Business Day following the date of mailing if delivered by
registered or certified mail, return receipt requested, postage prepaid. All
notices hereunder shall be delivered as set forth below, or pursuant to such
other instructions as may be designated in writing by the party to receive
such notice:

  

  

 

 

 

  

 

8  

  

 

 

 

  

  

(a) if to Parent to:

  

  

Baxter International Inc.

  

One Baxter Parkway

  

Deerfield, Illinois 60015

  

Facsimile: (847) 948-2450

  

Attention: General Counsel

  

  

with a copy (which shall not constitute notice to Parent) to:

  

  

Kirkland and Ellis LLP

  

300 North LaSalle Street

  

Chicago, Illinois 60654

  

Facsimile: (312) 862-2200

  

Attention: R. Scott Falk, P.C.

  

Roger D. Rhoten

  

  

(b) if to the Shareholder, to:

  

  

____________________

  

c/o Synovis Life Technologies, Inc.

  

2575 University Avenue West

  

St. Paul, Minnesota 55114

  

Facsimile: (651) 642-9018

  

Attention: Chief Executive Officer

  

  

with a copy (which shall not constitute notice to the Shareholder) to:

  

  

 

Dorsey and Whitney LLP   

Suite 1500   

50 South Sixth Street   

Minneapolis, Minnesota 55402-1498   

Facsimile: (612) 340-2868   

Attention: Timothy S. Hearn

  

Jonathan Van Horn

 

 

 

 

 

 

  

  

5.4 Interpretation; Definitions. When a reference is made in this Agreement to
a Section or Schedule, such reference shall be to a Section or Schedule of
this Agreement unless otherwise indicated. The headings contained in this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement. Whenever the words "include,"
"includes" or "including" are used in this Agreement, they shall be deemed to
be followed by the words "without limitation." The words "hereof," "herein"
and "hereunder" and words of similar import when used in this Agreement shall
refer to this Agreement as a whole and not to any particular provision of this
Agreement. All terms defined in this Agreement shall have the defined meanings
when used in any certificate or other document made or delivered pursuant
thereto unless otherwise defined therein. The definitions contained in this
Agreement are applicable to the singular as well as the plural forms of such
terms and to the masculine as well as to the feminine and neuter genders of
such term. Any agreement, instrument or statute defined or referred to herein
or in any agreement or instrument that is referred to herein means such
agreement, instrument or statute as from time to time amended, modified or
supplemented, including (in the case of agreements or instruments) by waiver
or consent and (in the case of statutes) by succession of comparable successor
statutes and references to all attachments thereto and instruments
incorporated therein. Each of the parties has participated in the drafting and
negotiation of this Agreement. If an ambiguity or question of intent or
interpretation arises, this Agreement must be construed as if it is drafted by
all the parties, and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of authorship of any of the provisions of this
Agreement.

  

  

 

 

 

  

 

9  

  

 

 

 

  

  

5.5 Counterparts. This Agreement may be executed in counterparts, all of which
shall be considered one and the same agreement, and shall become effective
when one or more counterparts have been signed by each of the parties and
delivered to the other parties.

  

  

5.6 Entire Agreement. This Agreement constitutes the entire agreement and
supersedes all prior agreements and understandings, both written and oral,
among the parties with respect to the subject matter of this Agreement. This
Agreement is not intended to and does not confer upon any Person other than
the parties hereto any rights or remedies hereunder.

  

  

5.7 Governing Law; Consent to Jurisdiction; Waiver of Jury Trial.

  

  

(a) Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Minnesota, without giving effect to
any choice or conflict of law provision or rule (whether of the State of
Minnesota or any other jurisdiction) that would cause the application of the
laws of any jurisdiction other than the State of Minnesota.

  

  

(b) Exclusive Jurisdiction. Each of the parties hereto irrevocably submits to
the exclusive jurisdiction of the state or federal courts located in Delaware,
in any action or proceeding arising out of, or relating to, this Agreement,
irrevocably consents to the service of process by registered mail or personal
service and agrees that all claims in respect of the action or proceeding may
be heard and determined in any such court, and agrees not to bring any action
or proceeding arising out of, or relating to, this Agreement in any other
court unless and until the foregoing court renders a final order that it
lacks, and cannot acquire, the necessary jurisdiction, and either all appeals
have been exhausted or the order is no longer appealable. Each of the parties
hereto irrevocably waives, to the fullest extent permitted by Law, any defense
of inconvenient forum to the maintenance of any action or proceeding so
brought, any objection which it may have or hereafter have as to personal
jurisdiction, the laying of the venue of any such action or proceeding brought
in any such court and waives any bond, surety or other security that might be
required of any other party with respect thereto. Each party hereto agrees
that a final judgment in any action or proceeding so brought shall be
conclusive and may be enforced by suit on the judgment or in any other manner
provided by law or at equity.

  

  

 

 

 

  

 

10  

  

 

 

 

  

  

(c) Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT
OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS
AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY,
AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 5.7.

  

  

5.8 Amendment; Waiver. This Agreement may not be amended except by an
instrument in writing signed by Parent and the Shareholder. Each party may
waive any right of such party hereunder by an instrument in writing signed by
such party and delivered to the other party.

  

  

5.9 Remedies. Each of the parties hereto acknowledges and agrees that the
other party would be damaged irreparably in the event any of the provisions of
this Agreement is not performed in accordance with its specific terms or is
otherwise breached. Accordingly, the parties hereto agree that the other party
shall be entitled to an injunction or injunctions to prevent breaches of the
provisions of this Agreement and to enforce specifically this Agreement and
the terms and provisions hereof in any action instituted in any court in the
United States or in any state having jurisdiction over the parties and the
matter in addition to any other remedy to which they may be entitled pursuant
hereto.

  

  

5.10 Severability. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any rule of Law or public
policy, all other terms, conditions and provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic and legal
substance of the transactions contemplated hereby are not affected in any
manner materially adverse to any party. Upon such determination that any term
or other provision is invalid, illegal or incapable of being enforced, the
parties shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible in a mutually
acceptable manner in order that the transactions contemplated by this
Agreement may be consummated as originally contemplated to the fullest extent
possible.

  

  

5.11 Successors and Assign. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned, in whole or in part, by
operation of Law or otherwise by any of the parties without the prior written
consent of the other party, and any assignment without such consent shall be
null and void, except that Parent, upon prior written notice to the
Shareholder, may assign, in its sole discretion, any of or all its rights,
interests and obligations under this Agreement to any direct or indirect
wholly owned Subsidiary of Parent but no such assignment shall relieve Parent
of any of its obligations hereunder. Subject to the preceding sentence, this
Agreement will be binding upon, inure to the benefit of, and be enforceable
by, the parties and their respective successors and assigns.

  

  

 

 

 

  

 

11  

  

 

 

 

  

  

5.12 Action by Shareholder Capacity Only. Parent acknowledges that the
Shareholder has entered into this Agreement solely in its capacity as the
record and/or beneficial owner of the Covered Shares (and not in any other
capacity, including without limitation, any capacity as a director or officer
of the Company). Nothing herein shall limit or affect any actions taken by the
Shareholder or its Affiliate or designee, or require the Shareholder or its
Affiliate or designee to take any action or refrain from taking any action, in
each case, in its or his capacity as a director or officer of the Company, and
any actions taken, or the failure to refrain from taking any actions, by it or
him in such capacity as a director or officer of the Company (including
actions taken, or the failure to refrain from taking any action, as permitted
in Section 4.2 of the Merger Agreement) shall not be deemed to constitute a
breach of this Agreement.

  

  

[Remainder of this page intentionally left blank]

  

  

 

 

 

  

 

12  

  

 

 

 

  

  

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be signed
(where applicable, by their respective officers or other authorized Person
thereunto duly authorized) as of the date first written above.

  

  

 

     | SHAREHOLDER: |   
---|---|--- 
   |  |  |   
   |  |  |   
   |  

By:

  |  |   
   |  | Name: |   
   |  |  |   
   |  |  |   
   |  

BAXTER INTERNATIONAL INC.

  |   
   |  |  |   
   |  |  |   
   | By:  |  |   
   |  | Name: |   
   |  | Title: |   
 

 

  

  

 

 

 

  

   

  

 

 

 

  

  

SCHEDULE 1

  

  

OWNERSHIP OF EXISTING SHARES

  

  

  

    

Class

  |  |  

Number of

  

Existing Shares

   
---|---|--- 
  

  

Company Common Stock

  |  |   
 

  

  

 

 

 

  

   

  

 

 

 

 

  

  

 

 

EXHIBIT B

 

  

  

AMENDED AND RESTATED

  

  

ARTICLES OF INCORPORATION 
 

  

  

OF

  

  

SYNOVIS LIFE TECHNOLOGIES, INC.

  

  

ARTICLE ONE

  

  

The name of the corporation is Synovis Life Technologies, Inc.

  

  

ARTICLE TWO

  

  

The address of the corporation's registered office in the State of Minnesota
is 2575 University Avenue, St. Paul, Minnesota, 55114-1024.

  

  

ARTICLE THREE

  

  

The nature of the business or purposes to be conducted or promoted is to
engage in any lawful act or activity for which corporations may be organized
under the Business Corporation Act of the State of Minnesota.

  

  

ARTICLE FOUR

  

  

The total number of shares of stock which the corporation has authority to
issue is 100 shares of Common Stock, with a par value of $.01 per share.

  

  

ARTICLE FIVE

  

  

The corporation is to have perpetual existence.

  

  

 

 

 

  

   

  

 

 

 

  

  

ARTICLE SIX

  

  

In furtherance and not in limitation of the powers conferred by statute, the
board of directors of the corporation is expressly authorized to make, alter
or repeal the by-laws of the corporation.

  

  

ARTICLE SEVEN

  

  

Meetings of shareholders may be held within or without the State of Minnesota,
as the by-laws of the corporation may provide. The books of the corporation
may be kept outside the State of Minnesota at such place or places as may be
designated from time to time by the board of directors or in the by-laws of
the corporation. Election of directors need not be by written ballot unless
the by-laws of the corporation so provide.

  

  

ARTICLE EIGHT

  

  

Any action required or permitted to be taken at a meeting of the Board of
Directors may be taken by written action signed by all of the directors or, in
cases where the action need not be approved by the shareholders, by written
action signed by the number of directors that would be required to take the
same action at a meeting of the Board of Directors at which all directors were
present.

  

  

ARTICLE NINE

  

  

A director of the Corporation shall not be personally liable to the
Corporation or its shareholders for monetary damages for any losses, claim,
damages or liabilities arising out of or in connection with such person's
actions as a director, except for any such loss, claim, damage or liability
caused by the negligence or willful misconduct or such person or any other
director of the Corporation. Any repeal or modification of this ARTICLE NINE
shall not adversely affect any right or protection of a director of the
corporation existing at the time of such repeal or modification.

  

  

ARTICLE TEN

  

  

The corporation reserves the right to amend, alter, change or repeal any
provision contained in these amended and restated articles of incorporation in
the manner now or hereafter prescribed herein and by the laws of the State of
Minnesota, and all rights conferred upon shareholders herein are granted
subject to this reservation.

     

    

 

 

 

     '

